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The interaction of a wide range of CD macrocycles with three groups of chiral analytes 
was examined using FSCE, NMR spectroscopy and several different HPLC 
methodologies. Novel enantiomeric separations of the analytes were observed in many 
instances.
Of all the HPLC methods examined, chiral resolution was greatest in the polar organic 
mode especially with the propranolol analogues. The influence of analyte / CD structure 
on enantio-resolution was discussed, along with the role played by the relevant inherent 
chromatographic mechanisms. A unique size dependent, steric repulsive effect was 
proposed to explain the observed %CRF and k' values in the polar organic mode. 
Resolution was generally very poor using CDs as mobile phase additives. The low 
chromatographic efficiency of several of these methods was suggested as a major factor 
in their inability to show significant chiral resolution. CD immobilisation onto a solid 
chromatographic support was found to engender different selectivities of the CDs towards 
the analytes when compared to the results obtained in the polar organic mode or when 
using CDs as mobile phase additives.
FSCE was found to provide higher chiral separations than HPLC for nearly all the 
analytes. CDs which had not provided chiral separation of certain analytes in HPLC, 
were then seen to do so in FSCE. This was generally linked to the much higher 
separation efficiencies obtained in the FSCE experiments.
There was no continuous direct relationship between Kf values, FSCE and HPLC 
analysis times/chiral resolution values and NMR generated analyte chemical shifts/signal 
splitting, when examining the same set of compounds in the presence of different CDs.
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Drug stereoisomerism is becoming increasingly recognised as an issue having clinical, 
research and regulatory implications. However, chirality is also an intricate and 
fundamental part of life and is not merely confined to the laboratory. Hormones, 
enzymes, proteins and so on, selectively interact with chemical messengers on a 
stereochemical basis in nearly all living systems. An understanding of chirality is vital 
to an understanding of many of the processes which underlie nature itself.
1.1.1. The Discovery of Stereochemistry.
The phenomenon of stereoisomerism was discovered via the isolation of two almost 
identical substances from the tartars deposited by maturing wine. It was the presence of 
small hemihedral facets on the crystals of racemic sodium ammonium tartrate that led 
Pasteur (Pasteur 1848, cited in Armstrong 1984) to the observation that the crystals could 
be divided into two categories. The major product (+)-tartaric acid, was found to be 
dextrorotatory to polarized light, whereas the minor product, racemic or paratartaric 
acid, proved to be optically inactive. Pasteur was able to physically separate these 
isomers and concluded that the individual molecules of (+ )  and (-) tartaric acid were 
structurally 'dissymmetric' i.e. related as non-superimposable mirror image forms. It was 
van't Hoff and Le Bel, both independently in 1874, (cited in Thorbum Bums 1994) who 
put forward the stereochemical theory associated with isomerism, based on the concept 
that carbon (and certain other nuclei) could be associated with four different groups such 
that it was possible to have two mirror images centered around an asymmetric atom.
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1.1.2. Stereochemical Definition and Nomenclature.
The three dimensional shape of an organic molecule depends upon the hybridization state 
of its constituent carbon atoms. When it proves impossible to superimpose the figure of 
a molecule onto its mirror image, the molecule is dissymmetric or chiral (from the Greek 
cheir meaning hand). The commonest cause of molecular chirality is the presence of an 
asymmetric carbon atom (silicon, nitrogen, phosphorous and sulphur atoms are possible 
alternatives) having four different groups linked to the same atom. There are two 
possible arrangements of these groups which will give rise to a pair of molecules which 
are related to one another as object to mirror image, variously described as enantiomers, 
enantiomorphs or antipodes. Enantiomers have identical chemical properties except 
toward optically active reagents.
Fischer (cited in Casy 1993a) introduced a convention to designate absolute configuration 
using the small letters D and L to denote the different isomers. When Bijvoet et al. 1951 
determined the absolute configuration of a rubidium salt using X-ray crystallography, it 
transpired that the configuration of D-glucose, arbitrarily assigned by Fischer, was by 
chance correct. The D/L system is still used for amino acids, glyceraldehyde and related 
carbohydrates. However it is not applicable to chiral molecules which possess either an 
asymmetric axis or plane and so Cahn, Ingold and Prelog 1956 introduced a new system 
based on three consecutive operations:
1. The groups around a centre of chirality are ranked according to a set of sequence rules 
of which atomic number is the prime consideration.
2. The attached groups, ordered A >  B >  C >  D, are viewed so that D (the lowest priority) 
is seen pointing backwards, away from the viewer.
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3. The other groups are then counted starting from A to C so that if this operation is in 
a clockwise direction the designation is R (Rectus) or if it follows an anti-clockwise 
movement, S (Sinister).
Using this procedure it is possible to systematically designate enantiomers where the 
existence of chirality is not due to the presence of an asymmetric centre. For example, 
allenes may be readily derivatised to generate chiral molecules with a chiral axis. The 
substitution of a hydrogen atom may be sufficient to invoke chirality (Allenmark 1991a). 
Due to the molecular rigidity of the molecule caused by the double bonds, 
interconversion between the two forms of the structure is prevented and so stable 
enantiomers arise.
Hindered rotation around a central bond caused by steric forces may also lead to the 
formation of stable enantiomers, as exemplified in the case of atropisomers (a form of 
conformational isomers). Certain substituted biaryls may exist as atropisomers due to the 
steric constraints on rotation engendered by their projecting groups (see Fig. 1.1., p. 5).
Roussel and Favrou 1993 have demonstrated the enantiomeric separation of the 
atropisomers of some substituted A-arylthiazolinethione compounds using y-CD in 
HPLC, Mannschreck et al. 1984 were able to resolve the atropisomers of methaqualone, 
a hypnotic agent, using a triacetylcellulose stationary phase in HPLC and Casy 1993 used 
y-CD to resolve the atropisomers of telenzepine, a muscarinic antagonist, in NMR.
Steric crowding in a molecule may also give rise to molecular distorsion and hence 
chirality e.g. helicenes are condensed aromatic hydrocarbons which give rise to right and 
left handed helical forms (denoted M (-) or P (+)). The energy barrier between these 
forms is high enough to permit their resolution (Allenmark 1991a).
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Figure 1.1. Atropisomerism of 0 ,0  -dinitrodiphenic acid.
Chiral molecules then, possess either a chiral centre, a chiral axis or planar chirality. 
However some molecules which contain chiral centres are not themselves optically 
active. 2,5-dimethyltetrahydrofuran is an example (Fig. 1.2., p.6). The carbon atoms 
denoted 1 and 2 have four different ligands attached but there is an axis of symmetry 
within the molecule (dotted line) and therefore the compound’s mirror image is 
superimposable, rendering it optically inactive. Such a molecule is known as a meso 
compound.
Diastereoisomers or diastereomers are stereoisomers which are not enantiomers of each 
other. They may arise when a molecule has more than one stereogenic centre e.g. a 
molecule with two asymmetric carbons could have N (number of optical forms) =  2n 
stereoisomers, where n is the number of chiral sites. Isomers among the group which 
are not related as object to mirror image are described as diastereoisomers. Although a 
molecule may have only one enantiomer, it may have several diastereoisomers. However, 
two stereoisomers cannot be both enantiomers and diastereoisomers of each other 
simultaneously (Ahuja 1991). Diastereoisomers differ in their physical interactions with 
achiral media and may be separated e.g. on the basis of differences in their solubilities 
or chromatographic retentions on achiral packings.
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1 .1 ,3 . Implications of,Chirality inJUYing System s
Many naturally occurring compounds exist in predominantly one chiral form. This may 
be due to small energy differences in their stability leading to isomeric enrichment i.e. 
the formation of one enantiomer is favoured over the other (Kondepudi and Nelson, 
1985). For example (-) morphine is obtained from the juice of certain poppies and (+)- 
digitoxin may be extracted from the leaf of the foxglove plant, Digitalis purpurea. In 
contrast, chemical synthesis in the laboratory generally leads to the production of 
optically inactive racemic mixtures (an equal ratio of enantiomers whose rotation of plane 
polarised light exactly cancels one another leaving a beam of polarised light unchanged 
from its original plane).
A large proportion of the thousands of chemicals in use today are chiral. Although more 
than 50 % of commercial drugs are chiral, less than half of these are marketed in an 
enantiomerically pure form and only 10% of synthetic drugs are available as pure 
enantiomers (Parker 1991). Because of the intrinsically chiral basis of many 
pharmacological interactions it is vital to assess the impact of an optically active 
xenobiotic on target organisms. Stereoselectivity in both the action and the metabolic 
conversion of bioactive chiral agents necessitates a full understanding of their 
pharmacodynamic and pharmacokinetic properties. Certain non-chiral compounds may
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also be converted to chiral ones following metabolic action. These prochiral agents may 
then exhibit differing effects in vivo due to their ‘acquired* chirality e.g. phenytoin 
undergoes metabolic para hydroxylation of one of its phenyl substituents to yield a chiral 
metabolite and the antihypertensive agent debrisoquine may be converted to its chiral 4- 
hydroxy derivative following metabolic conversion (Casy 1993a).
Pharmacokinetics is concerned with the absorption, distribution, metabolism and 
excretion of xenobiotic compounds whereas pharmacodynamics pertains to the action of 
such agents on target tissues. Pharmacodynamics comprises the receptor-effector 
coupling, that sequence of biological and biophysical events which is initiated by the 
receptor activation and leads to the end effect. The interaction is based on a chemical and 
thereby implicitly steric process between e.g. drugs and their specific receptor sites. 
Enantiomers may differ not only in their activity but also in their action and may even 
behave anatgonistically e.g. (-)-isopropylnoradrenaline acts as an agonist on otj- 
adrenergic receptors in rats while the (+)-isomer acts as a competitive antagonist with 
equivalent affinity (Ariens 1971).
Russell and Hills 1971 were among the first to demonstrate how enantiomers can induce 
different sensations in vivo. They showed how D-aspartamine tasted sweet while L- 
aspartamine was tasteless and that 4R-carvone had an odour of caraway while 4S-carvone 
smelt of spearmint. This difference in our perception of enantiomers is thought to be 
largely a result of the direct chiral discriminating action by receptor proteins, which 
means that the chiral binding site of the receptor preferentially binds one of the 
enantiomers (Allenmark 1990). The ratio of enantiomeric activity is known as the 
eudismic ratio and the isomers may be termed eutomers or distomers respectively, 
dependent on whether they produce the desired effect or are in some sense ‘inactive’, 
which may be manifested in various ways e.g.:
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• The enantiomers may have opposite effects not involving competitive antagonism
e.g. in DMBB, a barbiturate, the S(-)-isomer acts as a depressant, the R(-f )- 
isomer as a convulsant and rac-DMBB as a convulsant (Biich et al. 1973).
• The distomer may antagonise a side-effect of the eutomer. (+)-indacrinone is a
diuretic and creates a side-effect of uric acid retention which is antagonised by 
the (-)-isomer, a uricosuric (Tolbert et al. 1981).
• The enantiomers may produce different effects each of which may be of
therapeutic value e.g. davron is 2R,3S-(+)-dextropropoxyphene, an analgesic, 
whereas norvad (note the inversion of the trade names!) is 2S,3R-(-)- 
levopropoxyphene its enantiomer, which acts as an antitussive (Drayer 1986).
If a chiral agent can be optically resolved there is the possibility of studying the 
behaviour of its enantiomers in vivo and therefore to generate the necessary data for its 
market approval. EU guidelines (CPMP, 1988) state that in the case of a racemic drug 
already on the market, any application for marketing one of the enantiomers must be 
accompanied by full documentation, thus regarding it as a completely new substance. The 
FDA already requires information on stereochemical drug development (Fassihi 1993). 
If such information had been required in the late 1960's, it may have helped to prevent 
the thalidomide disaster. It has been reported that the teratogenic activity of thalidomide 
may reside exclusively in the S-isomer (Blaschke et al. 1979).
The different behaviour of enantiomers in biological systems has created a demand for 
analytical methods to determine the enantiomeric composition or purity of xenobiotics 
or their metabolites. Metabolism of enantiomeric drugs is exemplified in the case of 
propranolol a beta-adrenergic blocking agent ( which has been examined in this thesis in 
sections 3.3., 4.3. and 5.3.). The (-)-isomer is 100-times more effective than the (+ )- 
isomer and the oral clearance rate of the (+)-isomer is 40-50% higher (Coltart and Shand
1970 and Lindner et al. 1989). Other examples of chiral agents with clear differences in 
affinity and intrinsic activity are the adrenergic agents, some of which have also been 
examined in this thesis (the phenethylamines in sections 3.2., 4.2. and 5.2.). Table 1.1. 
(Allenmark 1991a) shows the ratios of (-)/(+) enantiomers for two phenethylamines 
related to their intrinsic activity (maximal effect as fraction of that of (-)-isoprenaline) 
and pD2  value (negative log of the concentration producing 50% of the maximal effect 
of the compound).
Table 1.1. Ratios (-)/(+) of enantiomers for pD2 values and intrinsic activity. See
text for explanation of parameters.
Compound (-)/(+) pD2 (-)/(+) intrinsic activity
Isoprenaline
Pj-receptors 8.45/7.42 1.00/0.96
P2 -receptors 7.42/5.87 1.00/1.04
Salbutamol •
Pl-receptors 6.17/4.47 0.51/0.56
p2 -receptors 6.20/3.75 1.00/0.96
1.2. Cvclodextrins (CDsl- Structure and Properties.
The analytical methods used in this thesis have employed CDs as the chiral selector for 
different groups of optically active compounds. Many other chiral agents besides CDs 
have been investigated for their ability to provide enantiomeric resolutions. Section 1.3. 
details some of these chiral selectors and the different techniques in which they have been 
utilised.
As early as 1908 Schardinger discovered that new crystalline carbohydrates could be 
formed during the degradation of starch by the micro-organism Bacillus macerans
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(Allenmark 1991b). These substances were dubbed Schardinger dextrins and are now 
commonly known as cyclodextrins (CDs). The three most common and naturally 
occurring CDs are a-, p- and y-CD with 6, 7, and 8 a-D-(+)-glucose units respectively, 
joined together by a-(l,4) linkages forming a hollow truncated cone with an axial cavity 
(see Fig. 1.3.). CDs with more than 8 glucose units have been reported but their stability 
is low (Duchene et al. 1987), The external face of each macrocycle is marked by 
hydroxyl groups found on either the wider secondary opening in the 2 and 3 positions 
or on the narrower primary opening in the 6 position, making the exterior hydrophilic 
in character. The internal face of the CDs is by contrast relatively hydrophobic due to 
the presence of the glucosidic oxygen atoms. Table 1.2. gives some physico-chemical 
properties of the three parent CDs.
Figure 1.3. Schematic representation of CD molecule. See Table 1.2. for details.












water at 25°C 
(g/100 ml)
a 5.7 13.7 7.8 174 972 + 150 14.5
P 7.8 15.3 7.8 262 1135 + 162 1.8
Y 9.5 16.9 7.8 427 1297 + 177 23.2
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The low aqueous solubility of P-CD has been attributed to its formation of aggregates 
having a herring-bone like structure, which reduces the ability of the macrocycle to 
hydrogen-bond with water molecules and hence decreases its solubility (Coleman et al. 
1992). The aqueous solubility of p-CD depends on the nature and concentration of any 
added organic modifier. MeCN produces the greatest increase in solubility, up to 20 % 
v/v, while MeOH steadily reduces p-CD and y-CD solubility to < 0 .7  g/100 ml at 20 
% v/v (Taghvaei and Stewart 1991 and Chatjigakis et al. 1993). Urea and NaOH have 
also been shown to alter the solubility of a-, p- and y-CD (Pharr et al. 1989).
1.2.1. Modified CDs.
Most CD derivatives are highly water soluble, generally more so than the parent CD 
from which they are produced. Methyl CDs are available with varying degrees of 
substitution around the CD rim e.g. either all C2 and C6 groups are methylated to give 
the dimethyl CDs or all the hydroxyls are methylated (C2, C3 and C6) to give the 
trimethyl CDs, with water solubilities of 57 and 31 g/100 ml respectively. However one 
disadvantage is their decrease in solubility with temperature. The hydroxypropyl CDs 
are also highly water soluble, >50 g/100 ml, but it is impossible to selectively substitute 
the CD hydroxyl groups as the hydroxyl reactivity changes as the derivatization reaction 
proceeds (Duchene and Wouessidjewe 1990). The result is a mixture of CD derivatives. 
Substitution of CDs at the hydroxy groups at the 3-position of the glucose unit is well 
known to be more difficult than substitution at the 2- and 6-positions (Deege et al. 1993). 
Unlike the methyl derivatives however, the solubility of these CDs does not decrease 
with temperature as their dissolution is endothermic. Hydroxethyl CDs closely resemble 
the hydroxypropyl derivatives and have comparable water solubilities, 50 g/100 ml, 
(Konishi et al. 1994).
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Many other CD derivatives have been produced and the application of some of them to 
the field of enantio-separations have been described in sections 3.1.1., 4.1.6. and 5.1.6.
It2t2Jiasis of StereQchemical lnteraction with CDs.
Dagleish 1952, who was examining the chiral separation of aromatic amino acids using 
paper chromatography, is credited with first having considered the three-point interaction 
concept in chromatographic separation. In order for either of two enantiomers (‘guest’ 
molecules) to have a stronger interaction with a chiral selector (the ‘host’), it is necessary 
that they interact with the chiral selector in such a way that of three possible points of 
interaction between them, only one enantiomer can fulfill all three i.e. at least one of the 
interactions is stereochemically based. This results in its preferential interaction (in the 
case of Dagleish this was evidenced by a stronger retention of one enantiomer on the 
chiral cellulose adsorbant) which may allow for the physical separation of the 
enantiomers. The forces which produce these host-guest interactions may be repulsive 
as well as attractive (Davankov and Kurganov 1983). When the sum total of all possible 
interactions are accounted for, there must be a slight difference (a few calories) in the 
association of one enantiomer over the other if separation is to be achieved (Boehm et 
al. 1988).
CDs are themselves chiral e.g. p-CD has 35 chiral centres and so they are able to interact 
with other chiral compounds under stereospecific conditions. Street 1987 has shown that 
the polarity of CD cavities is similar to that of Ji-octanol. As a result of this apolar cavity 
CDs can include other apolar/non-polar molecules of appropriate dimensions by virtue 
of hydrophobic interactions. No bonds are involved in the complex formation which is 
driven by hydrophobic forces when the CD and its guest are present in aqueous media. 
In examining a range of substitued aromatic compounds and common organic solvents 
in the presence of P-CD, Park and Nah 1994 concluded that the formation of inclusion
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complexes was dominated by non-polar (hydrophobic) dispersive interactions between 
the CD cavity and the solute and that hydrogen-bond formation played only a minor role. 
They also found that increasing guest dipolarity and hydrogen-bond acceptor basicity 
decreased the complex stability as the guest was then more likely to hydrogen-bond with 
water, which is more dipolar and hydrogen-bond acidic than p-CD, Inclusion complex 
formation may be influenced by other factors such as van der Waals interactions, the 
release of high energy water from the CD cavity and possibly a change in ring strain 
upon complexation (Boehm et al. 1988 and Krustulovic 1989b).
CDs also possess large dipole moments and therefore electrostatic effects may play an 
important role in substrate binding and orientation within the CD cavity (Sherrod 1992). 
Sakurai et al. 1990 measured the dipole moment of CDs and found that it increased with 
increasing ring size in the order a-CD < p-CD < y-CD and that directionally it ran 
from the secondary opening to the primary opening at an angle to the cavity axis. If guest 
molecules also possessed a dipole moment they may be more or less likely to interact 
with the CD depending on the direction of the dipole moment and its strength. This has 
been supported by other work e.g. Yoshida and Hayashi 1994 found that certain azo 
guest molecules could complex with a-CD dependant on the nature of the charged group 
on the guest, which influenced the orientation and/or direction of inclusion complexation.
Under reversed phase conditions hydrogen-bonding between the hydroxyl groups of CDs 
and other polar groups of guest molecules e.g. amines and hydroxyls, coupled with 
hydrophobic interactions, is believed to be the cause of enantioselection. These multiple 
interactions provide the basis of the three-point interaction model mentioned previously. 
A two point interaction between the CD and guest, such as an electrostatic attraction and 
a hydrogen bond, might be sufficient for chromatographic separation due to differential 
adsorption of the transient diastereomeric adducts on the achiral stationary phase 
(Martens and Bhushan 1992) providing the necessary third point of interaction. 
Furthermore, if one of the interactions defines an axis rather than a point e.g.
interactions between two aromatic rings, only two interactions may be necessary for 
chiral resolution (Krstulovic 1988). Section 3.1.5. details the equilibria involved in CD 
modified reversed phase chromatography.
Under ‘polar organic’ conditions (see section 3.1.3.) the mode of analyte:CD interaction 
is less well understood. Inclusion complexation is not thought to occur due to the high 
amount of organic modifier in the mobile phase which competes with the guest molecule 
for inclusion into the CD cavity (Chang et al. 1986). Various models of the analyte:CD 
interaction have been proposed, where the analyte sits like a lid over the CD cavity and 
interacts via hydrogen-bonding with the external hydroxyl groups of the CD (Armstrong 
et al. 1992 and Zukowski et al. 1993).
1.2.3. Uses of CDs.
CDs have numerous .applications in many scientific fields and industries, especially in 
the pharmaceutical and healthcare area. This is influenced by the fact that oral 
administration of a-, p- or y-CD does not present any adverse toxicity effects and that 
long term administration does not cause any significant change in the internal organs. 
However, their parenteral administration is not recommended due to the possibilty of 
ulceration and nephrotoxic and haemolytic effects (Szejtli 1987). They are also used 
extensively in catalysis studies, agrochemicals and the food industry.
CDs have been shown to encapsulate a range of volatile substances so that in cosmetics 
they are used in deodorants to trap unpleasant body odours (Itaro 1987), to complex 
excreted fatty acids so reducing acne (Unilever 1981) and in breath fresheners to remove 
odours such as fish and cigarettes (Asama 1980). They have been used in cooking to 
decrease the odour of mutton (Nagano 1980), raw fish (Goku 1974) and the smell of long 
term stored rice is reduced by initially cooking it with P-CD (Takeda 1981). Many gases
14
can be complexed by a-CD, the smallest natural macrocycle, to form solid crystalline 
products. Cramer and Henglein (cited in Duchene and Wouessidjewe 1990) were the first 
to demonstrate this in the 1950's with e.g. xenon, propane and oxygen. Ethylene, which 
is important in the ripening process of plants, has been included in CDs and sprayed on 
crops to increase their ripening and krypton 85 has been included by a-CD for use in car 
batteries (Akad Wissenschaft 1979).
CDs can also be used to stabilise certain compounds by encapsulating and so protecting 
them from potentially degrading external conditions e.g. heat, light and oxygen. 
Mitomycin antibiotics are protected from degradation upon complexation with y-CD, 
which protects a labile substituent on the antibiotic by encapsulating that portion of the 
molecule and shielding it from external interactions (Bekers et al. 1991). Oils and 
perfumes have been encapsulated using CDs and shown to remain stable in a dry form 
for >  1 year (Harangi and Nanasi 1994), vitamins A, D, E and K are more resistant to 
oxidation when complexed by p-CD (Szejtli et al. 1980b) and pyrethroid insecticides, 
which are sensitive to UV and oxygen, can be stabilised by inclusion with P-CD 
(Yamamoto et al. 1976). CDs may also improve the solubility of some pharmaceutical 
compounds such as flurbiprofen, which can be complexed by y-CD (Otagiri et al. 1983). 
However, it is necessary to have a low stability constant between the drug and the CD 
as well as an increase in aqueous solubility of the complex, to improve the bioavailability 
of the drug. Sometimes the increase in bioavailability is such that it is possible to propose 
a decrease in the dose administered (Uekama et al. 1983).
1.3. Enantiomeric Separations.
There are a wide variety of analytical methods employing chiral selectors other than 
CDs, which have been used to separate, quantify and identify enantiomeric compounds, 
as described in the following sections.
15
1.3.1. Enantiomeric Separations in HPLC.
Separations may be performed either by using chiral stationary phases or by dissolving 
optically active reagents in the mobile phase and employing achiral column packings. 
There are a number of synthetic chiral stationary phases in HPLC based on hydrogen- 
bonding, 7U-7T interactions, dipole stacking and electrostatic attractions. These so called 
‘Pirkle phases* (after their inventor William Pirkle) are prepared by reacting the ex- 
amino group of e.g. (R)-phenylglycine with 3,5-dinitrobenzoyl chloride and attaching the 
product to aminopropyl fiinctionalised silica (Pirkle et al. 1984). They have been used 
to separate the enantiomers of a number of compounds e.g. Wainer et al. 1984 separated 
the enantiomers of a-methylarylacetic acid anti-inflammatory drugs, Nicoll-Griffith 1987 
resolved the enantiomers of ibuprofen and Lienne et al. 1989 resolved the enantiomers 
of albendazole sulfoxide, an anthelmintic drug. The only problem with these types of 
stationary phases is that analytes frequently require derivatization (Krstulovic 1988).
Chiral ions may be added to the mobile phase for the optical separation of analytes in 
HPLC. Pettersson and No 1983 and Pettersson 1984 were able to separate the 
enantiomers of chiral carboxylic acids using cinchona alkaloids as chiral counter ions and 
Pettersson and Schill 1981 used (+)-10-camphorsulphonic acid to resolve some amino- 
alcohols. Metal complexes have been used in mobile phases creating the technique of 
chiral ligand exchange. Generally an amino-acid is immobilised on the stationary phase 
and in the presence of a metal ion dissolved in the mobile phase analytes form 
diastereomeric complexes of opposite configuration which are then resolved. Davankov 
pioneered this method in the late 1960's (Krstulovic 1988) and it has been modified by 
others more recently e.g. Oi et al. 1992 used novel N,S-dioctyl-(D)-penicillamine as a 
stationary phase with copper (II) ions in the mobile phase to resolve the enantiomers of 
more than twenty amino-acids.
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Wulff and Minarik 1990 used optically active imprinted polymeric sorbents to 
successfully resolve the enantiomers of a-phenylmannoside. The shape of cavities in the 
sorbent and the spatial arrangement of interactive groups within these cavities allowed 
chiral recognition and hence chromatographic resolution to occur. Cellulose based 
columns such as ‘chiralcel OD’ can be used in the normal phase chromatographic mode 
to resolve enantiomers e.g. Shah and Maryanoff 1991 separated the enantiomers and 
diastereoisomers of pyrroloisoquinoline antidepressants, while Castellani et al. 1992 
produced novel urea/formaldehyde based gels with copolymerised L-leucinamide to 
separate a series of organic acid racemates.
Immobilized proteins such as acid glycoprotein (AGP), bovine serum albumin (BSA) 
and ovomucoid (OVM) are commonly are employed as chromatographic supports in 
chiral chromatography. Analytes may be separated as a result of stereospecific binding 
to certain sites on the protein. Many analytes have been resolved by various workers 
using AGP columns e.g. Hermansson 1989 (bupivacain and ephedrine), Noctor et al. 
1990 (oxaminquine) and Schill et al. 1986a (cocaine and methadone). BSA has been 
shown to resolve the enantiomers of ketoprofen (Andersson and Allenmark 1989), 
oxazepam and benzoin (Erlandsson and Nilsson 1989) and temazepam (Thompson et al.
1989). OVM based packings have been used to chirally resolve propranolol (Haginaka 
et al. 1990), chlorprenaline (Miwa et al. 1987) and abscisic acid (Okamoto and 
Nakazawa 1990).
1.3.2. Enantiomeric Separations in Capillary Electrophoresis.
Host-guest complexations have also been carried out with crown ethers using FSCE. 
These are macrocyclic polyethers containing l , 4 -dioxabutan(-0 -CH2 -CH2 -0 -) units and 
they are able to form selective complexes with a variety of inorganic and organic cations 
(Snopek et al. 1992). The first reported separation in FSCE was by Kuhn et al. 1992a
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who separated racemic amino-acids using 18C6-tetracarboxylic acid. The carboxylic acid 
groups on the crown ethers are thought to affect chiral resolution through the formation 
of a chiral barrier to analyte entry or perhaps via electrostatic interactions between the 
host and guest (Kuhn et al. 1992b). Snopek et al. 1991 also used 18C6-tetracarboxylic 
acid to effect the enantio-resolution of a group of primary amines e.g. catecholamines, 
naphthylethylamines and aromatic amino-acids.
Chiral surfactants, which form micelles above certain concentrations, have also been 
used to resolve chiral compounds e.g. Otsuka and Terabe 1990 used digitonin/sodium 
dodecylsulphate to separate racemic PTH-amino acids, Dobashi et al. 1989 separated N- 
acetylated amino acid isopropylesters with sodium N-dodecanoyl-L-valinate and Nishi 
et al. 1989 used sodium taurodeoxycholate and sodium cholate to separate chiral 
binaphthyl derivatives.
Chiral ligand exchange is a method applicable to enantio-separation in capillary 
electrophoresis. It involves the formation of mixed ternary chelate complexes, consisting 
of a chiral bifunctional ligand, a transition-metal ion and the chiral analyte. It may be 
applied to molecules with two polar groups that are at. a proper distance from each other 
so that they act as ligands for the central transition-metal ion (Snopek et al. 1992). 
Gassman et al. 1985, Gozel et al. 1987 and Gozel and Zare 1988 have used this 
technique to separate the enantiomers of dansylated amino acids by producing copper(II) 
ions/L-histidine or aspartame complexes, which then interact with the amino acid 
derivatives to form diastereoisomeric ternary chelates having different stability constants. 
This affects their migration order which may then lead to their separation.
Proteins and peptides have also been successfully used as buffer additives in FSCE for 
the resolution of many chiral compounds. Their mode of interaction is not fully 
understood as they possess multiple interaction sites which may cause enantio- 
discrimination via a variety of mechanisms e.g. hydrophobic interactions, hydrogen-
bonding, steric forces etc. Bovine serum albumin has been used for the separation of 
leukoverin (Barker et al. 1992), pindolol, promethazine and warfarin have been 
examined using a range of protein additives - ovomucoid, bovine serum albumin, 
cellulase and orosomucoid, (Busch et al. 1993), a variety of P-blockers including 
propranolol have been chirally resolved using cellulase (Valcheva et al. 1993) and amino 
acids and indole lactic acid were optically separated with human serum albumin 
(Vespalec et al. 1993). Bimbaum and Nilsson 1992 used bovine serum albumin cross- 
linked with gluteraldehyde for the separation of trytophan enantiomers. This technique, 
called capillary gel affinity electrophoresis, suffers however from the problem of 
reproducibily preparing narrow gel filled capillary columns. Vancomycin, a peptide and 
antibiotic agent, has been dissolved in buffers and used as a chiral selector for the 
separation of dipeptides (Carpenter et al. 1992).
1.3.3. Enantiomeric Separations in NMR.
The determination of enantiomeric purity using NMR requires the use of a chiral 
auxiliary that converts the mixture of enantiomers into a diastereoisomeric mixture. The 
resonances of diastereoiosmers, of certain nuclei, are anisochronous and thus give rise 
to different chemical shift values. Chiral lanthanide shift reagents, chiral solvating agents 
and chiral derivatising reagents are frequently used to enable chiral discrimination in 
NMR.
Derivatisation of enantiomers is commonly used for chiral purity determination. MPTA, 
a-methoxy-a-(trifluoromethyl)phenylacetic acid, has been widely used for the NMR 
examinations of chiral amines and alcohols (Williams et al. 1990 and Nieduzak and Can-
1990). Baker et al. 1989 used (S)-methyl mandelate to derivatise carboxylic acids and 
Kato 1990 used a binaphthyl derivative in the presence of 1-methylimidazole to give 
diastereoisomers of a range of chiral alcohols. Chiral lanthanide reagents form weak
19
complexes with a large variety of organic compounds and cause their signals to shift (up 
or downfield) by a magnitude dependant mainly upon the distance between the nuclei of 
interest and the lanthanide group. Europium, praseodymium and ytterbium complexes 
have been widely used to induce shifts in a range of chiral sulfoxides, carboxylates and 
aromatic acids (Guanti 1990). Chiral solvating agents form diastereoisomeric solvation 
complexes with solute enantiomers via rapid reversible equilibria in competition with the 
bulk solvent. Non-polar solvents tend to maximise the observed signal shifts while more 
polar solvents tend to solvate the analyte and any induced chemical shift changes tend to 
zero (Parker 1991). (R)-2-naphthylethylamine has been used to cause chemical shifts of 
chiral carboxylic acids (Aitken and Gopal 1990) and l-(9-anthryl)-2,2,2-trifluoroethanol 
has been widely employed to examine lactones, ethers and oxaziridines (Pirkle and 
Adams 1980, Pirkle and Boeder 1977 and Pirkle and Rinaldi 1977).
1.3.4. Other Methods of Enantiomeric Analysis.
X-ray crystallography, which was first used by Bijvoet et al. in 1951 to determine the 
absolute configuration of a rubidium salt, provides the means to uniquivocally assign the 
absolute configuration of chiral molecules. It relied on the interpretation of an anomalous 
dispersion effect of the X-rays caused by heavy atoms present in a crystal lattice of the 
sample. Modern computerized diffractometers have negated the requirement for the 
addition of heavy atoms and improved the speed and accuracy of the technique. Examples 
of central chirality (Bijvoet et al. 1951), axial chirality (Akimoto et al. 1986) and planar 
chirality (Vogtle et al. 1983) have been studied and determined by X-ray analysis.
Infrared spectrophotometry is a principal identification test in specification and 
pharmacopoeial standards. The spectra of enantiomers and a racemic compound most 
often diverge due to the fact that the environment of one molecule in the crystal of the 
enantiomer differs from that of the corresponding molecule in the racemic compound
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(S0 rensen 1990). If the optical activity of a compound is measured and plotted as a 
function of the wavelength, an optical rotatory dispersion (ORD) curve is obtained. If no 
chromophore is present the optical rotation will continuously decrease with increasing 
wavelength and a plain curve is obtained. However, if  a chromophore does absorb within 
the spectral width of the measurement a Cotton effect occurs, where the curve will show 
one or more peaks (+ ) or troughs (-). The sign of the Cotton effect can then be used to 
correlate a compound of unknown stereochemistry with a structurally related one of 
known absolute configuration (Allenmark 1991a). Circular dichromism (CD) is also a 
spectroscopic method, based on the principle that a chiral molecule will produce a 
different absorption effect on a beam of right circularly polarized light to that of a beam 
of left circularly polarized light. This differential absorbtion can be measured as a 
function of the wavelength and also produces Cotton effects. Raman optical activity 
spectroscopy (ROA) is a recent development which can be used to discern enantiomeric 
conformations of e.g. proteins in solution and enantiomeric purities of pharmaceuticals 
down to 0.1 percent (Hall 1995).
Differential scanning calorimetry (DSC) is a quantitative analytical technique which 
measures the melting processes of compounds. It can be applied to analyse the chiral 
purity of drug substances based on the fact that an impure preparation will show a wider 
melting range than that of the pure compound (Fassihi 1993). Purity determination is 
limited to substances containing small amounts of impurities, around 0-3 %.
Gil-Av et al. 1966 were among the first to use gas chromatography (GC) to achieve 
direct optical resolution using a stationary phase composed of lauryl esters of isoleucine 
and chromatographing trifluoroacetyl amino acid esters. The problem with GC in 
achieving chiral separations with CDs is that high temperatures tend to lower analyte 
retention on the column which often leads to poor enantiomeric resolution. The column 
should be operable at relatively low temperatures yet not exhibit excessive column bleed 
which destroys the column packing and adversely affects the chromatography. Many GC
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phases using CDs have been introduced which help to overcome these problems. Venema 
et al. 1991 separated the enantiomers of substituted alkanes and alkanoic acids on 
alkylated p-CD columns operated at <  60°C, Wang et al. 1994 used derivatised a-CD 
columns to separate the enantiomers of ephedrine and its metabolites in human urine, 
Konig et al. 1993 resolved the atropisomers of polychlorinated biphenyls using alkyl 
derivatised y-CD columns, Korth et al. 1991 separated the enantiomers of cyanobacterial 
metabolites using a P-CD column and Bicchi et al. 1991 used permethylated a-, P- and 
y-CDs dissolved in polysiloxane polymers to resolve over 130 volatile compounds such 
as substituted aromatics and polar alkanes.
Supercritical fluid chromatography (SFC) is a recent technique employing a mobile phase 
of supercritical C 0 2, often combined with a polar modifier e.g. MeOH. It is mostly 
operated at temperatures below that of GC operation. This generally increases the 
possibility of chiral separations and reduces the chances of thermal racemization or 
enantiomeric decomposition (Petersson et al. 1992). SFC has been widely used for the 
resolution of enantiomers e.g. Siret et al. 1992 separated a series of P-blockers on a 
‘ChyRoSine-A’ stationary phase, Macaudiere et al. 1987 used CD based HPLC columns 
to separate the enantiomers of naphthyl and ortho-anisylphosphine oxides and Stauer et 
al. 1988 resolved the enantiomers of propranolol using a cyano HPLC column in 
subcritical fluid chromatography with chiral ion-pairing reagents in the mobile phase.
1.4. Aims and Objectives.
To develope novel analyte chiral separations using a range of analytical methodologies 
and CD macrocycles. To compare and contrast NMR, HPLC and FSCE for their ability 
to chirally resolve different groups of enantiomers and to determine if the nature of the 






2.1. Analytes and CDs Employed.
All materials were used as received unless stated otherwise.
2.1.1. Phenethvlamines.
The nine racemic phenethylamines were supplied, via the Pharmazeutisches Institut der 
Universitat Bonn, Germany, by Albert Roussel Pharma Gmbh, Mauver Pharma Gmbh, 
Boehringer Ingelheim, Hoechst AG and Glaxo Gmbh.
2.1.2. Propranolol Analogues.
Racemic samples of propranolol and five of its analogues as HC1 salts were kindly 
provided by Dr. G. Bedford of Zeneca Pharmaceuticals Ltd, Macclesfield, UK.
2.1.3. Mequitamium.
A racemic sample of Mequitamium (as an iodine salt) and individual samples of its two 
enantiomers, were kindly provided by Mr. Brian Meakin (School of Pharmacy, 
University of Bath, Bath, England) from Pharma, Milan, Italy.
2.1.4. CDs Employed.
All CDs (except for heptakis(2,3-di-O-acetyl)p-CD and peracetyl p-CD) were generously 
donated by Wacker Chemie Gmbh (Munich, Germany) and contained less than 10%
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water w/w). The CD parental derivatives were characterised in terms of their molar 
substitution (MS) or degree of substitution (DS), equivalent to the average number of 
substituent groups per glucose unit: hydroxypropyl a-CD (HP-a-CD, MS = 0.6) methyl 
p-CD (Me-p-CD, DS =  1.8), hydroxyethyl p-CD (HE-P-CD, MS =0.6), hydroxypropyl 
P-CD (HP-p-CD, MS 0.6), hydroxypropyl y-CD (HP-y-CD, MS 0.6). Heptakis{2,3-di- 
0-acetyl)p-CD and peracetyl-p-CD were produced, characterised and donated by 
Henning Mallwitz, Pharmazeutisches Institut der Universitat Bonn, Germany.
2.2. HPLC Studies.
2.2.1. Solvents and Buffers Employed.
HPLC grade acetonitrile (MeCN), methanol (MeOH), ethanol (EtOH), triethylamine 
(TEA), glacial acetic acid (HOAc) and orthophosphoric acid (H3P 0 4) were all obtained 
from FSA, Loughborough, England. Sodium dihydrogen orthophosphate (NaH2P 04), 
disodium hydrogen orthophosphate (Na2HP04), sodium dihydrogen citrate 
(H 0 2CCH2C(0H)(C0 2H)CH2C 0 2Na), potassium dihydrogen phosphate QCH4P O ), 
d ip o tass iu m  hydrogen phosphate (K2 H P 0 4), citric acid 
(H02CCH2C(0H)(C0 2H)CH2C 0 2H) and sodium hydroxide (NaOH) were all obtained 
from BDH, Poole, Dorset.
Water was distilled and passed through a 0.45 pm cellulose nitrate filter (Whatman, 
Maidstone, Kent) before use. Aqueous mobile phases were also passed through these 
filters, whilst mobile phases containing organic solvents were filtered through 0.45 pm 
nylon filters (Whatman, Maidstone, Kent) before being degassed with Helium. Polar 
organic mobile phases were not filtered prior to degassing. Buffer pH's were checked 
with a Kent EIL 7020 pH meter, calibrated at pH 4 and 9.
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2.2.2. HPLC Columns Employed.
Two LC-ABZ columns (250 x 2.1 mm and 250 x 4.6 mm, 5/un) containing novel silica 
surfaces, which are deactivated using a combination of steric/hydrophobic groups, were 
kindly donated by Supelco (Bellefonte, PA, USA). A C8  Inertsil column (100 x 2.1 mm, 
5/un) was obtained via GL Sciences Inc., Tokyo, Japan; a porous graphitic carbon based 
column, the Hypercarb S (100 x 4.6 mm), was donated by Shandon Scientific Ltd., 
Cheshire; a P-CD bonded column, Cyclobond 1 2000 (250 x 4.6 mm, 5/un) and a y-CD 
bonded column (250 x 4.6 mm, 5/un) were obtained from Technicol, Cheshire, UK; pKb 
pre-columns (20 x 4.6 mm, 5/un) were obtained from Supelco. All 4.6mm i.d. HPLC 
columns were used at a flow rate of 1 ml/min (unless stated otherwise) and all 2 . 1 . mm
i.d. columns were used at a flow rate of 0 . 2  ml/min (unless stated otherwise).
Inline filters with 0.5 /un frits, were used in all instances with the LC-ABZ and Inertsil 
columns.
2.2.3. Solute Preparation.
All solutes were dissolved using either mobile phase or acetonitrile (all analytes in the 
polar organic work). Where dissolution was incomplete, samples were sonicated and 
filtered through a 0.2 pm Acrodisc (FSA, Loughborough, UK) prior to injection.
2.2.4. HPLC Equipment.
Most work was carried out using an SSI model 300 LC pump (State College, PA, USA), 
a Rheodyne 7125 injection value (Cotati, CA, USA) and an SSI 500 UV detector 
connected to a Servogor 220 chart recorder. Other models used included a Milton Roy
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3100 UV detector, a Spectromonitor III UV detector and an LDC Constametric III 
Pump. Injection loops of either 10/d or 20/d were employed with 10/d or 50/d syringes 
(SGE, Milton Keynes) for sample injections (0.05 - 0.5 mg/ml).
All HPLC columns were thermostatted at 20°C (unless stated otherwise) using a water 
bath containing a Grant water heater. To conduct sub-ambient temperature experiments, 
ice was added to the water and the solution stirred without using the heating function of 
the Grant water heater. Temperatures were checked using a partial immersion 
thermometer fitted to the side of the bath.
All samples were detected at their UV maxima (unless stated otherwise). Where no 
literature value was obtainable, solutions of the analytes were scanned between 190 and 
360 nm using a photodiode array detector (Spectromonitor 5000, LDC Analytical).
2.2.5. Determination of Chromatographic Parameters.
1. Capacity factors, k', were calculated in the following way;
k '=  (tr - to)/to (Equation 2.01.)
where tr is the analyte retention time and to is the retention time for a solute unretained 
under the experimental conditions (generally calculated from the injection of water).
2. Selectivity, a. The selectivity between two peaks was calculated thus;
a  =  k7! / k' 2 (Equation 2.02.)
where k ’2 is the capacity factor for the least retained .of two enantiomers.
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3. Column efficiency, Nw^ , was calculated according to equation 2.03.;
Nw l 4  =  5.54 ( t W  (Equation 2.03.)
where w l/4 is the peak width at half peak height*
4. Chromatographic resolution, was calculated either according to equation 2.04. 
or equation 2.05. (for less clearly resolved peaks);
Rj. =  2 - trj) / (w2 +  Wj) (Equation 2.04.)
where w2 and wt are the peak widths measured at the baseline.
%CRF = f/g X 100/1 (Equation 2.05.)
where f is the vertical distance from the mid-point between the two peak apices to the 
lowest point of the connecting peak trough and g is the vertical distance from the mid­
point between two peak apices to the baseline. Baseline resolution of two peaks then 
corresponds to a %CRF of 100%.
2.3. FSCE Studies.
All the solvents and buffers employed in the FSCE studies were of the same specification 
and from the same sources as the HPLC work (section 2.2.1.). All samples and buffers 
were filtered through a 0.2 /zm cellulose nitrate or nylon filter (Whatman, Maidstone, 
Kent) and centrifuged for 5 mins (at 10,000 rpm) before use. Columns were conitioned 
by flushing with distilled water, MeCN and the appropriate running buffer before 
analysis of the samples.
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2.3.1. CE Equipment and Columns Used for Phenethvlamines.
Work was carried out on a BIORAD HPE CE system, using a Biorad coated-capillary 
of internal diameter 25 /im and a total length of 20 cm. Samples were loaded by 
electromigration and separated at room temperature using a constant current of 1 2  /tA. 
Data were recorded at the analyte Xniax value with the Biorad 800 HRLC system, version 
2.30. Samples of compounds 1-9 were prepared by dissolution in acetonitrile - 
potassium dihydrogen phosphate (0.1M, pH 3.0) (10:90 v/v) at about 0.5 mg/ml. Buffers 
at pH 3 to 6  for CE were all prepared from potassium dihydrogen phosphate at 0 .1M 
using freshly distilled and filtered water and adjusted with orthophosphoric acid or 1M 
sodium hydroxide. The buffer at pH 7.5 was a 50:50 mixture of 0.1M potassium 
dihydrogen phosphate and 0.1M dipotassium hydrogen phosphate, adjusted with 1M 
sodium hydroxide. See section 4.2. for experimental results and discussion.
2.3.2. CE Equipment and Columns Used for Propranolol Analogues.
A BIORAD HPE CE system was used with a BioRad coated capillary of internal 
diameter 25 /mi and a total length of 20 cm. Samples were loaded by electromigration 
and separated at room temperature at a constant current of 5 /xA. Data were recorded at 
the analyte A,max values (288 nm for compounds 1-3 and 254 nm for compounds 4 and 
5) with the Biorad 800 HRLC detector, version 2.30. Samples of compounds 1-5 were 
prepared by dissolution in MeOH-50 mM potassium dihydrogen phosphate pH 3.0 (30:70 
v/v) at about 0.5 mg/ml. Buffers were prepared from potassium dihydrogen phosphate 
(50 mM) using freshly distilled and filtered water and then adjusted to the appropiate pH 
with orthophosphoric acid before the addition of methanol. The required amount of CD 
was then added to the buffers. See section 4.3. for experimental results and discussion.
29
Electroendosmotic flow (EOF) measurements were attempted according to 
recommendations from the manufacturers BIORAD. A neutral marker, acetone, was 
loaded at the outlet reservoir in a running buffer to acetone ratio of 20:1. The polarity 
was set from negitive to positive and the time taken for the neutral marker to pass from 
the outlet reservoir to the detector window was measured (a distance of 4.6 cm). The A,max 
was 264 nm, the maximum for acetone in an aqueous acid.
2.3.3. CE Equipment and Columns Used for Mequitamium.
Work was conducted using a Dionex CES CE system (Sunnyvale, CA, USA) and bare 
fused silica capillaries of internal diameter 50 [xm and a total length of 50 cm. Samples 
were loaded by gravity (10 to 15 seconds at 90 mm) and separated at room temperature 
at a constant voltage of 15 KV. Data were recorded at the analyte A.max (254 nm) using 
the inbuilt UV detector and captured using the Dionex CES software. Samples of 
mequitamium and its enantiomers were prepared in MeCN-water (10-90% v/v).
The electroendosmotic flow rate (u^) was calculated using a solution of MeCN injected 
by gravity (15 seconds at 90 mm) and a constant voltage of 15 KV (the buffer used was 
MeCN-sodium dihydrogen citrate (50 mM, pH 3.5) (9.5 - 90.5 v/v%). The EOF value 
was found to be 3.8xl0 ' 6 cm 2 V 1 s 1 . See section 4.4. for experimental results and 
discussion.
2.4. NMR Studies.
All NMR studies were carried out at the School of Pharmacy and Pharmacology, 
University of Bath, Bath, England, except for the Job plot with etileffine HC1, which was
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carried out in the Pharmazeutisches Institut der Universitat Bonn, Bonn, Germany with 
the kind help of Henning Mallwitz and Ulrike Holzgrabe.
2.4.1. NMR Solvents.
Deuterium oxide (D20), methanol-^ (CD3 OD), methyl sulphoxide-a^ (DMSO-4J and 
acetonitrile-cfj (CD3CN) were obtained from Aldrich (Gillingham, Dorset) or Sigma 
(Poole, Dorset).
2.4.2. NMR Conditions.
Cyclodextrins were dried in vacuo over P4O10 before use and all chemical shifts were 
referenced to the HDO signal at 4.65 ppm. For the measurement of cyclodextrin-induced 
chemical shifts, coupling constants and the separation between signals arising from the 
individual enantiomers (|SR- 6 S|), sufficient quantities of all compounds with and without 
the appropriate cyclodextrin were dissolved in deuterated buffer to give approximately 
equimolar concentrations of each. Separated signals were not attributed to the respective 
enantiomers for the compounds. All the NMR experiments with the phenethylamines and 
propranolol analogues (see 5.2. and 5.3. respectively) were obtained using a Jeol EX400 
FT NMR spectrometer operating at 399.05 MHz for 1H. 64 scans with a frequency range 
of 5000 Hz were collected into 32K data points giving a digital resolution of 0.31Hz/pt. 
NMR experiments with mequitamium (see section 5.4), except for the COSY work, were 
obtained using a 270 MHz Jeol JNM-GX-270 instrument with 32K data points and a 
spectral width of 3001.2 Hz giving a digital resolution of 0.18 Hz/pt.
Where required, an appropriate Gaussian function was applied before Fourier 
transformation to enhance spectral resolution. The temperature for those experiments
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conducted with the 400 MHz instrument was controlled at 30(±1)°C and the residual 
protonated water signal was suppressed using homo-gated secondary irradiation 
(decoupler off during data acquisition).
Analysis of AB quartet signals (in ABX systems) was performed using equation 2.01.,
0o6 = \/ (fj-f^  ^ 2 ^ 3 ) (Equation 2.01.)
where f ^  are the four lines of the AB quartet. Defining Z as the centre of the multiplet 
(i.e. the midpoint between fj and f\  or f2  and f^ j), the frequencies of each doublet of the 
quartet is given by,
=  Z- fr0 6  (Equation 2.02.)
=  Z + h 0 6  (Equation 2.03.)
where is the higher field doublet and is the lower field doublet.
2.4.3. Job Plots and Association Constant. Kf. Determination.
The *H NMR experiments for the Job plots and measurement of complex formation 
constants with etilefrine HC1 (see section 5.2.) were performed on a Varian XL 300 FT 
NMR spectrometer operating at 299.956 MHz with a sample temperature of 26°C. Five 
solutions in deuterated 0.1 M phosphate buffer pH 4.5 having molar ratios (etilefrine 
HC1:CD) of 0.5:1, 0.75:1, 1:1, 1.25:1 and 1.5:1 with a total concentration of 14 mM 
were prepared for the Job plots.
32
The Job plots with Mequitamium (see section 5.4.) were were conducted with the 400 
MHz instrument in the School of Pharmacy and Pharmacology, Bath, England. The 
molar ratios of analyte to CD employed (in deuteratedMeCN - sodium dihydrogen citrate 
buffer, 50 mM, pH 3.5) were 3/4:l/4, 2/3:1/3, 172:1/2, l/3:2/3 and l/4:3/4 with a total 
concentration of 12 mM. Association constants were measured using solutions with 
analyte:CD ratios of 1:2.33, 1:3.0, 1:4.0, and 1:5.7 for etilefrine HCl:p-CD and Ac-f- 
CD. Ratios of 1:1.7, 1.3.3, 1.4.7 and 1:8.3 were used for mequitamium:y-CD and HP- 
p-CD.
2.4.4. Interpretation of Spectra.
Most spectra were assigned by inspection and with data from the literature. In the case 
of etilefrine HC1 (see section 5.2.) the two aromatic doublets (H4' and H6 ') were 
distinguished using the 400 MHz instrument with the aid of inverse *H-13C correlation 
spectroscopy with a HMQC pulse sequence on a 12 mM solution using a final data 
matrix of 512 x 512 real data points. Frequency widths of 5000 Hz (!H) and 30120.5 Hz 
(13C) gave row and column resolutions of 9.77 and 58.8 Hz respectively. 16 scans were 
accumulated per slice.
It was necessary to perform a ‘H^H COSY, a COSY, a broad-band decoupled *C 
and two DEPT (Distortionless Enhancement by Polarization Transfer) experiments (90 
and 135°) to unequivocally assign the spectra for mequitamium (see section 5.4). The 
^ - ‘H COSY was obtained using the 400 MHz instrument operated at 12 KHz with a 
frequency range of 3 KHz collected into 1024 data points giving a digital resolution of 
6.28 Hz/pt. Pulse widths were 7.8, 3.9 and 10 fxs with a Is pulse delay. 16 scans were 
collected at an ambient temperature of 21.2 °C. The 1H-13C COSY was obtained using 
the 400 MHz instrument operated at 8  KHz with a frequency range of 13 KHz collected 
into 2048 data points giving a digital resolution of 12.82 Hz/pt. Pulse widths were 10,
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2 0  and 2 0  /xs with a Is pulse delay. 16 scans were collected at an ambient temperature 
of 20.8°C.
The broad-band decoupled 13C and DEPT experiments were conducted using the 270 
MHz instrument operated at 67940.6 KHz for 13C with a frequency range of 18 KHz 
collected into 32K data points giving a digital resolution of 1.1 Hz/pt. 700 scans were 
collected at an ambient temperature of 20°C.
2.5. Molecular Modelling Parameters.
All molecules were constructed using the Discovery program, version 2.7.0. and 
Insight II program version 2.0.0. (Biosym Technologies, San Diego, CA), run on the 
Personal Iris from Silicon Graphics. The molecular structures of p-CD and Ac-p-CD 
were constructed using the building subroutine. Energy minimization of the 
geometries and conformations was iteratively performed until the energy deviations 
were less than 1 kcal/mol. See section 5.2.4. for experimental results and discussion.
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CHAPTER THREE 
HPLC RESULTS AND DISCUSSION
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3.1. Introduction.
Optical resolution by chromatography is possible through reversible diastereomeric 
association between a chiral environment introduced into a column and solute 
enantiomers. The multiplicity of experimental conditions under which direct 
chromatographic optical resolutions have been achieved with CDs suggests that the 
difference in association which is necessary can be achieved via many types of molecular 
interactions as detailed in the following sections.
3.1.1. CDs as Stationary Phases in Liquid Chromatography.
Initial efforts to use CDs as stationary phases in LC were attempted by Wiedenhof et al. 
1969, who managed to separate some benzoic acids in a non-chiral application, with 
polymerized p-CD gels. Harada et al. 1978 and Zsadon et al. 1979 used various 
crosslinked CD gels for the separation of mandelic acid derivatives and amino acids 
respectively. However, because of their low efficiency and poor mechanical strength, 
these polymer gels were unsuitable for HPLC.
Japanese researchers led the way in attempts to bond CDs to silica gel in order to 
overcome the problems found with the polymers. Fujimura et al. 1983, Kawaguchi et al. 
1983, Tanaka et al. 1984 and Feitsma et al. 1985, used propylamine, ethylene diamine 
and related binding agents in their work. However, the first hydrolytically stable CD 
phase was introduced by Armstrong 1985, who patented the process which uses silanes 
(e.g. 3-glycidoxypropyl trimethoxy silane) to form a linkage between the silica and CD 
hydroxyls of between 2 to 20 carbon atoms in length. These packings were soon 
commercialized as the Cyclobond™ columns and are now available with a, p and y-CDs.
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Armstrong et al. 1985a separated over eighty structural, geometric and epimeric isomers 
of a variety of compounds (e.g. polycyclic aromatics and prostaglandins) using the same 
p-CD columns which they had developed. Hinze et al. 1985 were able to resolve the 
enantiomers of a series of ester derivatised amino acids and barbiturates on similar 
columns. Armstrong et al. 1985b were further able to separate metallocene enantiomers 
and also a diverse group of pharmaceuticals, including p-blockers, anticonvulsants and 
calcium channel blockers with a P-CD column (Armstrong et al. 1986). Li and Purdy 
1991, Furuta and Nakazawa 1992, Friebe et al. 1992 ref, Park et al. 1992 and Piperaki 
et al. 1994 have all conducted experiments in enantiomeric resolution with a spectrum 
of analyte types on bonded P-CD columns. Agnus et al. 1994 developed a method for 
the detection of poorly UV-absorbing species oh a p-CD column viz. six-fold 
enhancement of pregnanolone by indirect UV detection with testosterone/progesterone 
as markers. Not all researchers have settled for the columns developed by Armstrong and 
have chosen to make their own. Thuaud et al. 1993 examined phenylhydantoins and 
hydroxycoumarin derivatives on supports produced by condensation of p-CD molecules 
with epichlorohydrin, although the efficiency of their columns was relatively poor. Rizzi 
et al. 1994 used a p-CD column to resolve some amphetamines, with and without 
derivatization to diastereomers. They found that indirect separation i.e. prior 
derivatisation, produced the best results for these relatively small molecules.
Tanaka et al. 1983 used a-CD bonded phases to separate various isomers of disubstituted 
benzene, but the first report on the use of an a-CD bonded phase for enantiomeric 
separation in LC was produced by Armstrong et al. 1987. They were able to directly 
resolve the enantiomers of over twenty compounds including several amino acids, which 
had proven difficult to separate on p-CD phases, which they attributed to the inability 
of the analytes to adequately complex with the relatively larger cavity of P-CD. Issaq et 
al. 1988, Vigh et al. 1989a, and Florance and Konteatis 1991 have all used a-CD 
columns to investigate different isomeric analytes. Armstrong and Zukowski 1994 were 
able to resolve the enaniomers of pinene and camphene hydrocarbons on an a-CD phase,
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which they attributed to 'shape selectivity' i.e. a tight steric fit of the guest into the CD 
cavity. y-CD phases have been tested by Vigh et al. 1989a, Berthod et al. 1990 and 
Chang et al. 1990 for separating positional isomers, stereoisomers and peptides 
respectively. Abidi and Mounts 1994 separated methyl-substituted tocols on p- and y-CD 
via a normal phase mechanism, whilst Loukas et al. 1994 determined the stability 
constants of a novel insecticide with a y-CD phase. However, most reports on native 
CDs still use the cheap and easy to obtain p-CD.
Modified CD phases have also been investigated for LC methods. Tanaka et al. 1984 
used acetylated versions of a- and p-CDs to separate positional isomers of aromatics, 
with the acetyl p-CD giving improved peak shapes over the parent macrocycle. Bamaby 
and MacLeod 1991 employed an acetyl-p-CD column to separate enantiomeric aza- 
bicycles following a novel complexation with borane. Other derivatised CD phases 
include hydroxypropyl-P-CD (Stalcup et al. 1990), S- and /?-naphthylethylcarbamate-p- 
CD (Vandenbosch et al. 1992 and Berthod et al. 1992), and toluoyl-p-CD (Lee et al. 
1992). Li and Purdy 1992 developed some novel derivatives of p-CD, whereby 
regiospecific modification was carried out by attaching groups on the narrow primary 
side of the CD torus, to produce 'multiple-interaction' phases.
3.1.2. Optimization of Enantioselectivity on a Bonded CD Column.
The first important consideration for analyte retention and possible chiral recognition in 
the reversed phase mode is proper fit of the molecule into the CD cavity. In the presence 
of aqueous mobile phases the basic mechanism which retains solutes is known as 
inclusion complexation (Technicol 1992). It is essential for the analyte to have at least 
one aromatic ring to facilitate the hydrophobic interactions which are believed to drive 
the inclusion complexation process (Allenmark 1991). If the solute is of a suitable size, 
contact with the internal CD surface may restrict its motion, so that differential
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interaction with the mouth of the cavity will cause a difference in enantiomeric 
association constants, Kf, and k' values (see equations 3.03. and 2.01. respectively).
MeCN and MeOH are the two most commonly used organic modifiers in CD bonded 
columns, although others have been tried (Street 1987). MeCN has a stronger solute 
displacement effect from the CD cavity and can generate different selectivites to that of 
MeOH (Li and Purdy 1992). The organic modifier competes with the analyte for the CD 
cavity and if it is present in too high a concentration, it will reduce both retention and 
chiral recognition. Anigbogu et al. 1992 reported the formation of ternary complexes 
between CDs, alcoholic modifiers and aromatic hydrocarbons during fluorescence 
studies, where the stoichiometry depended on the CD type (p or y). These ternary 
mixtures enhanced complexation with p-CD using an achiral column in reversed phase 
HPLC.
pH can play an important role in chiral recognition as well as affecting analyte k7 values. 
On altering pH, Armstrong et al. 1990 found three different types of solute retention 
behaviour occurred with a series of tobacco alkaloids, dependant on the analytes basicity. 
They concluded that the protonated species were less strongly complexed by the CD 
support. Li and Purdy 1992 came to a similar conclusion upon examining some dansyl 
amino acids on derivatised CD columns, as did Ventura et al. 1994 using a biphenylactic 
acid on various CD columns. However Konishi et al. 1994 observed that interaction 
between P-CD and a carboxylic acid analyte was promoted when the analyte was present 
as a carboxylic ion. They related this to an improved solute ability to hydrogen bond 
with the hydroxyls at the primary CD end. Lee et al. 1992 found that pH changes caused 
k' values to decrease for dansyl amino acids over a pH range where the ionic form of the 
analyte should not have altered. They suspected changes to the stationary phase surface 
were responsible. Overall, the influence of pH on chiral recognition can be somewhat 
variable.
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Under reversed-phase conditions buffers are known to include into the CD cavity and as 
the buffer concentration increases, solute peaks may become sharper with a concomitant 
reduction in k' values. Triethylamine (TEA), Ammonium nitrate (NH4N 03) and citrate 
are recommended for use with Cyclobond™ columns (Technicol 1992). TEA has been 
shown to be beneficial for a number of enantiomeric separations (Lee et al. 1992 and Li 
and Purdy 1991).
p-CD columns show a greater sensitivity to temperature variations than standard reversed 
phase columns. Reductions in temperature can lead to an improvement in separation 
factors (a), but this may not necessarily improve the solute resolutions due to poor 
efficiency as a result of slower mass transfer. Hinze et al. 1985 came to such a 
conclusion when examining dansylamino acids on a p-CD column with varying 
temperatures. Aboul-enein et al. 1988 found that temperature had little effect on the 
separation factor (a) with nomifensine, although the resolution and k7 values did increase 
over the same decreasing temperature range (8 °C to 30°C). Armstrong et al. 1985b and 
more recently Furuta and Nakazawa 1992, have shown that inclusion complexation is 
prevented at temperatures higher than 60°C for most analytes, a phenomenon that could 
prove useful when separating tightly bound solutes. Cabrera and Ludba 1994 described 
how changes in temperature can increase or decrease separations depending on the 
enthalpy and entropy contributions of the individual analytes.
3.1.3. CDs as Stationary Phases in the Polar Organic Mode.
This is a recent development in CD research and there are relatively few published 
papers. The presence of polar groups on the analytes may be more important for enantio- 
recognition in the polar organic than in conventional CD reversed phase methods. All the 
chiral analytes to have been separated so far contain at least two hydrogen bonding sites 
(donor and/or acceptor). The mobile phase consists of MeCN as the primary solvent
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( 90 to 99 % v/v) with MeOH present as a secondary modifier, principally to adjust 
retention. Acid (glacial acetic, HOAc) and base (e.g. triethylamine, TEA) are used in 
combination to control selectivity, with some effect on retention.
Changes in analyte retention behaviour were noticed by Chang et al. 1985 when 
examining organometallic compounds at a high MeOH content (60 to 80%) on a P-CD 
column and also when they tested some substituted phenols under similar conditions 
(Chang et al. 1986). They believed that the high organic modifier content was causing 
the column to display some form of 'normal phase' behaviour with the analytes unlikely 
to enter the CD cavity in such non-polar environments. Han and Armstrong 1987 
discovered that upon increasing the MeCN content with a P-CD column, both retentions 
and chiral resolutions initially decreased but then began to increase again at very high 
levels (95 % MeCN). This reversal suggested a change in the separation mechanism and 
in chiral recognition, which they also related to some form of 'normal phase' adsorption 
to the external hydroxyls of the CD. Seeman et al. 1988 likewise observed such a 
reversal of retention and chiral recognition values at high MeCN concentrations 
(>80% ). Armstrong and Jin 1989 were able to separate a series of mono-, di- and 
trisaccharides using P- and a-CD columns with mobile phases containing high MeCN 
levels (usually >80  %). These seem to be the first applications of the so called 'polar 
organic' methodology.
Zukowski et al. 1992 found they could improve on separations obtained under reversed 
phased conditions for FMOC derivatised imino acids, by employing a 
naphthylethylcarbamate-p-CD column with nonaqueous mobile phases, consisting of 
MeCN, HOAc and TEA. They also proposed the existance of external absorption (no 
cavity inclusion of the analytes) at the CD mouth and appear to have coined the term 
'polar organic1. Armstrong et a l  1992 performed a systematic study of the effects of 
polar organic mobile phase composition on the retention and enantio-selectivity of a 
series of P-blockers. They tentatively proposed the novel idea of the analyes sitting
astride the CD torous 'like a lid' and interacting via hydrogen bonding, to account for 
the difference in separations observed between this mode and the normal phase. Other 
work by Zukowski et al. 1993 and Chang et al. 1993 have supported this idea.
3.1.4. CDs as Mobile Phase Additives in Reversed Phase Liquid Chromatography.
Upon the addition of CD to the mobile phase in HPLC, analyte molecules may undergo 
inclusion complex formation much as in the same way with bonded CD columns i.e. the 
solute enters the CD cavity via hydrophobic forces, which may lead to a stereospecific 
interaction with the hydroxyl groups on the mouth of the CD torous. There is often a 
reduction in solute k' values when the diastereomeric complex formed is more 
hydrophilic than the free analyte. Differences in the adsorption of analyte:CD complexes 
on the stationary phase and/or differences in the complex Kf values (see p. 45 for Kf 
definition), is believed responsible for any observed chiral resolution (Sybilska et al. 
1986). This may result in a reversal of elution orders when comparing a CD containing 
mobile phase to a CD bonded column, as observed by Casy et al. 1991 when studying 
a series of phenothiazines.
CDs were first used as eluant additives by Uekama et al. 1977a in gel chromatography, 
although not for chiral resolution. Later, Hinze and Armstrong 1980 were able to 
separate a series of structural isomers using CDs as additives and in 1982 Debowski et 
al. were able to separate mandelic acid enantiomers by HPLC using P-CD dissolved in 
the mobile phase with an achiral column. Similarly, Tanaka et al. 1985 employed native 
and methylated a- and p-CDs to separate o, m and p  isomers of disubstituted benzenes, 
Mularz et al. 1988 used p-CD to resolve pseudoephedrine enantiomers, Shimada et al. 
1988 separated isomeric estrogens with p-CD and Zukowski et al. 1988 resolved some 
chiral barbituates with methylated P-CDs. More recently Shimada and Hirakata 1992 
separated a range of derivatised amino acids using p-CD but their results with dipetides
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were not so good, and Lamparczyk et al. 1994 successfully resolved norgestrel 
enantiomers with p-CD at low temperatures (0°C). .
Various CDs have been employed as mixtures in the mobile phase. Gazdag et al. 1988 
used a-, p- and y-CD as additives for the adjustment of isomeric k' values in HPLC. 
They suggested this was a rapid way to determine which CD would best complex with 
a given analyte as any CD which did not interact with a solute would not change the 
analyte k' value. Sybilska et al. 1992 used p-CD and permethylated p-CD together to 
improve on enantioselectivity and shorten the k' values of a group of therapeutic 
compounds. All the analytes except one (mephenytoin) showed an improvement in their 
separations. y-CD (Takeuchi 1992, Dodziuk et al. 1994 and Roussel and Favrou 1993), 
a-CD (Zukowski 1991) and various CD derivatives, y-CD and Me-y-CD (Shimada et 
al. 1989) have also been utilised as eluent additives in HPLC.
Wannman et al. 1992 demonstrated the novel use of microcolumn HPLC (255 x 0.32 
mm) to resolve the enantiomers of terbutaline with p-CD as an additive. They proposed 
that such a system would reduce material costs and enable the use of less readily 
available CD derivatives. Walhagen and Edholm 1991 separated enantiomers from 
complex biological fluids by column coupling and adding P-CD to the mobile phase with 
the last column. Cooper and Jefferies 1993 performed semi-preparative separation of 
brompheniramine enantiomers by column switching, again using p-CD as the chiral 
additive and obtaining optical purities > 8 8 %.
The factors affecting complexation and enantio-recognition in this mode are very similar 
to those operating when a bonded CD phase is used e.g. organic modifier, pH, buffer 
etc. One exceptional consideration is the solubility of the CD additive in the mobile 
phase. Taghvaei and Stewart 1991 have shown how the solubility of p-CD decreases in 
the presence of MeOH and DMF, whilst both DMSO and MeCN cause a solubility 
increase followed by an eventual decrease. MeCN at 20% v/v in aqueous solution
allowed the dissolution of 3.1 g/100 ml P-CD, more than twice its solubility in pure 
water. Pharr et al. 1989 demonstrated the ability of concentrated urea solutions to 
enhance the solubility of p-CD eleven-fold, while a 0.75 M NaOH solution gave a twenty 
one fold enhancement. It is thus possible to increase the absolute amount of CD but the 
high levels of these other additives may interfere with the complexation process.
3.1.5. Equilibria In CP Modified HPLC.
The equilibria in mobile phase additive systems is somewhat more complicated than for 
CD bonded columns. The solute may be complexed by more than one CD molecule, with 
differentiation of the eluting transient diastereomers arising as a result o f :
• differences in association (stability) constants (Kf) of CD:analyte complexes
• and/or differences in adsorption of CD:analyte complexes on to the stationary phase
These factors may act in an additive or subtractive manner. Uekama et al. 1978a and 
1978b proposed the following equilibria (Fig. 3.1.) to describe the important effects 
occurring when using CDs as eluant additives in reversed phase LC.
Figure 3.1. Equilibria model for effects of CDs in reversed phase LC.
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Kf




Distribution ratios Da, Da cd and the complex formation constant, Kf are given as 
follows,
• Da =  [A]st/[A]m (Equation 3.01.)
• Dacd =  [A.CD]sl/[A.CD]m (Equation 3.02.)
• Kf =  [A.CD]m/[A]m.[CD]m (Equation 3.03.)
where [A], [CD] and [A.CD] are the equilibrium concentrations of solute, cyclodextrin 
and complex respectively, with st and m denoting the stationary and mobile phases.
The observed distribution ratio, Dobs, is given by;
• Dobs = (Da- Dacd. Kf . [CD]J/(1 +  Kf.[CD]m) (Equation 3.04.)
Assuming that the addition of CD does not change the stationary phase, the distribution 
ratios can be related to chromatographic k' values viz.
Da =  k'a- Vm/Vst = (ta-yto).(Vm/Vst) (Equation 3.05.)
D a.cd =  k'a.cd • Vm/Vst = (tacd-to/to).(Vm/Vst) (Equation 3.06.)
Dobs = k'obs • Vm/v st = (tobs-to/to).(Vm/Vst) (Equation 3.07.)
where Vm/Vst is the phase volume ratio, to, ta, ^ cd and tobs are the retention times of an 
unretained solute, uncomplexed solute (no CD present), complexed solute and observed 
solute at equilibrium, respectively. Substitution of equation 3.04. and rearrangement then 
gives,
• [CD]m/(V tobs) =  (l/tfta.cdMCDJm +  (1 /Kf. (tj-t, cd) (Equation 3.08.)
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Plotting [CDyCt.-toJ vs [CD]m gives a straight line with slope equal to 1/ft "ti.cd ) and 
intercept of l/Kf.(ta-ta.cd), which allow the k' values of the complex and the association 
constant to be obtained. Sybilska et al. 1986 derived an analogous equation,
• k' =  (k'A - k')/[CD].KA + k'A.cu (Equation 3.09.)
where a plot of k' vs (k'A - k')/[CD] readily allows the determination of KA, the stability 
constant (1/slope) and k'ACD, the complex k' values (intercept). Inherent in these 
mathematical treatments are the suppositions that:
1 . only one species of the solute takes part in adsorption and complexation
2 . complexes of 1 : 1  stoichiometery are formed
3. the CD does not influence the nature of the stationary phase i.e. the adsorption of CD 
itself onto the stationary phase is very small or negligible.
However these conditions may not always hold true and other treatments have been 
developed to account for this.
Sybilska et al. 1982 have produced an expression for weak acids and bases;
• k' =  k'G +  k'i0 .K!1/[H +] +  k'0 cd.Ko[CD] +  k'i0 CD.Ki0 [CD]Ka/[H +]
1 + K /[H+] + K [CD] + K ,[CD]K /[H+]
a G iG a
(Equation 3.10.)
where K, is the acidity constant, KGand K iGare stability constants of CD complexes with 
neutral and ionic species respectively and k'G, k'iG, k^ cd and k'jQ cd are capacity factors 
of unionized, ionized, complexed-unionized and complexed-ionized solute forms 
respectively.
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The mobile phase frequently contains an organic modifier, whose competitive influence 
on the complexation equilibria has been described by Zukowski et al. 1985;
• [CD]m = [CD]m°/Ksolv[solv]m° +  1 (Equation 3.11.)
where [solv]m° is the initial molar concentration of organic solvent and Kj.0lv is the 
stability constant of the 1:1 CD inclusion complex with an organic solvent. The apparent 
CD molar concentration, [CD]m, is therefore smaller than the overall molar 
concentration, [CD]m°. This obviously affects any values calculated from equation 3.08.
3.1.6. CDs as Mobile Phase Additives with Porous Graphitic Carbon Columns.
Porous graphitic carbon (PGC) was first produced by Kaur and Knox in 1984 and its 
structure elucidated by X-ray diffraction and other related means two years later (Kaur 
1986 and Knox et al. 1986). It was made by impregnating porous silica with phenol and 
hexamine, heated to form a carbonized resin, which was then heated further to 2500°C 
after the silica had been dissolved away. The resulting material has a two dimensional 
structure of closely intertwined layers imparting the mechanical stability and rigidity 
necessary for use in HPLC. It possesses an extremely uniform surface devoid of any 
'functional sites' and can be used over the entire pH range (Lim 1992). It is more 
hydrophobic than ODS phases and consequently larger amounts of organic modifier are 
required for solute elution (Kaur 1990). The retention mechanism is strongly influenced 
by the unique electronic donor-acceptor interactions between analytes (donor) and the 
delocalized electron conduction bands (acceptor) of the PGC surface (Bell et al. 1994).
PGC is not optically active but it is sensitive to stereochemical changes in solutes due to 
its flat surface leading to the preferential retention of planar molecules (Tanaka et al.
1993). Fell et al. 1988 were the first to demonstrate the ability of a p-CD containing
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mobile phase to resolve the enantiomers of lorazepam and oxazepam on a PGC column 
(they also found that such a degree of separation could not be achieved using a bonded 
p-CD column, Clark 1989). Mama et a l 1989a were able to separate nomifensine 
enantiomers at pH 2.5 using p-CD and Clark and Mama 1989 used a pH of 2.5 to 
optically resolve glycyl-DL-phenyl alanine. These last two applications demonstrate how 
the unique ability of PGC to operate at extremes of pH, can prove highly beneficial.
The paucity of enantiomeric separations on PGC using CD additives may be related to 
the rather poor solubility of a-, p- and y-CD in eluents containing high levels of organic 
modifier. However Clark and Mama 1989 pointed the way in the use of CD derivatives, 
when they separated the enantiomers of chlorpheniramine by adding Me-p-CD to the 
mobile phase. Many CD derivatives are more soluble than the parent macrocycles, 
making them amenable for dissolution in the high organic content PGC mobile phases.
3.2. Phenethylamines - Results and Discussion
A series of nine structurally related chiral sympathomimetic agents (Fig. 3.2.) were 
chosen for examination with a variety of CD derivatives. These adrenergic ligands may 
display different isomeric potency ratios at p and a-receptors (Casy, 1993a). /- 
Noradrenaline, for instance, acts as an a-adrenergic lull agonist, whilst the inactive d- 
isomer acts as a competitive a-adrenergic antagonist. Furthermore, rac-isoprenaline and 
rac-salbutamol are known to exhibit clear differences in intrinsic activity towards p- 
receptors (Krstulovic 1989a).
Consequently, great interest lies in developing means to separate the enantiomers of these 
compounds and they can also function as probes for the investigation of complex 
formation mechanisms with CDs.
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Fig. 3.2. Structure of Phenethylamines.
2* j )H Ijl
C H — C H —N H — R2 
I 2
Com pound nam e X R l R 2
1 ephedrine II c h 3 c h 3
2 oxedrine 4-OH I-I c h 3
3 oxilofrine. 4-OH c h 3 c h 3
(oxyephedrine)
4 norfenefrine 3-OH H H
5 etilefrine 3-OH H C Il2 CH 3
6 orciprenaline 3,5-diOH H CI-I(CI-I3 ) 2
7 noradrenaline 3,4-diOH H H
(norepinephrine)
8 isoprenaline 3,4-diOH H CH(CH 3 ) 2
9 salbutamol 3-CH 20H ,4-0H H C(CH 3 ) 3
3.2.1. P-CP Column in Reversed Phase Mode.
Several HPLC methods for the determination of enantiomeric purity of certain 
phenethylamines have been developed; chiral stationary phases (Wainer et al. 1983, 
Schill et al. 1986 and Wu et al. 1990), a chiral complexing agent as liquid stationary 
phase (Pettersson and Stuurman 1984) or pre-column derivatization to form 
diastereoisomers (Gal 1984 and Noggle and Clark 1986). However, there seem to be no 
reports of chiral separation using CD columns without prior derivatization. It was only 
possible to resolve the enantiomers of orciprenaline, ephedrine and oxilofrine (Table
3.1.), which also displayed the three longest k' values.
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Table 3.1. Resolution values and k' values of phenethylamines with a p-CD column. 
HPLC conditions: 0.5% MeCN- 99.5% v/v TEA (0.8 % v/v, pH 8.0), p-CD bonded 
column (250 x 4.6 mm), 1 ml/min, Temp. 20°C. See equation 2.05 in section 2.2.5. for 
%CRF calculation procedure.
Compound k' values % CRF value
Ephedrine 4.3, 4.4 36%
Oxilofrine 3.5, 3.8 67%
Oxedrine 2 . 8 0




Orciprenaline 3.2, 3.4 39%
Salbutamol 2 . 2 0
Ephedrine and oxilofrine are the only compounds with a methyl group on the C2 carbon 
which seems then to be influencing their separation. Orciprenaline does not have a 
methyl on this carbon, but does possess hydroxy groups in a unique 3 ',5 ' substitution 
pattern on the aromatic ring. Hydrophobic / steric and hydrogen bonding phenonema, 
optimum for interaction with the tethered p-CD molecules, may account for the optical 
resolution and longer k' values of these three compounds.
3.2.2. Polar Organic Investigations.
The phenethylamines examined here possess one or more hydrogen bonding and/or 
acceptor sites (similar to the propranolol analogues in section 3.3.) and so may be
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expected to display some enantio-discrimination when using this mode of separation in 
conjunction with a p-CD bonded column (Technicol 1992).
Despite employing a range of varied experimental conditions, only the enantiomers of 
salbutamol were successfully separated to any degree (Table 3.2.), which strongly 
suggests that the mode of interaction between analyte and CD is significantly different 
in the polar organic mode to that in the conventional reversed phase situation, which 
gave contrasting results (section 3.2.1.). Salbutamol is the most bulky and hydrophobic 
of the phenethylamines and such structural features were also found to promote enantio- 
recognition for the propranolol analogues in the polar organic mode (section 3.3.2).
Table 3.2. Resolution and k' values for phenethylamines in polar organic mode.
HPLC conditions: mobile phase, MeCN-MeOH (97.5-2.5 % v/v), HOAc-TEA (0.3-0.2 
%v/v), p-CD column (250 x 4.6 mm), 1 ml/min, Temp. 20°C.
Compound k' values % CRF value
Ephedrine 43 0
Oxilofrine 46 0
Oxedrine >  1 0 0 -
Norfenefrine >  1 0 0 -
Etilefrine 52 0
Isoprenaline 80 0
Noradrenaline > 1 0 0 -
Orciprenaline 90 0
Salbutamol 59, 62 32
3.2.3. CDs as Mobile Phase Additives - Reversed Phase Mode.
Mularz et al. 1988, were able to resolve the enantiomers of pseudoephedrine but not 
ephedrine when using p-CD dissolved in the mobile phase in conjunction with an achiral
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cyano-bonded analytical column. They attributed this to the differing ability of the 
analytes hydroxyl and ammonium groups to hydrogen bond to the 2' and 3' hydroxyls 
of the p-CD molecule. There are no reports in the literature of further enantiomeric 
separations of phenethylamines using the above methodology.
Perhaps not surprisingly then, no resolution was found for any of the phenethylamines 
using a range of CDs with an achiral column viz. p-,a-, Me-p, HE-p, HP-p, HP-a-CD 
or peracetyl p-CD. p-CD produced the largest drop in k' values of the analytes when 
dissolved in the mobile phase while a-CD produced the smallest reduction. These results 
may suggest that chiral discrimination interactions between the analyte and CD are not 
occurring here but the use of p-CD in capillary electrophoresis experiments (section 4.2.) 
and peracetyl p-CD in PGC work (section 3.2.4.) has proven that such interactions could 
be happening in solution here and that their detection is linked to the technique in use.
3.2.4. Porous Graphitic Carbon (PGC) Column.
Clark and Mama 1989 have used modified CDs as additives to the mobile phase for the 
enantiomeric separation of analytes on a PGC phase. Here a series of mobile phases 
containing different CDs was examined for the ability to provide enantio-separation for 
the phenethylamine compounds on PGC, which has been shown to exhibit marked 
differences in retention characteristics for a series of phenol derivatives compared to a 
standard ODS column (Forgacs et al. 1993). For these reasons it may be expected to 
facilitate unique chiral separations commensurate with its novel surface structure.
Only orciprenaline, ephedrine and oxilofrine could be enantiomerically separated when 
using a p-CD containing mobile phase. The use of HE-p-CD, Me-p-CD, HP-p-CD and 
a-CD produced no resolution for any of the analytes. Peracetyl p-CD, previously 
unreported in use with a PGC column, gave a significant improvement on the results
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obtained with p-CD although it did not generate additional chiral separations (Table 3.3).
Table 3.3. Results obtained with p-CD and peracetyl p-CD containing mobile phases 
on a PGC column. HPLC conditons: (A) MeCN - Na2HP0 4 (3 mM), (30-70 %v/v), pH 
3.0 containing 2.5 mM P-CD or (B) MeCN - Na2HP0 4 (3 mM), (36-64 %v/v), pH 3.0 
containing 2.5 mM peracetyl p-CD. PGC column (100 x 4.6 mm), 0.8 ml/min, 
Temp.20°C.
Compound
HPLC conditions (A) HPLC conditions (B)
k' values %CRF value k' values %CRF value
orciprenaline 1.8, 2.3 2 0 1.3, 2.3 78
ephedrine 3.8, 4.0 <  5 4.0, 4.5 45
oxilofrine 2.8, 3.3 35 3.3, 3.8 82
Peracetyl p-CD is unable to donate a proton when hydrogen bonding and it is insoluble 
in water, making it amenable for use with a PGC column, where mobile phases need to 
contain high levels of organic modifier to reducing analyte k' values which then also 
facilitates the dissolution of peracetyl p-CD. This hydrophobic environment could 
promote otherwise weak hydrophilic forces and help explain the improved chiral 
recognition of peracetyl p-CD over the other, more hydrophilic CDs examined.
3.2.5. Comparison of HPLC Results for Phenethylamines.
The peracetyl p-CD mobile phase in conjunction with, a PGC column provided the most 
effective overall means of HPLC separation for the phenethylamines, with very short k' 
values and relatively high resolution values obtained for ephedrine, oxilofrine and 
orciprenaline but not for the other analogues (see Table 3.3.).
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Although the p-CD bonded column also resolved these three analytes (Table 3.1.), the 
k' values were longer than the PGC column and the resolution values were lower. All 
the analytes clearly displayed some affinity for the unmodified p-CD molecule (as 
assessed from their retention data), whether it was bound to the column surface (section
3.2,1.) or added to the mobile phase used with a PGC column (section 3,2.4.). However 
the solute resolution values found with the p-CD column clearly show that its chiral 
discrimination ability was the lesser of these two.
The presence of peracetyl p-CD as an additive with a standard ODS column did not 
result in any enantio-recognition, in contrast to the results on a PGC column. This can 
be attributed to the lack of retention of the analytes and/or the transient nature of the 
diastereomeric complexes, whose interaction with the ODS surface was reduced by 
having >35% of organic modifier in the mobile phase, which was necessary to dissolve 
the water-insoluble peracetyl p-CD to any significant extent. In fact no resolution was 
observed for any of the analytes using an ODS column with CDs as mobile phase 
additives (section 3.2.3.). Clearly the selectivity of the ODS and PGC stationary phases 
must be different as neither p-CD nor peracetyl p-CD produced any resolution with the 
same analytes. The unique two-dimensional surface of PGC, consisting of closely 
intertwined ribbons of graphite, is highly sensitive to steric changes that disturb the 
electron density of solute molecules (Lim 1992). Consequently its influence on the 
separation of optical isomers will be greater than that of the ODS phase where solute 
hydrophobicity is the dominating factor in the partition mechanism (Tanaka et al. 1993).
Only the salbutamol enantiomers could be separated in the polar organic experiments 
(section 3.2.2.). The absence of any correlation between the k' values and selectivity 
results obtained in this mode with those of the other three methods, indicates that the 
polar organic chromatographic mechanisms are considerably different to those which 
operate in less hydrophobic environments. Recent publications have indeed suggested this 
to be the case (Zukowski et al. 1992 and Chang et al. 1993).
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3.3. Propranolol Anologues - Results and Discussion.
Propranolol [l-(isopropylamino)-3-(l-naphthyloxy)-2-propanol] is a widely prescribed 
optically active p-blocker used in the treatment of various cardiovascular disorders. The 
R and S enantiomers of propranolol are known to exhibit different pharmacological 
effects in vivo (Krstulovic 1989b), which has led to considerable interest in developing 
chromatographic methods to separate its enantiomers (Haginaka et a l  1992).
This section presents the range of capacity factors, k', and enantio-selectivities observed 
for a series of structurally related compounds based on the drug propranolol (1; see Fig.
3.3.), when interacting with a range of CD molecules. Of the six compounds 
investigated, four were naphthyl derivatives (1, 2, 3 and 6 ) and two were phenyl 
derivatives (compounds 4 and 5). Each of these compounds had either an /-propyl or t- 
butyl group on the secondary amine, except for compound 6 , which possessed a unique 
CONH-ethyl group and compound 3, R =  ethyl. These analogues were manufactured 
by Zeneca Pharmaceuticals with the aim of identifying additional p-blocking drugs. It is 
thus of importance to identify chromatographic means of separating their enantiomers due 
to the strong possibility of the chiral forms displaying differing effects in vivo.
Figure 3.3. Structures of compounds 1-6.
R' - O - CH2  - CHOH - CH2  - NH - R
Compound 1, R' =  naphthyl, R = /-propyl Compound 4, R' =  phenyl, R =  /-propyl 
Compound 2, R' =  naphthyl, R =  f-butyl Compound 5, R' =  phenyl, R = f-butyl 
Compound 3, R' =  naphthyl, R = ethyl 
Compound 6 , R' =  naphthyl, R =  CONH-ethyl
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3.3.1. P-CD Column in Reversed Phase Mode.
Propranolol itself has been chirally resolved by HPLC using various bonded stationary 
phases, such as cellulose tris-3,5-dimethylphenylcarbamate (Vandenbosch et al. 1992), 
an ovomucoid bonded phase (Haginaka et al. 1992) and a cellulase silica phase (Marie 
etal. 1991).
It has however proved to be much more difficult to separate propranolol using bonded 
CD columns in the reverse phase mode. Thuaud et al. 1993, did manage to separate its 
enantiomers using a novel epichlorohydrin-p-CD-ammonium modified macrocycle, with 
a 20% MeOH-phosphate buffer at pH 4, although the resolution was low (R, = 0.5) and 
the column efficiency was poor. Armstrong et al. 1986 improved the chiral resolution 
of propranolol using two p-CD bonded phase columns joined in series with a mobile 
phase of 25% MeOH-Triethylammonium acetate (TEAA) (1% v/v), pH 4.1. Due to the 
prohibitive cost of obtaining two p-CD columns, work in this laboratory used one such 
column with a view to examining how the structural differences of compounds 1 - 6  would 
affect their possible chiral resolution within a range of mobile phases and operating 
temperatures.
No resolution could be observed here for propranolol using the mobile phase listed by 
Armstrong et al. 1986. It was expected that at least some resolution would occur, albeit 
with only one P-CD column in use, but the fact that none did so suggests that there were 
substantial selectivity differences between the columns employed in both cases. Only 
compound 2 showed any resolution (11.5 %CRF) with one p-CD column and the mobile 
phase conditions used by Armstrong et al. 1986. The MeOH content was lowered to 
increase the analyte retention times, which resulted in longer k' values as expected and 
caused all but compounds 3 and 6  to display some enantio-recognition (Table 3.4.).
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Compound 6  (R =  CONHC2H5) had the longest k' values of the entire group (the 
retention is believed to be due solely to interaction with the bonded p-CD molecules), 
yet it showed no chiral resolution, whilst 2 , the most non-polar of the analytes, eluted 
in half the time and displayed a clear %CRF of 34%. Obviously the structure of the 
analyte’s R group (both with R' =  naphthyl) is important for their chiral recognition, 
which occurred in the order 2 >  1 >  3/6 (3 and 6  %CRF= 0 (see Fig. 3.4. on p. 58).
Table 3.4. k' values and %CRF values (in parenthesis) of compounds 1-6. HPLC 
conditions: p-CD column (250 x 4.6 mm), flow rate 1 ml/min. Mobile phase: X  % 
MeOH-TEAA (1% v/v) pH 4.1. Temperature 25°C.
x %
MeOH
1 2 3 4 5 6
25% 0.6 0.55, 0.57 0.3 0.3 1.2
MeOH (0) 0.48
(11.5)
(0) (0) (0) (0)
5% 1.8,1.9 1.9, 2.0 1.7 0.66 0.67, 0.73 4.5
MeOH (5) (34) (0) (*) (30) (0)
* peak shoulder too small to measure %CRF.
Lowering the %MeOH further, changing the percentage of TEAA or altering the pH did 
not result in any significant improvement to the %CRF values of the compounds. It was 
then decided to vary the temperature and observe its effect.
Lowering the temperature can cause an improvement in chiral resolution when using CDs 
(Aboul-Enein et al. 1988) by increasing the k' values of the enantiomers due to an 
enhancement of the interaction between the CD stationary phase and the eluting analyte 
molecules i.e. an increase in the CD:analyte binding constant (Ahuja 1991). This can in 
turn cause an improvement in the chiral recognition process. In view of this effect, the
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temperature of the chromatographic system was varied between 10°C and 35 °C and the 
results on k' values and %CRF are shown in Figs. 3.5 and 3.6., respectively on p. 59.
Fig. 3.4. Chromatograms of compounds 1, 2 and 3 showing various degrees of chiral 
separation. HPLC conditions: p-CD column (250 x 4.6 mm), flow 1 ml/min. Mobile 
phase: 5% MeOH-Triethylammonium acetate (1% v/v) pH 4.1, Temp. 25°C.
injection point
10 8 6 4 2 0
injection point




All the compounds showed a decrease in k' values as the temperature was raised from 
10°C to 35°C. Compounds 1, 2, 4 and 5 demonstrated a reduction in %CRF values over 
the same increasing temperature range (Fig. 3.6.). Compounds 3 and 6  showed no 
enantio-separation under any of the conditions used here.
Fig. 3.5. and 3.6. k' values and %CRF values for 1-6 with changing temperature. 
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Only compounds 5 and 2 still showed chiral resolution at 35 °C. It was also seen that 
decreasing the temperature from 15°C to 10°C resulted in no further improvements in 
resolution for any of the analytes, except in the case of compound 2 .
Three bands occurred in the van't Hoff plots (log k' vs 1/T °K) for the compounds (see 
Fig. 3.7. on p.61). The fact that some of the compounds bunched together in this manner 
suggests a similarity in retention mechanisms, engendered by their relative structural 
similarities viz. compounds 1, 2 and 3 (naphthyl group with R =  /-propyl, f-butyl and 
ethyl respectively) produced one set of van’t Hoff plots very close together as did 
compounds 4 and 5 (phenyl group with R = /-propyl and f-butyl), whereas compound 
6  (naphthyl group with a urea linkage) produced a distinctly separate plot from these 
others. It was further noted that the plots were relatively non-linear (r <  0.9900), except 
for those of compounds 6  and 3, which showed straighter lines (r =  0.9972 and 0.9925 
respectively).
According to Horvath et a l  1976, non-linear plots can be expected whenever any one 
of the following three conditions holds;
(i) the eluate exists in two or more forms having a different retention,
(ii) there exists two or more retention mechanisms as a result of the heterogeneity of 
the stationary phase surface containing more than one type of binding site,
(iii) both (i) and (ii) are true.
It would appear here that condition (iii) is likely to be true as each analyte has two 
different 'forms' (R and S configuration, which can interact differently in a chiral 
environment even though they may not be chromatographically resolved) and the p-CD 
stationary phase is known to operate using a variety of binding forces, such as 
hydrophobic interactions, van der Waals forces and hydrogen bonding (Piperaki et al.
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1994). The fact that compounds 6 and 3 (with R and S configurations) have more linear 
van't Hoff plots than the others (coupled with their lack of optical resolution) suggests 
that they may be primarily interacting with the p-CD molecules via only one main 
driving force e.g. hydrophobicity. The long alkyl chain of 6 may be unfavourable for a 
chiral discriminatory interaction with the mouth of the p-CD molecules as the nitrogen 
nuclei of the urea group are less amenable to hydrogen-bond formation than the amine 
functions of the other analogues. Thus the 'three point interaction' model proposed by 
Dagleish 1952 would be more unlikely to occur, explaining its lack of optical resolution.
According to Issaq et a l  1987 when the percentage decrease in retention times (with a 
p-CD column) are the same for two or more analytes upon increasing the temperature, 
the interactions of the analytes with the stationary phase can be assumed to be similar. 
Table 3.5. shows how the % decrease in retention times for compounds 1 to 3, and 4/5 
are very close.
Fig. 3.7. van't Hoff plots for compounds 1-6. HPLC conditions as in Fig. 3.6.
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0.65 - * compound 2± m r -  0.9845
▼ compound 3
0.40 - r -  0.9925
cr>O •  compound 4r -  0 .9540- J 0 . 1 5 -
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- 0.10  -
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Table 3.5. The % decrease in retention times (mins) for compounds 1-6 upon 
increasing the tem perature from 10°C to 35°C. HPLC conditions as in Fig. 3.6.
Compound 1 2 3 4 5 6
% decrease in retention 
time (mins)
58.9% 58.4% 59.3% 78% 77.7% 47%
The value of the % decrease in retention time for compound 6  is much lower (only 47%) 
than that of the other analytes, which demonstrates, in conjunction with the van't Hoff 
plot (Fig. 3.6.), that its interaction with the P-CD stationary phase is significantly 
different to the other compounds.
Those analytes with a bulky non-polar f-butyl group (i.e. compounds 2 and 5) displayed 
the largest %CRF, with compound 2 always having the higher value (see Fig. 3.6.). The 
larger naphthyl moiety of compound 2  may allow for a tighter fit of the analyte inside 
the CD cavity (explaining its consistently longer retention than that of compound 5) and 
possibly provide for a more favourable chiral interaction of the analyte alkyl chain with 
the secondary hydroxyl groups of the host macrocycle.
3.3.2. Polar Organic Investigations.
Initial experiments used conditions developed by Armstrong et al. 1992. In that work 
propranolol (1 ) was stated to be baseline resolved using a polar organic mobile phase of 
MeCN-MeOH (95-5 %v/v), containing HOAc-TEA (0.3-0.2 %v/v) with a p-CD bonded 
column. However such a degree of separation for compound 1, under the same operating 
conditions, could not be achieved in this laboratory. Here the %CRF value for 
propranolol was only 22.5% as compared to the baseline (i.e. 100 %CRF) separation 
claimed by Armstrong et al. 1992.This may have been due to column efficiency 
differences caused by batch to batch reproducibility changes in the manufacturing process
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or possible alterations to the stationary phase surface caused by extensive use of this 
column for previous reversed phase applications. The separation values reported here are 
still reasonably good however and their value lies in comparing them with the varied 
structures of the analytes and in suggesting the important role which hydrophobic / steric 
forces may still possess in relatively non-polar environments.
Increasing the amount of MeOH in the mobile phase is known to decrease the retention 
time of p-blocker type molecules, by virtue of competition with the analytes for 
hydrogen-bonding sites on the CD rim. Thus the analyte:CD interaction is reduced, 
Chang et al. 1993. This behaviour is apparent from consideration of Fig. 3.8. which 
shows that the k' values of compounds 1-5 decreased with an increasing MeOH content 
and a concurrent fall in the MeCN concentration. A comparison of Fig. 3.8. and Fig. 
3.9., in which %CRF is plotted against %MeOH, shows that all the individual analytes 
except 3, displayed their highest observed %CRF in connection with their highest k' 
values i.e. the stronger any one specific analyte interacted with the p-CD stationary 
phase, then the higher was its %CRF.
Fig. 3.8. k' value vs % MeOH and Fig. 3.9. %CRF vs %MeOH.
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It is of interest to compare the rank order of %CRF and k ' values for the group of 
compounds studied. When R' was either naphthyl or phenyl, the k ' of the compounds 
decreased (3 <  2 <  1 and 4 < 5) as the size of the R group increased (ethyl <  /-propyl 
<  f-butyl). Conversely, for each subset of analogues, the %CRF showed an opppsite 
relationship and increased with the size of the R group (3 >  2 >  1 and 5 >  4, see Fig. 
3.9.). It appears that stronger interactions with P-CD, as indicated by longer k ' values, 
do not necessarily confer enantioselectivity. Thus an increase in hydrophobicity of the 
R group decreases the affinity of the ligand for the macrocycle while at the same time 
affecting those interactions which confer enantio-discrimination. It has been noted 
previously (Branch et al. 1994) that a derivatised p-CD, which showed greater chiral 
discrimination than p-CD, displayed weaker binding to some phenethylamine analytes.
It is considered that analytes do not enter the CD cavity in the polar organic mode but 
rather are believed to sit over the CD like a 'lid 1 and interact through some process 
involving hydrogen-bonding (Armstrong et al. 1992 and Chang et al. 1993). As 
compounds 1, 2 and 3 differ only in their R group, which is itself incapable of hydrogen- 
bonding, any differences seen in %CRF probably arise as a result of varied 
steric/hydrophobic interactions with the CD. Upon comparison of the analyte pairs 1/4 
and 2/5, it is apparent (see Fig. 3.9.) that for the same R groups, when R' =  naphthyl 
(as in 1 and 2), the %CRF is lower than if R' =  Phe (4 and 5). Figure 3.10. on p. 64 
shows the effect on resolution of a variation in the R group of compounds 1, 2 and 3 
where R' =  naphthyl and also compounds 4 and 5 where R' =  phenyl.
Fig. 3.11. on p. 6 6  shows the structure of the alkyl chain and the hydrogen-bonding 
(dashed lines) proposed to occur with the CD rim, as stated by Armstrong et al. 1986. 
If the van der Waals radius of the R group is large enough to cause steric repulsion with 
the CD it could explain the experimental observation that within each analyte subset,
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%CRF increases as R hydrophobicity (and steric bulk) increases and that k' values 
simultaneously fall due to a greater repulsive effect.
Fig. 3.10. Effect of R group on retention and %CRF values. [1] (R' = naphthyl) a) 3, 
R= ethyl, b) 2, R = /-butyl, c) 1, R= /-propyl and [2] (R'= phenyl) a) 4, R= /-propyl 
and b) 5, R =  /-butyl. HPLC conditions: p-CD column (250 x 4.6 mm), mobile phase; 
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It was not possible to observe enantio-discrimination for compound 6  under any of the 
experimental conditions tested. This analyte, which has an extended R group containing 
a urea linkage, was virtually unretained in all the experiments (<  5 mins). The decreased 
ability of the urea group to hydrogen bond (due to the participation of its nitrogen atom’s 
lone pairs in the resonance hybrid structure) may have been responsible for its rapid 
elution compared to compounds 1-5, each of which possessed a secondary amine group.
Figure 3.11. Complexation Structure between Propranolol Analogues and P-CD.
This figure is schematic only and does not represent the actual interaction model.
Using a mobile phase of MeCN-MeOH (95-5 %v/v) the TEA and HO Ac ratio was varied 
and the resulting effects on analyte k ' values are shown in Figs. 3.12 and 3.13. 
Increasing the %TEA relative to a fixed HO Ac of 0.3.%, caused a steady decrease in k' 
values for compounds 1 to 5 (Fig. 3.12), whereas increasing the %HOAc concentration 
(relative to a fixed TEA of 0.2%) caused firstly an initial decrease in k' values, followed 
by a subsequent increase and then finally little or no change in retention at a HOAc:TEA 
ratio of 4:1 (Fig. 3.13). All five analytes behaved in a similar manner. Due to the very
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low retention of compound 6 it was not possible to observe any significant change in its 
behaviour upon altering the HOAciTEA ratio and consequently the data is not reported 
here.
Figs. 3.12. Capacity factors (k') vs. % TEA and 3.13. Capacity factors (k') vs. % 
HOAc. HPLC conditions as in Fig. 3.10. with varying % of TEA or HOAc.
Fig. 3.12.
Fig. 3.13.
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Clearly the ratio of HOAc:TEA controls the degree of ionization of the analytes (all of 
which are secondary amines) and therefore their ability to hydrogen-bond to the CD 
hydroxyl groups. Any reduction in the hydrogen-bonding is likely to reduce analyte 
retention and it would appear that increasing the HOAc:TEA ratio from 1:1 to 1:2 (Fig.
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3.12) did indeed reduce the analyte-CD complexation. The TEA molecules, which are 
strong hydrogen acceptors, will compete with the analytes for the hydroxyl groups on 
the cyclodextrin rim. An increase in the TEA content of the mobile phase will enhance 
this competitive effect, which may explain the lower analyte k ' values. The effect on 
%CRF was rather muted however, with all the analytes showing little change in %CRF 
(see Fig. 3.14. on p.69). Factors other than hydrogen bonding would seem to also be 
important for enantio-recognition as implied from the rather small %CRF differences 
seen with these analytes when changes are made to the acid:base ratio as described 
above.
The initial decrease in retention time seen with increasing the HOAc to 0.4% may also 
have been caused by the ability of the HOAc molecules to hydrogen-bond to the CDs, 
but the subsequent formation of acetate salts of the analytes at relatively high acid 
concentrations (which are less soluble in organic solvents, Armstrong et al. 1992), may 
have accounted for the later increase in analyte retention (Fig. 3.13.). The effect on 
%CRF of increasing the %HOAc concentration was less straightforward (see Fig. 3.15 
on p .69). Compounds 2, 3 and 5 showed only relatively slight differences in %CRF 
(<  12%) whereas compounds 1 and 4 (both with R =  z-propyl), had a larger range in 
%CRF of 17% and 24% respectively.
Thus %HOAc had a stronger effect on %CRF than %TEA over the range studied. All 
the analytes, except compound 6, gave a maximum %CRF at a HOAc:TEA ratio of 
0.3:0.2 % v/v. This emphasises the proposed importance of hydrogen-bonding in the 
polar organic mode, as all these analytes would exist in the same ionization state at this 
acid-base ratio (due to their similar amine sites), which has proven to be optimum for 
their enantio-resolution. In reversed phase systems, alcohols are known to have a 
stronger association with cyclodextrins in the order PrOH > EtOH > MeOH (Technicol 
1992). When MeOH was replaced by EtOH in the polar organic mobile phase, all the 
compounds showed a decrease in their k7 values presumably caused by a stronger
68
Figs. 3.14. % CRF vs %TEA and Fig. 3.15. % CRF vs % HOAc. HPLC conditions 
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displacement from around the CD by the EtOH molecules (Table 3.9., see p.69). 
Another explanation for this decrease in k' values may be associated with the moisture 
contents of MeCN (0.02%), MeOH (0.002%) and absolute ethanol (0.2%) used in these 
studies. Whilst the presence of 5% MeOH would not significantly change the moisture
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content of the MeCN, its replacement by 5% EtOH would raise the moisture content of 
the mobile phase from 0.002% to 0.03%. Although it has been shown that moisture 
levels below 4% can dramatically reduce k7 and a  values, it is not clear wether this small 
increase is sufficient to reduce k7 values here.
Two of the analytes (compounds 1 and 3) showed a reduction in enantio-selectivity whilst 
three of them (compounds 2, 4 and 5) actually gave improved %CRF values. The 
structure of the alcoholic modifier clearly has an important influence on the overall 
enantio-recognition process probably through alterations to the solvation shell around the 
analyte and cyclodextrin, which is also likely to vary from solute to solute.
Table 3.9. Effect of MeOH and EtOH alcoholic modifiers on k ' values and enantio- 
resolution (%CRF) of compounds 1-6. HPLC conditions: p-cyclodextrin bonded 
column (250 x 4.6mm), mobile phase; MeCN-MeOH or EtOH (95-5 %v/v), HOAc-TEA 
(0.3-0.2 %v/v) at 1 ml/min. Temp 25°C.
k' values (first peak) %CRF
Compound 5% MeOH 5% EtOH 5% MeOH 5% EtOH
1 15.1 10.1 62 58
2 11.9 7.9 77 87
3 21.1 16.5 17 5
4 16.4 10.6 65 75
5 12.6 8.6 82 89
6 2.4 1.9 0 0
3.3.3. CDs as Mobile Phase Additives - Reversed Phase Mode.
Propranolol has reportedly been separated by Mularz et a l  1988, using p-CD as a 
mobile phase additive in RP-HPLC, although the a value was low (1.04). There appear
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to be no other published reports concerning the resolution of propranolol enantiomers by 
this means. In this study a series of CD derivatives were dissolved in a mobile phase of 
MeCN-KH2P 0 4 (15-85 %v/v), 5 mM, pH 3.5 at a concentration of 12 mmol with an 
achiral C8 Inertsil column (10 x 0.21 cm). These conditions were chosen to allow for 
reasonable k' values i.e. 5 to 20 and to minimize the amount of mobile phase needed as 
some of the CDs were in short supply. The Inertsil column is strongly base deactivated 
which makes it ideal for the study of basic compounds by preventing excessive peak 
tailing. Despite these measures and subsequent alterations to the chromatographic 
conditions (changes in the organic modifier content and pH), no chiral resolution was 
observed for propranolol (1) in the presence of any of the CD molecules. Only compound 
2 displayed enantio-recognition, with a %CRF = 30 % upon addition of 12 mM HE-p- 
CD.
Figure 3.16. shows the k' values of compounds 1-5 in the presence of various CD 
derivatives. Inclusion of the analyte by the CD molecule will tend to result in shorter 
retention times due to a reduction in the free analyte - stationary phase interaction. The 
k' values of compound 6 were always greater than 45, giving a small and very broad 
peak. This suggests that this analyte interacts very little, if at all, with the CD molecules 
under these conditions.
Although practically no enantiospecific discrimination occurred for any of the compounds 
it can be seen from Fig. 3.16., on p.72, that non-specific inclusion did occur in most 
cases i.e. significant changes in the analyte retention were found upon addition of the 
various CD molecules. a-CD produced little change in the retention of compounds 1-3 
which would be expected due to the large size of the naphthyl group of these analytes 
preventing inclusion with the smaller CD torous.
The He and Me derivatives of p-CD produced the largest reduction in k' values for 
compounds 1-3. Derivatization of the three parent CDs did therefore effect all the
analytes behaviour but no chiral resolution was observed (except in the one case noted 
before). Apparent increases in the analyte-CD binding (as denoted by reduced k' values) 
were found to be no guarantee of optical separation.
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3.3.4. Porous Graphitic Carbon (PGC) Column.
Josefsson et al. 1993 have resolved diastereomeric derivatives of propranolol {a(-) 
menthyl chloroformate} using a Hypercarb S column and Clark and Mama 1989, have 
stated that the enantiomers of propranolol (1) can be separated using a porous graphitic
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carbon (PGC) stationary phase (100 x 4.6 mm) and a mobile phase of MeCN-Na2HP04 
3 mM (90:10), pH 3, containing 2.5 mM p-CD. Other p-blocking agents have reportedly 
been separated under similar conditions eg Mama et al. 1989 have described the partial 
separation of the enantiomers of metoprolol. It was thus decided to examine the 
propranolol analogues (compounds 1-6) using this methodology to try to effect some 
novel separations with a PGC column (100 x 4.6mm, 7/nn dp).
Despite repeated attempts it proved impossible to dissolve 2.5 mM of p-CD in a mobile 
phase with 90% MeCN so that it was not possible to reproduce the results stated by 
Clark et al. 1989 for the separation of the propranolol (1) enantiomers. The organic 
modifier content was lowered to 50% which allowed a dissolution of 5.3 mM p-CD (the 
maximum possible at that MeCN level according to Taghvaei et al. 1991) but no chiral 
resolution was observed for any of the compounds. Subsequent changes to the buffer 
concentration and pH were to no avail. The additions of HP-p-CD, HE-P-CD, Me-p-CD 
or p-CD, failed to produce any observable enantio-recognition for compounds 1-6. 
However, the CDs did cause the k' values of the analytes to decrease when compared to 
a mobile phase lacking any CD additive, indicating that some CD:analyte interaction 
probably did occur.
Upon addition of 2.5 mM peracetyl p-CD to a mobile phase of MeCN-Na2HP04, 3 mM, 
(36:64 %v/v) pH 3, enantio-resolution was observed for compounds 4 and 5 (Fig. 3.17.). 
It would appear that the bulky naphthyl moiety of compounds 1 and 2 may be responsible 
for their lack of resolution as they only differ from analytes 4 and 5 in this respect. 
Compounds 3 and 6, which also possessed a naphthyl group, did not exhibit any chiral 
resolution either.
Peracetyl p-CD is an extremely hydrophobic CD derivative (it is water insoluble), which 
unlike the other CDs tried, can only function as a hydrogen bond acceptor in the 2, 3 and
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6 positions. Due to its hydrophobic nature high levels of organic modifier are required 
to dissolve it. A saturated peracetyl p-CD mobile phase of 50% MeOH-H20  has been
Figure 3.17. Chiral resolution of compounds 4 and 5 using a porous graphic carbon 
stationary phase. Mobile phase: MeCN-Na2HP04, 3 mM, (36:64 %v/v) pH 3, 2.5 mM 
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shown to resolve the enantiomers of methylphenobarbital and two derivatives using a 
LiChrosorb RP 18 column (250 x 1 mm) (Krustulovic 1989c) with retention times of 
between 25 and 110 mins, whilst the slight enantio-resolution observed by Sybilska et 
al. 1988 for the enantiomers of norgestrel under similar conditions took over 35 mins. 
However the k' values here were under 1.1 for compounds 4 and 5 (retention times <1.0 
mins). These very quick elution times are due to the absence of functional sites on the 
carbon stationary phase surface retarding the movement of the analytes (Kaur, 1991). A
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porous graphitic carbon column seems then to offer an attractive alternative to the use 
of conventional reverse columns when high amounts of organic modifier are necessary 
to allow dissolution of hydrophobic mobile phase additives e.g. peracetyl P-CD.
3.3.5. Comparison of HPLC Results for Propranolol Analogues.
Of the four different chromatographic approaches used (reversed phase CD bonded, 
reversed phase CD additive, PGC CD additive and polar organic mode), the propranolol 
analogues were best separated using the polar organic methodology, employing the same 
p-CD column as in the reversed phase mode. p-CD as a mobile phase additive, produced 
no chiral resolution for any of the analytes when used with either an ODS or a PGC 
column. With p-CD as the chiral selector in each of the four HPLC techniques 
employed, the order of analyte retention ( 6 > 2 > 1 > 3 > 5 > 4 )  was identical in three 
modes i.e. reversed phase CD bonded, reversed phase CD additive and PGC CD 
additive. With the polar organic approach however, the order of analyte retention was 
different ( 3 > 4 > 1 > 5 > 2 > 6 ) .  Furthermore, the analyte resolution order on the reversed 
phase CD bonded column (section 3.3.3.) was different in every case i.e. in the reversed 
phase CD bonded mode the enantio-resolution order was compound 2 > 5, 1 >  4 and 
3 =  6, but in the polar organic mode this order changed to 5 >  2, 4 >  1 and 3 >  6.
These results suggest that the separation and retention mechanisms operating in the polar 
organic conditions are significantly different to those in the reversed phase situation. This 
is consistent with the findings of Zukowski et al. 1993 and Armstrong et al. 1992, who 
suggested that polar organic enantioselectivity is caused by hydrogen bonding at the CD 
mouth, where the analyte is positioned like fa lid'. Hydrogen-bonding alone will not be 
enough for chiral discrimination in the polar organic mode. If it were, then separations 
would be repeatable under normal phase conditions. This is not the case (Chang et al.
1993). With no inclusion complexation occuring, the analyte aromatic rings will be
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readily solvated in the hydrophobic solvent, whilst the alkyl chain containing polar sites 
and a terminal hydrophobic group, will be brought into closer contact with the 
cyclodextrin rim. If this terminal hydrophobic group exerts a size dependant repulsive 
steric effect with the polar cyclodextrin rim, it could, in conjunction with the hydrogen- 
bonding, provide the necessary 'three point interaction1 required for chiral 
discrimination. Interactions necessary for optical resolution may be attractive or repulsive 
(Krstulovic 1989b).
Peracetyl p-CD displayed a unique selectivity towards compounds 4 and 5 on the PGC 
column, but subsequent experiments on an ODS column failed to reproduce this 
behaviour (no analyte retention was observed by virtue of the high level of organic 
modifier required for dissolution of the CD). The very short retentions and yet high 
resolutions seen on PGC with peracetyl p-CD, demonstrate that judicial selection of the 
stationary phase can be as important as the choice of chiral selectand.
Only compound 2 was resolved under reversed phase conditions on an ODS column, 
when HE-p-CD was added to the mobile phase (section 3.3.1.). However, by virtue of 
the observed reductions in analyte k' values (see Fig. 3.16.) in the presence of various 
CDs, it was clear that inclusion complexation was occurring in many cases. a-CD, HP- 
a-CD, HP-y-CD and HP-p-CD tended to produce the smallest changes in compound k' 
values. This may be linked to the ‘tightness’ of analyte fit within the CD cavity, where 
a-CD and HP-a-CD were too small to allow inclusion, while HP-y-CD and HP-P-CD 
provided too large a cavity to provide for effective steric interaction. This was clearly 
the least successful method of chiral resolution for the propranolol analogues and 
explains the lack of publications dealing with this particular approach.
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3.4. Mequitamium - Results and Discussion.
Mequitamium (see Fig. 3.18.) is a chiral anti-microbial compound developed for 
disinfecting solutions contact lenses thus aiding in the prevention of eye infections caused 
by the presence of certain pathogenic bacteria. Pharmacological tests have shown that the 
R-isomer is the most active form of the compound and it was thus desirable for the 
manufacturers to develop chromatographic methods to separate the enantiomers.
Fig. 3.18. Structure of Mequitamium.
3.4.1. CD Column in Reversed Phase Mode.
It was not possible to enantiomerically resolve mequitamium using a y-CD bonded 




the organic modifier concentration / type, pH, buffer and flow rates were to no avail. 
The analyte eluted with a k' value <  4 with no observable chiral discrimination. The 
analyte was clearly interacting weakly with the stationary phase surface under most of 
these experimental conditions.
The chiral selector, y-CD, may be influenced in some way when bound to the column 
surface in the manufacturing process. The CD is joined to the silica gel via one or more 
silane linkages, mostly at the narrow primary end of the CD molecule (Armstrong 1985). 
This connecting spacer arm will clearly restrict the orientation and motion of the y-CD 
molecule, which may explain its lack of interaction with the analyte. Some workers have 
observed discrepancies when comparing data between CDs in the eluent and bonded 
phase modes (Cooper and Jefferies 1991, Armstrong et al. 1985).
Similar experiments with mequitamium using a p-CD bonded column also failed to 
produce any enantioselectivity. A comparison of the k' values of the analyte with each 
bonded column type, under the same operating conditions, showed that there was no 
significant difference in the degree of retention.
3.4.2. Polar Organic Investigations.
In order to accomplish separations in the polar organic mode the analyte must possess 
more than one hydrogen donor and/or acceptor group (Technicol 1992). Examination of 
the structure of mequitamium (Fig. 3.18.) shows that it does not fit the criteria for 
enantiomeric resolution in this mode. A few initial experiments with a y-CD bonded 
column demonstrated that the analyte was poorly retained using a polar organic mobile 
phase and that no chiral resolution occurred, as may have been expected.
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3.4.3. CDs as Mobile Phase Additives - Reversed Phase Mode.
Mequitamium is a quaternary ammonium compound and will be strongly retained on any 
material possessing negatively charged groups, such as unreacted silanols present on 
a column surface. During initial achiral experiments using a highly base deactivated 
column (LC-ABZ, 250 x 4.6 mm) it proved impossible to elute the analyte without 
having at least 40% MeCN in the mobile phase. This amount of organic modifier then 
severely limits the amount of CD which can be dissolved in the mobile phase. In a novel 
solution to these problems, experiments were conducted using two pKb pre-columns (20 
x 4.6 mm) joined in series as the analytical columns (Eto and Noda 1992 have used 25 
or 50 mm ODS cartridges in chiral separations with p-CD mobile phases).
Using this chromatographic system the elution time of mequitamium was still over 80 
minutes with a mobile phase containing 12% MeCN. Addition of various CD molecules 
generally produced a reduction in the analyte retention time and caused enantio- 
separations in two instances: with y-CD (Fig. 3.19., see p .81) and HP-p-CD (Table 
3.10., see p .80).
The addition of a-CD produced no resolution or reduction in k' values as might have 
been expected, due to its rather small cavity diameter (4.7 - 5.2 A) being unable to 
accommodate any portion of the much larger mequitamium structure. Two CDs, p and 
HP-y, caused the analyte to elute faster than HP-p-CD and y-CD respectively (indicating 
stronger complexation), yet unlike these aforementioned CDs, produced no observable 
enantio-resolution. Of the other three CDs tested, no chiral resolution occurred though 
analyte k' values were decreased. CD inclusion around the aromatic portion of 
mequitamium would probably reduce analyte retention on the column, so accounting for 
the faster elution, but such interaction may be at a point too far removed from the 
analyte's chiral centre on the bulky aliphatic ring, to provide for stereospecific 
resolution.
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When MeOH was substituted for MeCN under the mobile phase conditions stated in Fig. 
3.19. (see p .81), mequitamium chiral resolution was completely removed and the k' 
values increased from around 20 to 45. Selectivity differences between organic modifiers 
may be attributed to their solvation strengths and varied associations with the CD 
molecules viz. MeOH is known to be able to hydrogen-bond with the external hydroxyl 
groups of CDs so that it may lessen analyte interaction (Technicol 1992), which may 
account for the removal of mequitamium enantio-resolution and increase in k' factor seen 
here.
Table 3.10. k' values and enantio-resolution values (Rs) for mequitamium. HPLC 
conditions: pKb pre-column (20 x 4.6 mm) x2, mobile phase 12% MeCN:88 % 
NaH2Citrate (10 mM) containing 12 mM of CD, 0.8 ml/min flow rate, Temp. 25 °C, UV 
detection 254 nm.
Cyclodextrin none a P Y HP-a HP-p HP-y Me-P HE-p
k' values 81 81 6.12 18.7,20.7 46 6.75,
7.44
45.6 21 31
Rs values - 0 0 1.06 0 0.3 0 0 0
Further method development proceeded using y-CD, which clearly demonstrated a higher 
degree of chiral selectivity than the other CD molecules. The optimum MeCN content 
was found to be 12%. Below this the k' values of the enantiomers were approaching 45 
or greater, which is unacceptable for routine analysis work, whilst the increase in chiral 
resolution seen (1.1 at 8% MeCN) was small. The selectivity (a) was quite high (1.11) 
but the efficiency of the chromatographic system was inherently very low, with typical 
N values between 2500 and 4500 theoretical plates. Resolution is strongly dependant on 
the number of such plates, which are generally greater than 10,000 in a standard HPLC 
set-up. An increase in the number of theoretical plates may have improved the peak 
separations but the already high k' values precluded the use of a conventional 250 x 4.6
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mm column to accomplish this. Capillary electrophoresis, where large N values are 
common, provided a solution to this problem (see section 4.4.).
Figure 3.19. Chromatogram of mequitamium in the presence of y-CD. HPLC 
conditions: pKb pre-column (20 x 4.6 mm) x2, 12% MeCN:88% NaH2Citrate (10 mM) 
containing 12 mmol y-CD, 0.8 ml/min flow, Temp. 25°C, UV detection 254 nm.
Injection point
Kf (association constants) and k ^  cd (complex retention values) were determined for each 
enantiomer from the variation of k' with mobile phase y-CD concentration. By plotting 
k'obs vs (k's -k'obs)/(CD) as in Figure 3.20., the Kf and k'a cd may be determined from 
the inverse slope and y-axis intercept respectively. This is the method proposed by 
Sybilska et al. 1986 and given in equation 3.09 (section 3.1.5.). The calculated values 
are given in Table 3.11. The relatively large k'a cd values indicate the high retentivity 
of the diastereomeric complexes on the stationary phase. The adsorption of 
diastereomeric complexes is believed to be practically zero when the included guest is
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completely immersed in the CD cavity (Botta et al. 1988). The adsorption (capacity 
factor) of y-CD on a ODS stationary phase has been shown to be close to zero, under 
reversed phase conditions (Dodziuk et al. 1994). These results suggest that a significant 
portion of the mequitamium structure must be protuding from the y-CD cavity so that 
it can still be retained strongly by the pKb pre-columns. The Kf values themselves are 
not significantly different from each other, indicating that the chiral resolution was more 
strongly influenced by the large k'a cd values. Sybilska et al. 1986 reported that the 
resolution of mephenytoin enantiomers arises from the differential adsorption of their 
diastereomeric complexes on an ODS column.
Figure 3.20. Plot of k'obs vs (k's -k'obs)/(y-CD) mmol. HPLC conditions as Fig. 3.19.
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Table 3.11. Kf and k'a cd values for mequitamium in the presence of y-CD.
HPLC conditions as in Figure 3.19.
Enantiomer Kf M 1  ^a.cd..... r value
R-isomer 396 8.5 0.9983
S-isomer 427 6.8 0.9953
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3.4.4, Porous Graphitic Carbon (PGC) column.
Although porous graphic carbon (PGC) does not possess any surface functional groups 
(Kaur 1991), which would make it amenable to the analysis of quaternary nitrogen 
compounds such as mequitamium, electron rich solutes will be strongly retained due to 
a unique interaction with the delocalized electron conduction bands of PGC (Bell et al.
1994). The TT-electron aromatic rings of mequitamium may have been responsible for the 
strong retention of the analyte seen on the PGC column. High amounts of organic 
modifier (>60%  MeCN and MeOH) were necessary to elute the solute even in the 
presence of various CD molecules (Table 3.12., see p .84). Such high levels of organic 
modifier may explain the total absence of any optical resolution in the presence of any 
of these CDs, as the modifiers out-competed the analyte for the CD cavities.
The overall pattern of k' factor changes here is similar to that observed when using a 
standard hydrophobic HPLC column under reversed phase conditions (Table 3.10.), 
although the extent of the changes here is smaller viz. the high level of organic modifier 
has lessened the ability of the CDs to complex with the analyte and hence reduce its 
interaction with the PGC surface. However Me-p-CD caused a much greater relative 
reduction in analyte retention with the PGC phase than with the pKb columns. This is 
likely to have been due to the preferential adsorption of this rather hydrophobic CD onto 
the PGC surface and the subsequent generation of a 'dynamically coated stationary 
phase', which hindered the interaction of mequitamium with the column surface, thus 
causing its faster elution. Such 'dynamically coated phases' have been reported before, 
but only with C l8 stationary phases and methylated CDs (Zukowski et al. 1989).
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Table 3.12. k ' values for mequitamium in the presence of various CDs. HPLC 
conditions: Na2H P04 (3 mM) - MeCN, (40-60 v/v%), pH 3.1, containing 2.5 mM CD. 
PGC column Hypercarb S (100 x 4.6 mm), 1 ml/min, UV detection 254 nm. Temp. 
25 °C.
CD none a P Y HP-ct HP-P HP-y Me-p HE-p
k' values 97 90 74 66 87 61 81 19 52
3.4.5. Comparison of HPLC Results for Mequitamium.
The only method to separate the mequitamium enantiomers was that using a reversed 
phase pKb pre-column with the addition of a CD (either y or HP-p-CD) to the mobile 
phase (section 3.4.3.). When a PGC column was employed the k' values increased 
greatly, from <  21 with the pKb columns to over 60, even in the presence of y-CD and 
enantio-recognition was lost. The two aromatic electron rings of mequitamium will have 
a greater influence on its retention with the PGC surface than on an ODS type phase, 
due to the possibility of charge transfer and /or 7i-electron overlap occurring with the 
delocalized electron bands of PGC (Lim 1992). This explains the longer k/ values found 
on the PGC column for mequitamium and also accounts for its lack of chiral resolution 
as the affinity of the enantiomers for the CD molecules in the mobile phase is reduced 
by their strong adsorption on to the stationary phase surface.
A y-CD bonded column was unable to provide optical resolution (section 3.4.1.) in 
contrast to the use of the same chiral selector when dissolved in the mobile phase (section
3.4.3.). Clearly the selectivity of the y-CD macrocycles towards mequitamium has been 
adversely affected by tethering the host molecules to the silica stationary phase. 
Constraints on the CD orientation, alterations to its overall geometry and possible solute 
interaction with the linking spacer arm, are potential reasons for such observations. 
Analyte:CD stoichiometric ratios are often 1:1, but higher ratios have been reported
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(Hamilton and Chen 1988 and Szejtli 1981). If the stoichiometric ratio was greater than 
1:1 with mequitamium (e.g. 2:1 in favour of the y-CD molecule), it could help to 
account for the lack of resolution using the bonded phase, as the sterically constrained 
CD molecules would be less able to form such ratios. However the linear relationship 
seen in Fig. 3.20. between k ^ g  vs (k'g -k'obs)/(y-CD) is in accord with a 1:1 complex 
stoichiometry (Allenmark 1991), which suggests that some aspect of the linkage 
procedure itself is responsble for the lack of resolution. Further, calculation of the kfa C(j 
values of the enantiomers (section 3.4.3.) showed that the high retention of the 
diastereomeric adducts on the achiral column surface, was very important to their optical 
resolution. This behaviour is no longer a factor when employing a CD bonded column 
and it is not unexpected then, that no resolution should occur because the difference in 
the R and S enantiomer Kf values was not significant (Table 3.11.). Separations in the 
polar organic mode were not possible because of the lack of suitable hydrogen bonding 
/ acceptor sites on mequitamium. The criteria for chiral recognition by this means are 








Electrophoresis can be defined as the differential movement of charged species by 
attraction or repulsion in an electrical field. As a separation technique it was first 
introduced by Tiselius in 1937 when he demonstrated the separation of charged proteins 
in a buffer filled tube. Most later work concentrated on using anti-conductive stabilizers 
such as gels, in order to try to overcome the inherent problems of sample thermal 
diffusion and convection (Joule heating), which severely limited efficiency and 
resolution. However these stabilizers have associated problems such as eddy migration 
and matrix interactions with the samples (Smith and Evans 1994). Narrow capillaries 
filled with buffers overcome these problems and the work of Hjerten in 1967 and 
Mikkers in 1979 led the way in using capillaries with internal diameters of ^1 mm. 
Jorgenson and Lukacs (1981a and 1981b) pioneered the application of fused silica 
capillaries with internal diameters of 75 /xm (with potential differences around 30 KV) 
and demonstrated for the first time that very high efficiencies and short analysis times 
were achievable.
4.1.1. Basic Theory of FSCE.
The mathematical treatment described here is largely based on the theoretical work 
performed by Jorgenson and Lukacs 1981a and 1981b and Jorgenson 1984. When an 
electric field is applied across a capillary filled with a buffer (FSCE), anions migrate 
toward the anode (positive electrode) and cations migrate towards the cathode (negative 
electrode). The velocity of migration, v, can be given by;
(Equation 4.01.)
where E is the potential field strength (equal to V, the applied voltage divided by L, the 
total length of the capillary) and nm  is the apparent electrophoretic mobility.
The time taken, t, for a charged sample to migrate the length of a capillary is given by; 
t =  L2//xappV (Equation 4.02.)
There are two capillary lengths involved in the separation process, namely L the total 
length and W the length from the inlet to the detector window, such that equation 4.02. 
may be expressed more accurately by;
t =  WL/^apPV (Equation 4.03.)
This equation predicts that high voltages and/or short capillaries will provide rapid 
analysis times. Molecular longitudinal diffusion occurs as the analyte migrates along the 
capillary producing band broadening (peak variance, a2), which may be determined by;
a2 =  2Dt =  2DWL//xappY (Equation 4.04.)
where D is the analyte diffusion coefficient. Radial diffusion (across the capillary) is 
unimportant due to the plug flow profile caused by electroendosmotic flow (EOF). This 
is the bulk flow of liquid within the capillary across the inner surface upon application 
of an electric field, which arises as a consequence of the formation of an electrical 
double-layer on the interior wall. Ionized silanols (negative charge) attract positively 
charged buffer components to maintain a charge balance, causing the formation of an 
electrical potential (the zeta potential, 0  close to the capillary wall. The cations are 
strongly hydrated such that upon creating a potential drop across the capillary, both they 
and the bulk liquid are drawn towards the cathode creating a flat flow profile.
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The mobility of EOF, (first described by Pretorius et al.) may be given as;
Me o = (efE/4n:r|) (Equation 4.05.)
where e is the dielectric constant of the buffer and rj is the buffer viscosity. The EOF is 
strongly pH dependant; at high pH, where the silanols are significanly deprotonated, the 
flow will be rapid whereas at low pH the EOF will be greatly reduced due to the small 
zeta potential. In the presence of EOF the apparent elgtrophoretic mobility, /*app, is given 
by;
Mapp =  Me p +  Me o = WL/tV (Equation 4.06.)
The /Xeo may be determined by injecting a neutral analyte (eg. acetone, DMSO, MeCN) 
and measuring the time taken for this sample to reach the detection window and then 
applying equation 4.06., remembering that the ^  (the samples electrophoretic mobility) 
value will be zero.
4.1.2. Operational Modes of Capillary Electrophoresis Utilising CDs.
Electrophoresis encompasses a family of techniques, the main ones being free solution 
capillary electrophoresis (FSCE), micellar electrokinetic chromatography (MEKC), 
isoelectric focusing (IEF), capillary gel electrophoresis (CGE) and isotachophoresis 
(ITP). IEF is used to separate and identify proteins and peptides based on differences in 
their isoelectric points (pi). It is not of benefit to add cyclodextrins to the ampholytes and 
so IEF has not been employed for chiral work. However all the other modes have been 




ITP can be used to separate samples that contain either positively or negatively charged 
species. The mixture to be separated is introduced between the so-called leading (LE) and 
terminating electrolytes (TE). The LE contains an ion with a higher effective mobility 
than that of any of the sample ions whilst the TE contains an ion with a lower effective 
mobility than any sample ion. Upon application of an electric field migration proceeds 
until a steady state is achieved, with the sample separated into distinct zones, which 
migrate in close contact with one another at the same velocity.
In the first sucessful report of optical resolution in electrophoresis, Snopek et al. 1988 
examined a series of ephedrine related alkaloids with p-CD derivatives by ITP and found 
that separation depended upon using an acidic pH of 5 (at pH 9.7 no resolution occured). 
Shortly thereafter, Smolkova-Keulemansova 1988 used a-CD in the LE to separate 
positional isomers of halogen substituted benzoate anions along with p~ and dimethyl-P- 
CD for the chiral resolution of pseudoephedrine and related alkaloids. Phenothiazine and 
some allied drugs were achirally resolved by Snopek et al. 1989 using trimethyl-p-CD, 
whilst v  and p-CD proved effective for the chiral resolution of some of these test 
solutes. Tanaka et al. 1991 employed p-CD in the LE to resolve the enantiomers of 
several catecholamines and found that addition of a neutral surfactant affected resolution.
4.1.4. Micellar Electrokinetic Chromatography (MEKC1.
MEKC was first introduced by Terabe et al. 1984 for the resolution of neutral phenol 
derivatives, where the separation was based on solute partitioning between a pseudo- 
stationary phase consisting of micelles (Sodium dodecylsulphate, SDS) and the bulk 
liquid phase. The technique allows for the separation of neutral and charged solutes at
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the same time. Partitioning into the micelles is affected by solute size, hydrophobicity 
and charge (where the micelle itself is charged eg. SDS, Hexadecyltrimethylammonium 
bromide [HTAB], bile salts).
Terabe 1989 and Terabe et al. 1990 further modified the MEKC separation mechanism 
with the addition of CDs. They were able to resolve a series of chlorinated benzene 
congeners and tetrachlorodibenzodioxin isomers using y-CD and SDS in the buffer. The 
CDs are not believed to interact with the micelles due to their hydrophilic exterior but 
induce an additional solute complexation equilibrium with the sample moving between 
the CD, micelle and the bulk solution. Nishi et al. 1991, Soini et al. 1992 and Nussbaum 
et al. 1994 have all used this method to enantiomerically resolve barbiturates, NSAID's 
and other pharmaceuticals using a variety of CDs and micelles. The basic equation for 
MEKC, as derived by Terabe et al 1984 is;
k = fRm “ W  foU^ RnAnc]
where k7 is the ‘capacity factor’, tRm is the solute retention time, to is the retention time 
of a solute with no interaction with the micelles and t^. is the retention time of a solute 
completely solubilised by the micelles.
4.1.5. Capillary Gel Electrophoresis (CGE).
CGE is mainly associated with separation based on differences in solute size as analytes 
pass through the pores of a gel matrix which acts as a 'molecular sieve'. Larger solutes 
are hindered more than smaller ones with the result that they migrate more slowly. 
Traditionally the technique has been used to separate proteins and DNA fragments. 
However the addition of CDs to the matrix may allow chiral separations to occur.
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Guttman et a l  1988 demonstrated the separation of a range of dansyl amino acids using 
a polyacrylamide gel containing a-, p- or y-CD. p-CD gave the best chiral resolution 
values for these analytes. Swartz 1993 reported the use of derivatized CDs incorporated 
into similar gels for the resolution of both acidic and basic small pharmaceuticals. 
Cruzado and Vigh 1992 synthesised allyl carbamloy derivatised p-CD and polymerised 
this with acrylamide to form CD containing gels, which were used to resolve the 
enantiomers of homatropine and dansyl amino acids.
4.1.6. Free Solution Capillary Electrophoresis (FSCE).
This is the most widely employed electrophoretic technique due mostly to the ease and 
speed with which an analysis can be performed. Buffer compositions are inherently more 
simple than the other methods and the fused silica capillaries required are relatively 
cheap and readily available so that optimization is more tractable. The underlying theory 
was discussed in section 4.1.1. and the following text details some related work in the 
field with CDs.
Fanali 1989 was among the first to describe chiral resolution in FSCE using P-CD and 
methylated derivatives to separate the enantiomers of some sympathomimetic drugs. He 
extended this work using other analytes and investigated the affect of methanol, urea and 
temperature on resolution (Fanali 1991 and Schutzner and Fanali 1992). Snopek et al. 
1991 added alkylhydroxyalkycellulose derivatives to buffers containing CDs and found 
that it resulted in improvements in the resolution of chloramphenicol and thioridazine 
enantiomers. Quang and Khaledi 1993 used tetraalkylammonium reagents in conjunction 
with various CDs to improve the chiral separation of a group of basic pharmaceuticals. 
They suggested this occurred due to capillary wall coverage by the reagents preventing 
analyte interaction with the negative surface layer, so improving efficiency and hence
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observable resolution. Hjerten 1985 coated the inner silica surface with a neutral polymer 
to eliminate EOF and was able to separate a group of aromatic carboxylic acids which 
could not be done with an uncoated tube. Towns and Regnier 1991 prepared nonionic 
surfactant coated capillaries for the separation of proteins, which allowed the pH to be 
altered (to improve selectivity) without affecting the flow rate.
A huge range of CDs have been tested in FSCE to effect novel separations. A charged 
CD, (2-O-carboxymethyl-p-CD) was used by Terabe et al. 1985 to resolve positional 
isomers of substituted benzenes, Sepaniak et al. 1992 used glycosylated a-CD to separate 
phosphorylated binaphthyl enantiomers and Nardi et al. 1993 resolved some 2-hydroxy 
acids with 6-methylamino-P-CD. Other CDs that have been employed for chiral 
resolutions include y and hydroxypropyl-p-CD (Copper et al. 1994); a-, P-, dimethyl-p 
and hydroxypropyl-p-CD (Palmarsdottir and Edhlom 1994); hydroxyethyl-p-CD and 
methyl-p-CD (Peterson 1993); sulfobutyl ether p-CD (Chankvetadze et al. 1994); 
hydroxypropyl-a-CD and hydroxypropyl-y-CD (Rogan et al. 1994), permethylated el­
and p-CDs (Valko et al. 1994) and a carboxymethylated-p-CD polymer (Aturki and 
Fanali 1994).
4.1.7. Equilibria in FSCE upon the Addition of CDs.
Wren and Rowe 1992 were the first to propose a simple mathematical model for FSCE 
which described the behaviour of a solute when in contact with a chiral agent added to 
the buffer. They subsequently went on to substantiate this model with an investigation 
into the interaction between some p-blockers and methyl-p-CD (Wren and Rowe 1993).




A +  C ^  AC (Equation 4.07.)
i i
Ml M2
where /xj is the electrophoretic mobility of the analyte enantiomer in free solution, /x2 is 
the electrophoretic mobility of the analyte-chiral selector complex and Kj is the 
equilibrium constant. A second equilibria, K2, exists for the other analyte enantiomer and 
if these two equilibrium constants are different (i.e. the enantiomers have different 
affinities for the chiral selector) and the mobilities /Xj and ^  are also different, then 
chiral resolution may occur.
The apparent electrophoretic mobility of A, /xa, will be a function of the time it spends 
as the free solute and in a complexed form;
/xa _ {[A] / [A] +  [AC]} /X! +  {[AC] / [A] +  [AC]} /xj (Equation 4.08.)
[AC] =  Kj[A][C] (Equation 4.09.)
hence,
Ma =  Mi + M2 AT7[C] / 1 +  Kj[C] (Equation 4.10.)
The difference in apparent electrophoretic mobilities of the two enantiomers can then be 
given by;
A/xa =  [C](Ax1 - nJ(K2 -Kj) / 1 +  [C W j+KJ +  KjK2[C]2
(Equation 4.11.)
Mobility differences (and thus resolution) will be zero if one of the following holds, Kj 
= K2y fii =  /X2 , [C] =  0 or is very large. Between these two extremes of [C] lies some
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value which will produce the optimum mobility difference and provide good resolution. 
Penn et al. 1993 developed a similar equation to equation 4.11. and showed (via 
differential calculus of equation 4.11.) that the maximum mobility difference occurs 
when A/xa //xa[C] =  0. This condition is fulfilled when;
where is the average binding constant. Furthermore the maximum resolution of the 
enantiomers will occur when;
where fi^ is the EOF rate, /x0 is the mobility of the free analyte and ^  is the 
electrophoretic mobility of the analyte-chiral selector complex. Penn et al. 1993 
investigated the interaction of tioconazole enantiomers with hydroxypropyl-p-CD by 
FSCE and found good agreement between their actual and predicted results.
Resolution in FSCE can be expressed according to Giddings 1969, by;
r s =  y4 N ,/4-A pin (Equation 4.14.)
where A/x is the difference in electrophoretic mobilities of two analytes (enantiomers), 
/x is their average electrophoretic mobility and N is the number of theoretical plates given
K JC ] =  1 (Equation 4.12.)
KaV[C] =  [(Meo +  MqVG*co +  / O P (Equation 4.13.)
by;
N = jnVW/2DL (Equation 4.15.)
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Combination of equations 4.11. and 4.14. gives a general expression for the resolution 
of enantiomers with CDs (Palmarsdottir and Edholm 1994);
Rs = K N* [C](K2- Kjyfa - +  Vi CKj + K2)(^  + r ilC l  +  IhK M C ]2
(Equation 4.16.)
However this equation is too unwieldy to be applied generally and resolution is often 
calculated by;
Rs =  1.177 • (t2 - tjVCW^ +  W5V4) (Equation 4.17.)
where WaV4 is the peak width at half height for the first migrating enantiomer (Wren and 
Rowe 1992).
4.1.8. Experimental Parameters Affecting Separation in FSCE.
EOF, which is strongly pH dependant, can prove detrimental to resolution by 'sweeping' 
the analytes along at such a rate as to overcome their individual electrophoretic 
mobilities. Terabe et al. 1988 developed an equation to describe resolution, including a 
term for EOF, fjLe0;
Rs =  !/4 (V/32D)* * (W/L)» • AMep/(Mep +  /x j*  (Equation 4.18.)
Increasing the EOF will then reduce Rj therefore it is necessary to control pH to maintain 
a high resolution, whilst having migration times that are short enough to be of practical 
use.
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Increasing the applied voltage will lower solute migration times according to equation
4.03. and improve R, according to equation 4.18. but there is a practical limit to the 
voltage strength caused by Joule heating (Ohmic resistance of the buffer to electrical 
flow). If the buffer temperature rises beyond the heat dissipation capabilities of the 
capillary, then band-broadening will occur due to thermal convection altering the buffer 
viscosity. Hence narrow capillaries with good thermal dissipation properties are 
favoured. Short capillaries will provide rapid analysis times according to equation 4.03. 
but lower R  according to equation 4.18. Therefore some compromise is required 
between the overall capillary dimensions and the applied voltage to provide adequate 
analysis conditions.
Buffer concentration and ionic strength are related to EOF by equation 4.05. whereby 
an increase in concentration will increase the viscosity, rj, and so reduce EOF. With 
narrow capillaries 50 mm) migration times will increase as the buffer ionic strength 
is increased. The pH should be within ± 2  pH units of the buffer pKa in order to 
maintain effective pH control and thus consistent migration times. Generally speaking, 
buffers of low conductivity are preferred as they allow high voltages (and thus rapid 
separations) with minimum temperature rises inside the capillary (Bello et al. 1992).
Organic solvents are often added in FSCE buffers where they can act as solubilizing 
agents and modifiers of EOF. Alcohols tend to decrease EOF whereas acetonitrile often 
causes a small increase (Weinberger 1991). Fujiwara and Honda 1987 also found that the 
alcohol methanol increased solute migration times whilst acetonitrile lowered them (i.e. 
faster migration times). Wren and Rowe 1992 suggested that organic modifiers could 
either increase or decrease analyte enantio-resolution values (in the presence of CDs) 
depending upon the concentration of CD in the buffer. An examination of propranolol 
with p- and methyl-p-CD supported their proposals.
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4.2. CE Investigation of Phenethvlamines.
The resolution of nine sympathomimetic phenethylamine racemates (see Fig. 3.2. on p. 
49 for their structures) by p-CD and /zeprfl&w(2,3-di-0-acetyl)P-cyclodextrin (Ac-p-CD) 
was investigated by capillary electrophoresis. Only p-CD and peracetyl p-CD had 
provided any chiral resolution for this group of analytes by HPLC (section 3.2.). It was 
found impossible to use peracetyl p-CD in the CE buffers as the required levels of 
organic modifier (for CD dissolution) caused problems with consistent current 
generation. The addition of urea did not improve CD solubility. Consequently the related 
2,3-di-O-acetyl derivative, which is more water soluble, was examined.
The resolution of some phenethylamines by CE has been reported previously using 
cyclodextrins. Fanali 1989 resolved the enantiomers of ephedrine, isoproterenol 
(isoprenaline) and noradrenaline using di-0-methyl-p-CD but could not repeat this with 
native p-CD. Nielen 1993 was able to determine a 100-fold excess of ( + )-ephedrine in 
the presence of the (-) isomer, also using di-0-methyl-p-CD, but not p-CD. Dette et al. 
1994 used an anionic p-CD derivative to chirally resolve ephedrine and found that it gave 
better results than p-CD itself. Rogan et al. 1994 separated salbutamol enantiomers with 
dimethyl-p-CD, calculating that they possessed a weak binding constant with the CD. 
Bechet et al. 1994 resolved ephedrine and isoprenaline with a range of CD types, 
Heuermann and Blaschke 1993 resolved oxedrine (amongst others) with Me-P-CD and 
Chankvetadze et al. 1994, employing a charged p-CD derivative, separated the 
enantiomers of etilefrine.
Data for the chiral discrimination of a range of phenethylamines by p-CD and the 
previously untried Ac-p-CD are reported here.
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4.2.1. Complexation with Various CDs.
a-, HP-a and y-CD were found to have little effect on the migration times of the 
analytes and did not produce any chiral resolution. The migration times for all nine 
compounds using 0.1M phosphate buffer pH 3.0 are shown in Table 4.1., which also 
gives the migration times (O  and resolution values (R,) measured in the presence of P- 
CD or Ac-p-CD.
Table 4.1. CE migration times (minutes) and resolution values (RJ for some 
phenethylamines. CE conditions: 0.1M phosphate buffer pH 3.0 with and without 12 
mM p-CD or Ac-p-CD. Coated-capillary (20 cm x 25 pm). Samples were loaded by 








ephedrine 5.39 9.98 0 6.66,6.87 1.25
oxedrine 8.98 10.91 0 7.55,7.93 1.62
oxilofrine 6.09 12.33,12.71 1.16 6.32,7.97 1.74
norfenefrine 8.36 11.95 0 7.43,7.65 1.31
etilefrine 9.49 10.92,11.11 0.47 8.84.9.82 4.28
orciprenaline 7.12 12.61,12.94 0.89 9.22,9.48 1.32
noradrenaline 9.39 11.80 0 7.55 0
isoprenaline 11.10 13.84 0 9.24 0
salbutamol 12.18 12.74 0 9.27,9.45 0.85
The migration times in Table 4.1. correspond to electrophoretic mobilities ranging from 
0.58 x 10 A (t,,, =  13.84 min) to 1.72 x 10^ (t,,, =  5.39 min) cm 2 s V  'l , which were 
calculated according to equation 4.06 (see section 4.1.1.).
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In an attempt to measure /xeo under the experimental conditions used, acetone was 
employed as a neutral marker during a time of 90 minutes over a column distance of 2.8 
cm. No response for acetone was obtained. This indicated that nco must be less than 
1.8x1 O'6 cm2 s'1 V'1 which is lower than that in a previous report (Wren and Rowe 1993 
refU), where the effect of /xe0 was discounted at 0.04x10 A cm 2 s _1 V "1. Thus the endo- 
osmotic flow, which is minimised when using coated capillary columns, can be ignored 
SO that A*ep =  /*app.
p-CD increased the migration times for all compounds relative to the uncomplexed drug 
whereas Ac-p-CD caused a decrease in migration except for three compounds (ephedrine, 
oxilofrine and orciprenaline). The increase in migration times for these three compounds 
with the derivatised CD was less than that observed with p-CD and thus permitted more 
rapid analysis. p-CD resolved only three compounds (oxilofrine, etilefrine and 
orciprenaline) and the acetylated CD increased the resolution of all racemates compared 
to the underivatised oligosaccharide, except for noradrenaline and isoprenaline, which 
were not resolved by either CD. Individual enantiomers of the compounds were not 
available so the elution order of the R- and S-isomers is not known, with the exception 
of ephedrine, where the (4-)-enantiomer was found to migrate fastest i.e. it had a weaker 
complexation with the CD molecule.
The effect of buffer pH on migration times and resolution was fully investigated for all 
compounds in the presence of Ac-p-CD. Migration times at pH 3.0, 4.5, 6.0 and 7.5 are 
given in Table 4.2., while Figure 4.1., on p. 101, shows the effect of pH on resolution. 
Generally, as the pH was raised migration times increased and resolution decreased, 
although with etilefrine the resolution showed a minimum at pH 6.0.
The effect of adding 5, 10, 15 and 20%v/v acetonitrile to the 0.1M phosphate buffer at 
pH 3.0 was investigated for three compounds (ephedrine, oxilofrine and orciprenaline). 
Migration decreased to a minimum at 15%v/v and then increased again at 20%v/v.
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Resolution decreased with increasing concentration of the organic modifier and was 
accompanied by deterioration of peak shape.
Figure 4.1. Influence of pH on resolution (RJ of various racemic phenethylamines.
CE conditions, 100 mM phosphate buffer pH 3.0 in the presence of 12 mM Ac-P-CD. 
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Table 4.2. Effect of pH on CE migration times (minutes) for the phenethylamines.
CE conditions, phosphate buffer (0.1M, pH 3.0) in the presence of Ac-P-CD. Other 
conditions as in Table 4.1. pKa values are approximately 8 - 9 .
Compound pH 3.0 pH 4.5 pH 6.0 pH 7.5
ephedrine 6.66, 6.87 7.18,7.35 8.04, 8.24 12.77, 13.17
oxedrine 7.55, 7.93 7.70, 7.97 10.30, 10.66 14.40, 14.81
oxilofrine 7.97, 8.32 8.12, 8.47 9.13,9.48 15.94, 16.65
norfenefrine 7.43, 7.56 7.19, 7.30 9.06, 9.23 15.00, 15.34
etilefrine 8.84, 9.82 8.62, 9.26 10.40, 11.10 16.93, 18.42
orciprenaline 9.22, 9.48 9.73, 10.00 11.20, 11.49 19.12, 19.54
noradrenaline 7.55 7.71 10.08 18.81
isoprenaline 9.24 9.53 13.96 20.82
salbutamol 9.27, 9.45 9.97, 10.10 13.03, 13.22 16.41
4.2.2. Comparison of Results.
The phenethylamines discussed have amine pIC* values in the range 8.6 to 9.3, and thus 
under the conditions used here for CE, they are expected to be fully protonated and 
migrate to the cathode. p-CD caused an increase in migration time consistent with 
complexation reducing the mobility of the drug (Table 4.1.). Ac-p-CD complexes 
migrated more quickly than p-cyclodextrin complexes with all the phenethylamines 
studied, which could perhaps be explained by the formation constants being smaller for 
the derivatised cyclodextrin. Unexpectedly, however, Ac-p-CD also caused a decrease 
in migration times relative to the uncomplexed molecule for six of the nine compounds 
which is difficult to explain. Although migration times were faster with the derivatised 
CD, seven of the nine compounds were resolved compared with only three for p-CD.
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Figure 4.2. Electropherograms of (1) etilefrine HC1 and (2) norfcnefrine HC1.








Overall, increasing pH caused an increase in migration times as would be expected by 
increasing the proportion of neutral phenethylamine species in the buffer. Addition of up 
to 15% MeCN to the buffer in the presence of p-CD decreased mobility for the three 
compounds tested (ephedrine, oxilofrine and orciprenaline) perhaps by causing an 
increase in the affinity of the analytes for the bulk solvent, which migrates very slowly 
under these conditions of low electroendosmosis. It was not added to the buffer in the
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final conditions chosen because it lengthened analysis time and gave poorer resolution
and peak shape.
On the basis of plots of migration times versus CD concentration, Fanali 1989 suggested 
that ephedrine fits into the oligosaccharide cavity better than compounds with a 
substituted phenyl ring, while the catecholamine enantiomers show greater chiral 
discrimination. There is no evidence in the CE studies reported here to support this 
assertion as ephedrine does not show atypical behaviour.
4.2.3. Analyte Structure Relative to Chiral Discrimination.
Noradrenaline and isoprenaline were the only analytes not resolved by either CD type. 
Also the analyte pairs norfenefrine (Rs =  1.31) / noradrenaline (R,= 0) and orciprenaline 
(Rs= 0.89 p~CD,Rs = 1 .3 2  Ac-P-CD) / isoprenaline (R =  0) have respectively, identical 
R groups but different OH substitution patterns of their aromatic OH groups. The unique 
position of these groups may have sterically hindered their chiral interaction with the 
CDs. Norfenefrine and etilefrine differed only in the R2 position, with the ethyl group 
of etilefrine proving more favourable for enantio-recognition (Rs =  4.28) than the 
solitary hydrogen on norfenefrine (Rj =  1.31). Comparison of the CE data for oxedrine 
and oxilofrine, which contrast only by the 2-Me group in oxilofrine, shows that the 
methyl group is required for resolution by p-CD. Although ephedrine also has the 2-Me 
group, it was not resolved and this may be due to the lack of a hydroxy substituent on 
the aromatic ring. Differences in hydrogen bonding patterns could explain why Ac-p-CD 
(a hydrogen bond acceptor) is better than P-CD (a hydrogen bond donor/acceptor) at 
discriminating between phenethylamine enantiomers.
Rogan et al. 1994 and Heuermann and Blaschke 1993 found that substituted phenyls, 
such as the phenethylamines, did not complex strongly (if at all) with the rather small a-
CD cavity. Steric constraints and possibly the weak dipole moment of a-CD (Sherrod 
1992) have been suggested as reasons for such behaviour (Gelb et al. 1981). In the other 
extreme, y-CD cavity is much larger than these analytes and any inclusion would not be 
sufficiently 'tight' to allow retardation of solute migration or provide for chiral 
recognition. Beider and Schomburg 1994 observed that if the aromatic ring of an analyte 
had sufficient bulky substituents, then it would be retained and possibly chirally resolved 
by y-CD. These results are consistent with a 'size inclusion’ model influencing 
complexation, where the 'tightness of fit’ between an analyte and a CD may determine 
enantio-resolution.
4.2.4. Determination of Complex Formation Constants (Kf).
Gareil et al. 1993 have developed a method for determining complex association 
constants (Kf) between CDs and guest molecules in CE. They were able to calculate the 
binding between retinoic acid and Me-p-CD from the abscissa of the point of inflection 
on a graph of /xapp versus -log [CD]. Here, measurement of the Kf value of etilefrine with 
p-CD and Ac-p-CD was attempted by a similar means.
The results are shown in Figures 4.3a and b. Each measurement was performed in 
triplicate and the calculated average Kf value found for etilefrine with p-CD was 155M'1, 
but it was not possible to estimate its binding with Ac-p-CD, due to the absence of a 
lower plateau region on the graph, where the analyte is bound by the CD. The low 
aqueous solubility of Ac-p-CD prevented the dissolution of any higher concentrations. 
The shape of the curve in Fig. 4.3b approximates to that region where the analyte has 
yet to be fully complexed by the chiral selector. This strongly suggests that the analyte 
forms a weaker complex with the acetylated p-CD, although the actual Kf value was not 
measurable. This view is supported by examination of etilefrine's migration times (Table
4.1.), which are fastest in the presence of Ac-p-CD, again implying a weaker
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complexation constant. In view of the fact that all the phenethylamines possess faster 
migration times with Ac-p-CD it seems likely that they too have weaker complexation 
constants than with P-CD.
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4.3. CE Investigation of Propranolol Analogues.
In this work propranolol (1 in Fig. 3.3.) and related compounds were used to study how 
changes in molecular structure can affect the complexation process with the various CD's 
which had provided promising results from the HPLC studies i.e. p-CD, HE-p-CD and 
Me-P-CD. Heptakis(2,3-di-0-Acetyl)p-cyclodextrin (Ac-p-CD) was also employed in the 
CE aqueous buffers, as the peracetylated derivative (water insoluble) had resolved 
compounds 4 and 5 using the PGC column (3.2.4.). Compounds 2 and 3 are f-butyl and 
ethyl analogues of 1. Compounds 4 and 5 are /-propyl and r-butyl analogues of 1 
respectively, but with a phenyl ring - not a naphthyl group. Compound 6 (with a 
naphthyl group) has a unique urea-ethyl linkage, which proved impossible to examine by 
CE as the weakly basic urea group is not readily available for protonation. Coupled with
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its high molecular weight, this resulted in impractical migration times, often greater than 
one and a half hours.
The aqueous/buffer mixture was chosen to ensure a pH (3.0) at which analytes 1-5 
possessed a positive charge (pKa's of compounds 1-5 are around 9±0.5) and thus 
migrated towards the cathode. Attempts to measure the EOF under these conditions were 
successful only in that they gave a maximum possible value of 8 x 10 * cm 2 V -1 s 
This is very low and compares favourably with Wren and Rowe 1993, who ignored EOF 
at the higher value of 0.04 x 10 ^ c m 2 V _1 s _1.
4.3.1. Complexation of Propranolol Analogues with Ac-p-CD.
Ac-p-CD only resolved the enantiomers of compounds 1 and 2 under these experimental 
conditions (Table 4.3.). Acetylation increases the hydrophobicity of the CD and changes 
its hydrogen bonding ability, which often results in low enantio-selectivity (Krustulovic 
1989b).
With only the two most hydrophobic compounds (1 and 2) showing any enantio- 
recognition (Fig. 4.4., see p. 109) and possessing the longest migration times, it would 
appear that analyte hydrophobicity is a major factor in the determination of resolution 
values and complex formation constants when using this CD derivative in FSCE. 
According to Bamaby and MacLeod 1991 there are few published incidents were Ac-p- 
CD has provided enhanced separation over the underivatized p-CD. However Yamashoji 
et al. 1992 have shown that /zepta£/s(2,3-di-O-Acetyl)P-CD can be used to give improved 
chiral resolution of DL-alanine p-naphthylamide in CE when compared to P-CD.
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Table 4.3. Migration times (tm, mins) for compounds 1-5 in the presence of increasing 
amounts (mM) of Ac-P-CD. Resolution values (Rs) in parentheses. FSCE conditions: 
KH2P 0 4 50mM, pH3, 30% MeOH buffer. Constant current of 5/xA. * 4M urea was 
necessary to enable dissolution of this amount of CD.
Analyte O.OmM 4mM 7.4mM 15mM 25mM 35mM
*
1 6.84 10.82 10.88 11.56,11.65 11.78,11.89 8.48
(0) (0) (0) « 0 .1 ) (0.26) (0)
2 6.94 11.07 11.35,11.39 12.27,12.41 12.39,12.56 8.98
(0) (0) (<0 .1) (0.63) (0.81) (0)
3 6.32 10.58 10.67 11.29 11.37 8.24
(0) (0) (0) (0) (0) (0)
4 4.30 9.82 10.02 10.34 10.39 6.53
(0) (0) (0) (0) (0) (0)
5 5.59 10.27 10.43 10.86 11.05 7.51
(0) (0) (0) (0) (0) (0)
All five analytes however showed longer migration times as the concentration of Ac-P- 
CD was increased, indicating that they underwent increasing complexation. Due to the 
insoluble nature of Ac-P-CD it was necessary to use 4M urea to solubilise 35 mM in the 
buffer. This resulted in lower migration times than would have been expected if urea was 
absent, and also in the removal of all signs of enantio-recognition for compounds 1 and 
2. The strongly polar urea molecules may have significantly reduced any possible 
hydrogen-bonding of the CD with compounds 1 and 2, thus negating resolution and 
shortening the migration times by increasing the amount of time compounds 1 and 2 
spent as faster moving, free analytes.
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Figure 4.4. Electropherograms for compounds 1 and 2 in the presence of 25 mM Ac-p-
CD. FSCE conditions: 30% MeOH - KH2P04 50 mM, pH 2.5, constant current of 5 /xA.





4.3.2. Complexation with Me-p-CD.
Methylated p-CDs have been extensively employed in CE chiral separations, often 
demonstrating enhanced resolutions over the parent macrocycle (Nielen 1993, Soini et 
al. 1992, Rogan et al. 1994, Heuermann and Blaschke 1993 and Gareil et al. 1993). 
Wren and Rowe 1993 stated that in the presence of Me-p-CD, hydrophobicity would be 
the major force driving complexation in a series of p-blockers. More hydrophobic
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solutes would require the presence of less CD to achieve their individual optimum 
resolution values. This hypothesis is partly supported by these results.
Compounds 1 and 2 each gave maximum resolution values at 25 mM Me-p-CD, with the 
more hydrophobic compound 2 having a higher resolution value of 0.73, compared with 
compound 1 which is less non-polar and gave a lower resolution of 0.54 (see Table 4.4., 
see p.111). Compound 3 is less hydrophobic than either 1 or 2 and gave a lower 
maximum resolution of 0.32 at the highest Me-p-CD concentration of 35 mM (see Fig.
4.5., see p. 112). Similar in behaviour was compound 5 which is less hydrophobic than 
compounds 1, 2 or 3 and also gave its maximum resolution at 35 mM. However the 
resolution of compound 5 (1.54) was higher than observed with the other more non-polar 
analytes. Also, the least hydrophobic of the compounds, 4, unexpectedly showed its 
maximum resolution of 0.68 at only 25 mM Me-p-CD, when it would have been thought 
to require a higher concentration than the other compounds, based on the simple model 
advanced by Wren and Rowe 1993.
Different structural features of the five analytes therefore seem to be important not only 
in the actual complexation process but also in the overall enantio-recognition mechanism. 
Compounds 4 and 5 gave higher maximum resolution values than compounds 1 and 2 
respectively, suggesting that the presence of the naphthyl moiety proved detrimental to 
resolution by perhaps holding the stereogenic centre too far from the CD rim to permit 
optimum hydrogen-bonding with the CD hydroxyl groups.
The bulky f-butyl R group promoted enantio-recognition in comparison to the /-propyl 
R group with maximum resolution values of 2 >  1 and 5 >  4. This may be related to 
the proposed hydrophobicity effect, with the more non-polar compounds having a 
stronger association with the Me-p-CD and hence also displaying longer migration times.
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Table 4.4. Migration times (tn,, mins) for compounds 1-5 in the presence of
increasing amounts (mM) of Me-p-CD. Resolution values (Rs) in parentheses. FSCE


































































The R groups could interact with the modified CD rim to influence enantio-recognition, 
perhaps via some steric and/or hydrophobic effect, which alters the analyte's position in 
the CD cavity and by doing so, holds the analyte hydroxyl and amine groups in a more 
favourable orientation to encourage chiral recognition.
I l l
Figure 4.5. Electropherograms for Compounds 1, 2 and 3 in the presence of Me-p 
CD at 25 mM, 25 mM and 35 mM respectively. FSCE conditions: 30% MeOH 
KH2P 04 50 mM, pH 2.5. Constant current of 5/xA.
%AU (AU 0.005)|
m igration  tim e (m ins)
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4.3.3. Complexation with HE-P-CD.
Propranolol (1) has been chirally resolved using HE-p-CD in CE (Peterson 1993), 
although a similar degree of separation with Me-p-CD could not be achieved. In the same 
work, the author found that HP-p-CD gave equivalent results to HE-p-CD when 
examining propranolol enantiomers. Other authors have indicated that HE-P-CD 
generally gave poorer chiral separations than both methylated p-CDs (Rogan et a l  1994) 
and even p-CD itself (Heuermann and Blaschke 1993).
In this work HE-p-CD gave longer migration times for all five compounds than did Me- 
p-CD or Ac-p-CD, suggesting that the analytes formed stronger inclusion complexes 
with this CD derivative under the experimental conditions used here. HE-p-CD was also 
the only CD to provide any enantio-recognition at the 4 mM level, where it partially 
resolved compounds 1 and 2, with the more non-polar 2 having a higher resolution value 
of 0.66.
HE-p-CD caused a reversal in the migration order of compounds 1 and 2 when compared 
to the results obtained with Me-p-CD and Ac-p-CD. Thus compound 2 had faster 
migration times than compound 1 over the entire CD concentration range, yet still 
maintained higher enantio-resolution values than compound 1. The presence of the 
analyte naphthyl moiety had a more varied effect on enantio-resolution with HE-p-CD. 
Although the maximum resolution value of 4 was still greater than that of compound 1 
(as with Me-p-CD), compound 5 had a lower maximum resolution than compound 2 
which was not the case with Me-p-CD. The most hydrophobic of the solutes i.e. 
compound 2, therefore gave the highest individual maximum resolution with HE-p-CD 
(see Fig. 4.6., p. 115) whereas the less non-polar compound 5 displayed the largest 
resolution with Me-p-CD.
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Table 4.5. Migration times (tm, mins) for compounds 1-5 in the presence of
increasing amounts (mM) of HE-p-CD. Resolution values (Rs) in parentheses. FSCE
conditions: KH2P 04 50 mM, pH3, 30% MeOH buffer. Constant current of 5 /xA.
No CD 4mM 7.4mM 15mM 25mM 35mM
1 6.84 12.48,12.56 12.64,12.78 14.39,14.63 15.84,16.12 16.06,16.36
(0) « 0 .1 ) (0.44) (0.74) (0.83) (0.74)
2 6.94 12.42,12.54 12.53,12.71 13.85,14.14 15.34,15.68 16.00,16.39
(0) (0.66) (1.08) (1.31) (1.51) (1.67)
3 6.32 11.19 11.99,12.07 13.86,14.01 15.61.15.80 16.63,16.84
(0) (0) (<0.1) (0.62) (0.69) (0.77)
4 4.30 10.10 10.64,10.72 12.19,12.41 13.57,13.84 13.78,14.04
(0) (0) « 0 .1 ) (0.94) (1.03) (0.29)
5 5.59 10.52 10.90,11.01 13.08,13.32 14.45,14.77 15.53,15.90
(0) (0) (CO.l) (1.12) (1.30) (1.54)
Analyte pairs 1 / 4  and 2 / 5 ,  differing only in their R1 groups, displayed different 
enantio-resolution values. That part of the structure which is believed responsible for 
inclusion into the CD cavity (Rf group) thus played a crucial role, perhaps by holding 
the molecule in the correct orientation for optimum enantio-recognition.
4.3.4. Complexation with P-CD.
It was not possible to fully investigate the effects of p-CD under the buffer conditions 
used with the other CDs due to its very low solubility in 30% MeOH (0.64 g/100 mL), 
Taghvaei and Stewart 1991. Therefore only a 4 mM P-CD buffer was prepared (30% 
Me0H-KH2P 0 4 50 mM v/v, pH3). No enantio-resolution was observed for any of the 
analytes at this concentration.
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Figure 4.6. Electropherogram for compound 2 in the presence of 35 mM HE-P-CD. 
FSCE conditions: 30% MeOH - KH2P 04 50 mM, pH 2.5. Constant current of 5 /*A.
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Urea solubilized p-CD (40 mM) was found to enhance chiral separations, with compound 
resolution values of the order 2 > 1 > 5 > 3 > 4  (Table 4.6., see p. 116). The presence of 
a f-butyl group helped promote resolution with compounds 2 >  1 and 5>4.  When R* = 
naphthyl, enantio-resolutions increased with compounds 1 > 4  and 2>5 .  It would seem 
therefore that under these conditions p-CD favours the recognition of compounds 1 and 
2, the bulkiest and most hydrophobic of the five analytes.
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Table 4.6. Resolution values (R*) and migration times (t^, mins) for compounds 1-5 
in the presence of 40 mM p-CD. FSCE conditions: 30% MeOH - KH2P 0 4 50 mM, pH 
2.5, 4M urea. Constant current of 5 fiA.
Analyte Resolution values Migration time (mins)
1 1.05 12.06, 12.23
2 1.31 10.80, 11.03
3 0.28 10.43, 10.54
4 <0.1 8.76, 8.87
5 0.63 9.86, 10.04
4.3.5. Influence of Methanol (MeOH) on Resolution and Migration Times.
With both HE-p-CD and Ac-p-CD the removal of MeOH had a detrimental effect on 
resolution. None was observed for any of the analytes with HE-p-CD in the absence of 
MeOH, whereas they all formerly displayed some resolution when MeOH was present. 
Ac-p-CD (at 7.4 mM) had only previously resolved compound 2 when MeOH was 
present. This slight enantio-resolution was removed when MeOH was absent. With Me- 
p-CD the effect on resolutions seemed more variable. Enantio-resolutions of compounds 
1, 2 and 3 increased when no MeOH was present, whilst those of compounds 4 and 5 
decreased. Migration times increased in every case when MeOH was removed.
As stated by Wren and Rowe 1992, organic solvents are believed to change the apparent 
mobility difference between the analyte enantiomers in FSCE, which in turn can increase 
or decrease the observed enantioselectivity depending on the CD type and concentration. 
This finding is mirrored in these results where 30% MeOH was shown to have a 
beneficial effect on resolution with HE-p-CD and Ac-p-CD, yet it produced both higher 
and lower resolutions using Me-p-CD, dependent on the analyte structure (and hence its 
CD complex formation constant). Solvation can radically alter both the geometry and.
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relative stabilities of various cyclodextrin:analyte conformations (Sherrod 1992), so it is 
not unexpected that enantio-resolution values and migration times should be affected.
4,3.6. Determination of Complex Formation Constants (Kf).
Using the method developed by Gareil et al. 1993, plots of /xapp versus -log[CD] were 
constructed for compounds 1-5 with Me-p-CD (Fig. 4.7a) and HE-p-CD (Fig. 4.7b), 
both on pagell8 . All the plots showed a classical sigmoidal shape from which the Kf 
values were estimated by measurement of the abscissa of the point of inflection. The Kf 
values are given in Table 4.7. (see p. 118).
The magnitude of Kf values of the compounds is the same with both CDs i.e. 
2 >  1 > 3 > 5 > 4 .  It is apparent however that the analytes show stronger binding to the 
HE-p-CD by virtue of their larger Kf values. HE-P-CD also produced the largest 
maximum resolution values for compounds 1-4 (compound 5 had an equal maximum R, 
value with HE-p-CD and Me-p-CD). Furthermore, the order of binding constants 
parallels the analyte’s hydrophobicity, indicating that this is a major factor in 
complexation with the CDs.
It was not possible to calculate Kf values with Ac-p-CD as its limited aqueous solubility 
restricted the number of experimental points that could be plotted, rendering the data 
inconclusive.
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Figure 4.7. /*app versus -log [CD] of compounds 1-5, (a) Me-f-CD and (b) HE-p-CD.
FSCE conditions: 30% MeOH - KH2P04 50 mM, pH 2.5. Constant current of 5 /xA.
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Table 4.7. Estimated Kf (M*1) values of compounds 1-5 with Me-p- and HE-p-CD.
FSCE conditions: 30% MeOH - KH2P 04 50 mM, pH 2.5. Constant current of 5 i^A.







4.3.7. Comparison of Results for Propranolol Analogues.
The migration times of compounds 1-5 were longer in the presence of Ac-p-CD than Me- 
p-CD up to the 15 mM level, suggesting higher association constants. Additionally, these 
migration times were shorter than those seen with HE-p-CD, suggesting lower 
association constants. Yet enantio-resolution was much higher for all the analytes with 
HE-p-CD and also Me-P-CD, except in the case of compound 2. The strength of binding 
between the analytes and CDs does not appear to be directly related to enantio- 
discrimination. The ability of a molecule to form an inclusion complex with a CD does 
not cause enantio-discrimination per se (Fanali 1989), although it is deemed to be a 
necessary pre-requisite in most instances (Sherrod 1992).
Methylation is known to make the parent p-CD more hydrophobic (Tanaka et al. 1985), 
to increase the cavity depth and enhance the molecular flexibility of the macrocycle due 
to a reduction in the number of possible hydrogen-bonds between the 0(2) and 0(3) 
hydroxyl groups (Harta et al. 1984). These changes may explain the analyte enantio- 
recognition seen with Me-P-CD by allowing a 'better fit' of one enantiomer with the 
hydrophobic and conformationally flexible Me-P-CD molecule.
HE-p-CD has additional hydrogen-bonding sites on its modified rim, which may account 
for it displaying the highest maximum resolution values observed in this work and thus 
allow a closer spatial interaction with the hydrogen-donor/acceptor sites near the 
asymmetric centre on the analyte alkyl chains. Furthermore, alkylation of a CD (as 
mentioned above with Me-p-CD) is believed to increase the host macrocycle's flexibility, 
which can improve solute chiral resolution via an 'induced-fit' interaction (Palmarsdottir 
and Edholm 1994). This could explain the larger Kf values with HE-p-CD than Me-p- 
CD. The ability of many modified CD's to improve on enantio-recognition values seen 
with the parent CDs has been described before in other FSCE applications (Fanali 1991, 
Fanali 1989, Tanaka et al. 1985 and Nardi et al. 1993).
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Perhaps structural changes to the rim of the CD cavity are responsible for the reversal 
in migration order of compounds 1 and 2 when compared to the results obtained with 
Ac-P-CD and Me-p-CD. As with Me-p-CD, the existence of a f-butyl group on the 
analytes promoted enantio-recognition in the presence of HE-P-CD, with resolution 
values of compounds 2 >  1 and 5 > 4  at all CD concentrations.
The migration times were faster with p-CD (4 mM) than with the other three CD 
derivatives, suggesting the possibility of lower CD:analyte formation constants. p-CD 
did not display analyte separation at 4 mM, unlike HE-p-CD, which was the only CD 
to resolve compounds 1 and 2 at this CD concentration. Solubilization with urea did 
allow higher concentrations to be dissolved and produced enantio-recognition in all cases 
in contrast to Ac-P-CD, where the addition of urea removed all evidence of resolution.
As seen with the CD derivatives, a f-butyl group helped promote resolution in the 
presence of p-CD with compounds 2 > 1  and 5 > 4 .  When R' = naphthyl, enantio- 
resolutions increased with compounds 1 > 4  and 2 > 5 ,  which is directly opposite to the 
results obtained with Me-p-CD and also in contrast to the resolution order seen for 
compounds 1 and 4 with HE-p-CD (Matchett et al. 1995).
The presence of MeOH was found to have a varied effect on enantio-resolutions which 
was linked to the findings of Wren and Rowe 1992 who stated that organic solvents 
altered the apparent mobility difference between enantiomers. Such a change could then 
alter the resolution values, depending on the type and concentration of CD used.
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4.4. CE Investigation of Mequitamium.
From a range of CDs only y-CD and hydroxypropyl-p-CD (HP-p-CD) had provided any 
enantio-resolution for mequitamium by HPLC (section 3.4.1.). CE investigations utilised 
the same group of macrocycles with particular regard to y-CD, which had proven most 
successful in the liquid chromatography experiments. The affect of CD type, CD 
concentration, %MeCN and buffer type/concentration were examined.
4.4.1. Complexation with Various CDs.
The strong positive charge on Mequitamium (see Fig. 3.17.) as a result of its quaternary 
nitrogen atom, means that it will migrate towards the cathode of a capillary 
electrophoresis instrument. At low pH's it will not be expected to adhere to the capillary 
wall due to a pre-existing coverage of positive charge, resulting from buffer ions 
electrostatically attracted to ionised silanol groups on the surface. There is thus no 
'stationary phase' interaction, unlike that observed in HPLC experiments (section 3.4.).
Table 4.8. (see p. 122) shows the migration times and enantio-separations of 
mequitamium in the presence of various CD molecules, three of which demonstrated 
chiral resolution for the analyte. In all cases where separation occured, repeated 
injections with the individual enantiomers showed that the R-isomer was migrating first 
i.e. its degree of complexation with the CD was lower than that of the S-isomer. All 
migration times and resolutions are a mean of two separate injections.
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Table 4.8. M igration times and Resolution values for mequitamium with various 
CDs. FSCE conditions: 9.5% MeCN-NaH2Citrate 50 mM, pH 3.5, containing 10 mM 
CD. Bare silica capillary (50 cm x 50 /mi), constant voltage 15.1 KV (i -  20 /xA). 
Gravity injection 15 sec., height 90 mm. Sample concentration 0.2 mg/ml, dissolved in 
running buffer.




Y 21.84, 22.24 1.72
HP-a 16.34 0.0
HP-p 24.74, 25.02 1.22
HP-y 22.00, 22.20 0.86
Me-P 17.01 0.0
HE-P 20.24 0.0
Modification of the parent y-CD hydroxyl groups to form the hydroxypropyl derivative 
resulted in a lowering of enantioselectivity although the analyte migration times did not 
alter appreciably. HP-p-CD proved a better chiral discriminating agent than HP-y-CD, 
however the parent p-CD molecule was unable to resolve the mequitamium enantiomers. 
Electropherograms of mequitamium showing clear enantio-resolution in the presence of 
the different CDs are shown in Figure 4.8. (see p. 123). Derivatization with 
hydroxypropyl chains thus proved beneficial for p-CD but detrimental for y-CD. a-CD 
and HP-a-CD had no effect on resolution and little effect on migration times, as did Me 
and HE-P-CD.
Optical resolution in aqueous systems depends on the analyte forming a close spatial fit 
with the cavity of the host CD molecule and thence a chiral interaction via the fixed 
hydroxyls on the CD rim. Derivatization (e.g. of y-CD to form the hydroxypropyl
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macrocycle) affects the hosts hydrogen bonding ability and may also alter the size (depth 
and width) of its cavity (Meier-Augenstein et al. 1992 and Palmarsdottir and Edholm 
1994). Such changes could account for the reduction in enantio-selectivity seen with HP- 
y-CD relative to y-CD.
Conversely, an increase in cavity size and/or extension of the hydrogen bonding of the 
smaller p-CD molecule (to form HP-p-CD) may have allowed a more favourable 
interaction with the large mequitamium structure, rationalising the observed improvement 
in chiral discrimination. However HE-p-CD and Me-p-CD did not resolve the 
mequitamium enantiomers, suggesting that the length of the alkyl chains on the CD 
hydroxyl groups was a major factor in the chiral recognition process.
The small size of the a-CD cavity, 0.5 - 0.6 nm, (Technicol 1992) seems the most likely 
reason for its lack of enantio-resolution of mequitamium and the insignificant change in 
migration time of the free analyte upon the addition of a-CD to the FSCE buffer. If the 
host and guest molecules cannot form an inclusion complex in aqueous solution because 
of their steric incompatibility, then no optical resolution will occur. HP-a-CD caused the 
analyte migration time to increase only slightly (<  1 minute) and produced no 
resolution. The size of the host cavity is clearly important for complexation as is the 
overall derivatization of the rim hydroxyl groups.
4.4.2. Effect of Operating Parameters on Resolution and Migration Times.
It was not possible to observe chiral discrimination when using KH2P 0 4 as the buffer 
component even in the presence of y-CD. Upon switching to NaH2citrate however, chiral 
resolution was clearly evident. Bechet et al. 1994, found that different buffers had varied
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Figure 4.8. Electropherograms of mequitamium, (a) with HP-p -CD, (b) HP-y-CD and






















effects on analyte enantio-resolutions and migration times in FSCE, which they attributed 
to their ability to modulate electroendosmotic flow. It is also known that buffer molecules
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compete with analytes for penetration into CD cavities (Technicol 1992). Altria et al. 
1992 suggested the formation of an ion-pair between certain buffer ions and the 
CDranalyte complex, to account for optimum chiral resolutions observed under certain 
buffer conditions. The nature of the buffer, which is often selected capriciously, clearly 
influenced the resulting analysis.
Increasing the buffer concentration will reduce the electroendosmotic flow (Weinberger 
1991) and so may lead to an increase in analyte migration times. However it will also 
affect the complexation equilibria by enhancing the displacement of analytes from the CD 
cavity, which means the analyte will spend longer in the faster moving uncomplexed 
form. Upon using a 75 mM or 100 mM NaH2citrate buffer (as opposed to a 50 mM 
buffer), migration times decreased and chiral resolution was negated, which suggests that 
here, the aforementioned equilibria shift predominates.
The level of organic modifier (MeCN) present in the running buffer had a strong affect 
on migration times and enantio-resolution values. Using a fixed y-CD concentration of 
10 mM, the % of MeCN was varied between 5 and 19.5% (at least 5% MeCN was 
necessary to ensure dissolution of the analyte). The migration time and chiral resolution 
values initially increased at 9.5% MeCN and then both successively decreased as the 
MeCN concentration was raised further (Table 4.9., see p. 126).
A CD containing buffer with a %MeCN concentration of 9.5% displayed the highest 
resolution value and longest migration time of the mequitamium enantiomers, suggesting 
a longer analyte:CD interaction allows a better chiral discrimination interaction to occur. 
Increasing the %MeCN above this optimum level led to a decrease in migration times 
(i.e. less CDranalyte interaction) and a concurrent fall in chiral resolution as a result of
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Table 4.9. Affect on migration time (mins) and resolution value of MeCN addition. 
FSCE conditions: NaH2Citrate 50 mM, pH 3.5, 10 mM y-CD, containing MeCN. Bare 
silica capillary (50 cm x 50 /ml), constant voltage 15.1 KV (i- 20 fiA). Gravity injection 
15 sec., height 90 mm. Mequitamium concentration 0.2 mg/ml, dissolved in running 
buffer.












Resolution 0.24 1.53 0.63 0.21 <0.1
the increasing numbers of MeCN molecules displacing mequitamium from the y-CD 
cavity (see Fig. 4.9., p. 127). Furthermore, MeCN has been shown to increase 
electroendosmotic flow (Fujiwara and Honda 1987), which may also have contributed 
to the noted quickening of analyte migration times.
4.4.3. Influence of y-CD.
The most enantio-selective CD additive for the mequitamium enantiomers was seen to 
be y-CD (Table 4.8., see p. 122). It is well known that the concentration of chiral 
selector can affect enantiomeric optical resolutions and migration times (Penn et al. 
1993, Snopek et a l  1991 and Nardi et al. 1992). If the two enantiomers have different 
affinities for the CD i.e. different Kf values, and the electrophoretic mobilities of the free 
and complexed forms are different, then chiral resolution may be observed (Wren and 
Rowe 1992). Consequently the concentration of y-CD was varied between 0.0 and 50 
mM and the resultant migration times, electrophoretic mobilities (jjLm ) and chiral 
resolutions of mequitamium are given in Table 4.10. (see p. 128).
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Figure 4.9. Pherograms of mequitamium in presence of increasing MeCN content. 
FSCE conditions: as in Table 4.7., plus (a) 5%MeCN, (b) 9.5%MeCN, (c) 12%MeCN, 
(d) 15%MeCN and (e) 19.5%MeCN.
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Table 4.10. Effect of y-CD concentration on FSCE examination of mequitamium.


















0 12.08 0 - 20.44 - -
0.15 12.90 0 3.82 19.10 - -
0.5 13.15,
13.23
0.22 3.30 18.78 18.67 0.11
1.0 14.22,
14.32
0.63 3.00 17.36 17.25 0.11
2.0 15.14,
15.32
1.11 2.70 16.31 16.12 0.19
2.5 17.26,
17.54
1.78 2.60 14.31 14.08 0.23
5.0 20.72,
21.12
1.82 2.30 11.92 11.69 0.23
10 22.22,
22.60
1.72 2.00 11.11 10.93 0.18
15 24.44,
24.80
1.41 1.82 10.10 9.96 0.14
20 26.44,
26.80
1.30 1.70 9.34 9.22 0.12
30 30.28,
30.62
1.02 1.52 8.15 8.07 0.08
50 30.64 0 1.30 8.06 - -
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Increasing the CD concentration over the entire range caused the enantiomer migration 
times to successively lengthen, indicating stronger CD:analyte complexation. However 
it is clear that this did not always lead to a concurrent improvement in optical resolution. 
The maximum resolution value occurred at a y-CD level of 5 mM, whilst higher 
concentrations only produced lower resolutions and longer migration times. The 
enantiomer mobility difference, A/xapp , plateaued between 2.5 and 5.0 mM y-CD. 
Equation 4.11. (section 4.1.) explains these phenomena, whereby the optimum 
enantiomer mobility difference will occur between some zero and infinite CD 
concentration as will the maxiumum resolution. However both values are not necessarily 
identical as demonstrated by Penn et al. 1993 (see also equations 4.12 and 4.13). This 
is in agreement with the results found here, with maximum resolution observed at 5 mM 
y-CD and maximum A p ^  seen to range from 2.5 to 5.0 mM y-CD. Figure 4.10. (see 
p. 130) shows representative electropherograms of mequitamium as the y-CD 
concentration was continually increased.
4.4.4, Determination of Complex Association Constants (Kf).
Using the method described by Gariel et al. 1993 for FSCE experiments (applied in 
sections 4.2.4. and 4.3.6.), the complex association constants for the enantiomers of 
mequitamium, denoted Ks and KR, in the presence of y-CD where found by plotting /*app 
versus -log[CD] M (Fig. 4.11., see p. 131). These values were estimated to be 355 M'1 
and 316 M*1 respectively. The optimum CD concentration for mobility difference, /xapp, 
which can be calculated from equation 4.12., was then determined to be 3.0 mM y-CD. 
Examination of Table 4.10. shows that this value lies within the plateau region observed 
for /zapp i.e. 2.5 to 5.0 mM and so is in good agreement with these results.
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Figure 4.10. Electropherograms of mequitamium with increasing y-CD 
concentration. FSCE conditions as Table 4.9.
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Minutes
Fig. 4.11. n app versus -log [CD] for mequitamium with y-CD. FSCE conditions as in 
Table 4.9.
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Furthermore, the concentration of CD required for optimum enantio-resolution can be 
found using equation 4.13. The mobility of the y-CD:mequitamium complex, /x„ , was 
taken as the mobility value in the presence of 50 mM y-CD i.e. that part of the curve 
in Fig. 4.11. which corresponds to the analyte being fully complex. /aco, the 
electroendosmotic flow rate, was estimated using MeCN as the neutral marker and found 
to be 3.8 xlO 6 cm 2 V' 1 s1 . The electrophoretic mobility of mequitamium in the 
absence of y-CD was 20.44 xlO ‘5 cm 2 V' 1 s 1 . Substitution of these values into 
equation 4.13. indicated that a y-CD concentration of 4.7 mM would have provided 
optimum enantio-resolution. Table 4.8. shows that 5 mM y-CD gave the highest 
observed resolution and is therefore in good agreement with the predictive theory.
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CHAPTER FIVE 
NMR RESULTS AND DISCUSSION
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5.1. Introduction.
NMR can be effectively used to assess the interaction sites between CDs and various 
chiral guest molecules. Chemical shifts, 6's, and coupling constants, / ,  of both host and 
guest nuclei are sensitive to changes that have occurred within the molecular environment 
of the complex. Hence NMR can provide an insight into the molecular positions and 
orientations adopted during the interaction process. .
5.1.1. XH-NMR Spectra of CDs.
Table 5.1. gives the typical JH-NMR signals generated by the three parent CDs, a-, p- 
and y-CD when dissolved in D20  (from Casy and Mercer 1988). Figures 5.1. (a) and 
(b) show respectively, the proton numbering pattern assigned to each glucose residue in 
the parent CDs and the overall shape of the CD macrocycle when the residues are linked 
together.
Table 5.1. *H-NMR signals and multiplet separations (Hz) in parentheses of a , p and 
y-CD. (at 400 MHz).
Cyclodextrin H -l H-2 H-3 H-4 H-5 6-CH2



























a Overlap to form multiplet centered near 3.85 ppm.
133
The proton spectrum of free p-CD in D20  was initially assigned by Demarco and 
Thakkar 1970. Wood et al. 1977 (and ref. 21 cited therein) established that each glucose 
residue in the parent CDs exists in a similar chemical environment to that of the others, 
so that the overall NMR spectrum of the macrocycle does not differ greatly from that of 
an individual residue. Many other workers have gone on to assign the spectra of various 
CD derivatives e.g. methylated p-CDs using 13C-NMR (Szejtli et al. 1980), methylated 
a  and P-CDs using *H and ,3C-NMR (Yamamoto et al. 1987 and Inoue et al. 1986), 
alkylated P-CDs using !H and 13C-NMR ID and 2D experiments (Meier-Augenstein et 
al. 1992 and Hirayama et al. 1993) and peracetylated and methylated p-CDs (Tezuka and 
Hermawan 1994). Takahashi 1993 synthesised a mono-tyrosylamino derivatised CD and 
reported that the glucopyranose units were magnetically non-equivalent when examined 
by 13C-NMR.





OH OH OH OH
6" Ik 
CH2 OHc h 2 o h
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CDs are soluble in water and D20  so they can be applied directly to water soluble chiral 
analytes e.g. many therapeutic compounds are in the form of protonated salts or alkali 
metal salts of acids. Thus, they can be easily used for the examination of a wide range 
of pharmaceutical compounds. CDs also have no broadening effect on ^ -N M R  signals 
and their 6 range is relatively narrow (3.5 - 5.1 ppm) so they do not greatly obscure the 
spectra of many compounds of interest (Casy 1993a).
Casu et al. 1968 were among the first to show how the glucose residues adopt the 4Q  
chair conformation in solution, using NMR analysis. X-ray diffraction studies (e.g. 
Lindner and Saenger 1982) have since proved this to be the case. Intramolecular 
hydrogen bonding is known to occur in solution between the secondary hydroxyl groups 
of underivatised CDs (St-Jacques et al. 1976 and Onda et al. 1988). When dissolved in 
DMSO (and also in D20), the OH group in position (2) and that in position (3), are seen 
to form a hydrogen bond where OH(3) is the main hydrogen donor. This bond helps to 
maintain the structure of the CDs and may explain why some derivatised CDs possess 
a more distorted / flexible structure when the hydrogen bonding capacity at these points 
has been lessened (Inoue et al. 1987, Ventura et al. 1994 and Myles et al. 1994).
5.1.2. Guest Induced Chemical Shifts of CDs.
Upon complexation with many guest molecules, CDs display characteristic changes in 
the chemical shifts of their protons. Aromatic guest species in particular tend to cause 
the inner H3" and H5" CD protons to be shifted upfield e.g. up to -0.25 ppm shifts 
(Smith et al. 1994) and -0.288 shifts (Yoshida et a l  1990a) have been reported i.e. the 
protons are shielded by the diamagnetic anisotropy of the penetrating aromatic group. 
The two H6" protons can also experience relatively large shifts, which may be 
attributable to their proximity to the CD cavity. These phenomena have been widely
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reported by other workers e.g. Komiyama and Hirai 1980a, Nakajima et al. 1984, 
Yamashoji et al. 1990, Rekharsky et al. 1994, Azaroual-Bellanger and Perly 1994.
The resonances of the other CD protons, H I", H2", H4" and H6a" / H6b", generally do 
not show A6 changes as large as those of the inner H3" and H5" protons. Bergeron et 
al. 1978 noted this effect between a-CD and benzoic acid, as did Smith et al. 1994 
(when examining the interaction of catechin with a-, p- and y-CD); Mulinacci et al. 
1993 found H3" P-CD signals shifted by more than four times the extent of HI" and H2" 
signals in the presence of ibuproxam; Jaime et al. 1990 noted a continuous shielding of 
H3" and H5" protons when the ratio between p-CD and 1-bromoadamantane was varied 
but that no changes occurred for the outer p-CD protons, whilst Uccello-Barretta et al. 
1993 noted only minor shifts for HI", H2" and H4" protons of P-CD when complexing 
with (S)-(+)-fenoprofen. This evidence reinforces the view that inclusion complexation 
is the primary mechanism by which CDs interact with guest molecules in aqueous 
environments and that those protons located on the 'outer-face' of the macrocycle (HI" 
and H4") do not generally come into intimate contact with the included species.
5.1.3. NMR Equilibria for Complex Formation.
The association constant, Kf, can be evaluated from NMR measurements using graphical 
procedures if the chemical shift of one species is observed in the presence of a large 
excess of another species. Assuming that a 1:1 complex, A.CD, is formed between a 
guest molecule, A, and a cyclodextrin, CD, then the following equations are applicable;
[A] +  [CD] ** [A.CD] (Equation 5.01.)
Kf (association constant) =  [A.CD] / [A] +  [CD]
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(Equation 5.02.)
[A.CD] =  A6obs. [A]t . 1/A6C (Equation 5.03.)
where [A]t is the total guest concentration and A6obs and A6C are given by,
A6obs =  6obs - 6f (Equation 5.04.)
(Equation 5.05.)
with 6f and £>a .CD representing the chemical shifts of a given nuclei in the free and 
complexed forms respectively. It may be shown that the measured chemical shift is 
related to the total CD concentration, [CD]t, by,
The stability of analyte-CD complexes can then be measured via equation 5.06. by 
varying the CD concentration and observing its effect on the chemical shifts of specific 
nuclei. Bergeron et al. 1977 provided much of the mathematical basis for the above 
treatment, using a modified form of the Hildebrand-Benesi equation (see Benesi and 
Hildebrand 1949 ref. 12 cited in Bergeron et al. 1977), to calculate the dissociation 
constants between a-CD and a series of phenol derivatives. By plotting l/A6obs versus 
1/[CD] a linear relationship results, where the slope is l/(Kf . A6C), the x-axis intercept 
is -Kf and the y-axis intercept is 1/ A6C. Various workers have since applied the same 
principles to other CDs and guest compounds e.g. Smith et al. 1989, Wenz and von der 
Bey 1988 and Casy et al. 1991.
Rearranging equation 5.06. to,
A60bs =  Kf . [C D ],. A6C . (1 +  Kf . [CD],)'1 (Equation 5.06.)
A60bs . ([CD],)'1 =  Kf . (A6C - A6obs) (Equation 5.07.)
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allows the association constant, Kf, to be evaluated by plotting A6obs/[CD] versus A60^s 
where the slope equals -Kf. This is the Foster-Fyfe method (Foster and Fyfe 1965), 
which enables a more straightforward graphical determination of Kf than the Hildebrand- 
Benesi method. It too has been used by other workers e.g. Uccello-Barretta et al. 1993.
If the association constants for enantiomers with a given CD are very similar, the 
observed enantiotrophic shifts may be attributed to the different orientation of the 
enantiomers in the CD cavity (Uekama et al. 1985).
5.1.4. 2D NMR Techniques - NOESY and ROESY.
NOESY (Nuclear Overhauser Effect Spectroscopy) allows the spatial visualization of 3D 
interactions between e.g. a CD and guest molecule, whose nuclei are close enough 
together in space to affect each other through dipole-dipole interaction mechanisms. The 
magnitude of the NOE depends on the distance between interacting nuclei and diminshes 
dramatically (to the sixth power) as the distance between saturated and observed nuclei 
increases (Field 1989). Bekers et al. 1991 were able to partially determine the mode of 
interaction between y-CD and doxorubicin using NOESY spectra but could not 
unequivocally assign the spectra due to extensive peak overlap. Bates et al. 1994 tried 
to observe NOE’s between the protons of ‘poly’-O-octyl-a-CD and the aryl protons of 
ephedrinium ion but they were also unsucessful. Hartzell et al. 1993 used proton 2D 
exchange spectroscopy (EXSY), which employs a phase sensitive NOESY pulse 
sequence, to determine rate constants for the exchange process between P-CD and 
TCNQ- (tetracyanoquinodimethane), corroborating other evidence that they exist as a 
bonded dimer in solution.
The ROESY (Rotating Frame Nuclear Overhauser Effect Spectroscopy) or CAMELSPIN 
experiment is a variation of the NOESY technique, where a spin-locking field is used to
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view the NOE’s within a rotating frame of reference. The magnitude of the NOE 
depends, amongst other factors, on the molecular tumbling rate (correlation time) of the 
molecule. Small molecules tumble rapidly in solution giving positive NOE’s, whilst the 
opposite is true for larger molecules. ROESY allows extremely small NOE’s, which can 
result from the unfavorable correlation times of host-guest complexes with a molecular 
weight of around 1000 - 2000, to be observed at high field strengths. This technique was 
first described by Bothner-By et al. 1984 and causes all NOE’s to appear positive under 
any value of £)tc, where cb is the angular Larmor frequency and t c is the motional 
correlation time of the complex (Neuhaus and Williamson 1989). Many CD complexes 
have a molecular weight within the region where NOE’s are difficult to detect with 
NOESY experiments, so lending themselves to investigation by the ROESY technique.
Schneider et al. 1991 used 2D ROESY experiments to prove greater inclusion of phenyl 
and naphthyl moieties by y-CD than p- and a-CD. Amato et al. 1992 found that ROESY 
evidence of dipolar contacts between p-CD and a chiral anti-amnesic drug supported 
molecular modelling results of the complex’s geometry. Amato et al. 1993 were further 
able to show via ROESY experiments that p-CD more fully complexed a selected chiral 
cognition activator drug than did a-CD, which was also shown to be unable to chirally 
discriminate between the drug enantiomers as opposed to p-CD. Ndou et al. 1993 used 
2D ROESY to show the preferential location of ephedrine inside P-CD with the guest 
alkyl chain in close proximity to the bulk aqueous environment on the primary CD side 
and the aromatic group residing in the P-CD cavity..
5.1.5. Determination of Complex Stoichiometry.
It is posible to determine the host-guest complexation ratio (stoichiometry) when 
exchange is rapid on the NMR time scale, by recording the spectra of solutions where 
the ratio of the two constituents is varied but the overall molar concentration of the
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solution remains constant. If a physical parameter which is related to the concentration 
of the complex e.g. proton chemical shift can be measured and plotted as a function of 
the A:CD ratio, a maximum value will be reached which shows the stoichiometry of the 
complex. This is known as a Job plot (Job 1928) and may be visualised by plotting 6obs 
Hz*[CD]/[CD] +  [A] versus [CD]/[CD] +  [A] where 6cbs Hz is the 6 value in Hertz.
Greatbanks and Pickford 1987 performed a Job plot with p-CD and propranolol HC1 in 
D2 O at 30°C and concluded that they complexed in a 1:1 ratio. Bekers et a l  1991 
calculated the stoichiometric ratios between two anthracyclines and y-CD. They found 
that a 1:1 ratio was formed for both guest molecules at a low pH of three, which was 
necessary to allow maximum stability for the guest molecules. Fronza et a l  1992 also 
estimated a 1:1 host-guest complexation ratio between p-CD and piroxicam, a 
nonsteroidal anti-inflammatory. They were investigating means of improving the 
absorption of the drug from the gastrointestinal tract by preparing it in a carrier molecule 
(p-CD). Djedai'ni et a l  1990 calculated a 1:1 complex ratio between p-CD and 
indomethacin in aqueous solution at p2H, in order to mimic physiological conditions.
5.1.6. CDs in *H and 13C-NMR Spectroscopy.
If equilibrium between analyte-CD complexes and the free analytes is achieved rapidly 
on the NMR time scale, the NMR signals observed will reflect the net resultant of 
contributions of the free and bound forms (Casy 1993a). Duplication of certain guest 
signals in the presence of CDs is indicative of the formation of diastereomeric complexes 
(Casy and Mercer 1988) and may arise as a result of differences in complex stabilities 
and / or intrinsic chemical shifts (Cooper et a l  1991). There has been a great deal of 
attention paid to the effects of CDs on the NMR spectra of included species. In examples 
of early work, Bergeron and Rowan 1976 provided evidence (via A6's) for the formation 
of inclusion complexes between a- and p-CD with sodium p-nitrophenolate using *H-
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NMR. Wood et al. 1977 examined the interaction of a-CD in D20  with /7-iodoaniline and 
suggested that the formation of an inclusion complex was responsible for the observed 
A6 changes. Uekama et al. 1977 measured 13C spin-lattice relaxation times (Tj) of P-CD 
and sulfathiazole (a sulphur containing drug) and suggested that the overall decrease in 
Ti was the result of inclusion complex formation, whilst Komiyama and Hirai 1980b also 
used 13C-NMR to elucidate the conformation of a-CD and 3-nitrophenol in solution.
CDs have been used in NMR to observe complexation with fullerenes (Andersson et al. 
1994), atropisomers (Casy 1993b), pharmaceuticals (El-Gendy and El-Gendy 1993 and 
Hanna and Lau-Cam 1993), glycolipids (Casu et al. 1990) and cyclohexane derivatives 
(Rekharsky et al. 1994). Inoue et al. 1985 demonstrated for the first time how the 
orientation of p-nitrophenol with methyl-a-CD in solution differed from that seen in the 
solid state by examining *H AS's of the included guest. Xiang and Anderson 1990 used 
^-N M R  A6's of host and guest compounds to help show the complexation structure 
between HP-p-CD and several purine nucleosides was enhanced when the guest 
molecules were present in an ionically neutral form. Suzuki et al. 1990 showed how azo 
dyes protruded from the narrow rim of various CDs by virtue of induced shifts of both 
the CD CH2OH groups and of certain nuclei of the guest species. Inoue et al. 1987 were 
able to determine the mode of inclusion between various CDs and phenylalanine by 
considering A6's of host and guest nuclei. Coleman et al. 1988 confirmed molecular 
modelling assignments for menthol and p-CD using !H-NMR, as did Weise et al. 1989 
with p-CD and indomethacin, whilst Lehmann et al. 1991 probed the formation of 
inclusion complexes with permethylated and peracetylated p-CDs and a variety of 
aromatic guests in D20  and CD3OD, observing complexation in D20  only.
Molecular complexes of various explosives with a-, p- and y-CD have been studied by 
Cahill and Bulusu 1993 using !H spin-lattice relaxation times (Tl) to show which 
explosives bind more strongly in solution with a view to improving the long term 
stability of the explosive materials. Wenzel et al. 1994 and Sherry et al. 1994 examined
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lanthanide ion induced chemical shifts of CDs and selected hosts e.g. propranolol, 
ibuprofen and pheniramine. They found that lanthanide ions such as dysprosium were 
able to enhance the the extent of chiral resolution seen in the NMR spectra for the 
enantiomers. Pirkle and Sikkenga 1975, were the first to demonstrate this effect.
5.1.7. CDs in Multinuclear NMR Spectroscopy.
Analytes bearing nuclei other than !H and 13C, which are sensitive to NMR spectroscopy, 
have been examined using a variety of CDs. MacNicol and Rycroft 1977 were able to 
induce enantiomeric shifts of fluorine bearing analytes (using 19F-NMR) in the presence 
of a and P-CD, which they attributed to guest binding inside the CD cavities. Dyllick- 
Brenzinger and Roberts 1980 measured 15N chemical shift changes of a racemic 
tetrahydroquinoline in the presence of p-CD and found that the nature of the solvent was 
very important when quantifying the shift values. Taylor et al. 1991 used 19F-NMR to 
examine the signal splitting occuring with Me-p-CD and a proprietary compound bearing 
a trifluoromethyl group. They found the spectrum was greatly simplified compared to *H- 
NMR and that several other derivatised CDs were also able to induce partial signal 
splitting of the fluorine containing moiety. Line broadening of 81Br-NMR signals caused 
by derivatised a-CDs has been noted by Yamashoji et al. 1993.
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5.2. NMR Investigation of Phenethylamines.
Figure 5.2. shows the structures of those phenethylamines examined and the numbering 
scheme adopted for NMR assignments.
Figure 5.2. Numbering scheme used in NMR assignment of phenethylamines.
CI-I—C H - N H — R2
pound nam e X R i r 2
1 cphcdrinc H CM 3 c h 3
2 oxedrine 4-011 II c h 3
3 oxilofrinc 4-OH c h 3 c h 3
(oxycphcdrine)
4 norfenefrine 3-OH H 1-1
5 etilefrinc 3-OH H CI-l2CI-I3
6 orciprenalinc 3,5-diOH II CH(CH3)2
7 noradrenaline 3,4-diOH II 1-1
(norepinephrine)
8 isoprenalinc 3,4-diOH II CH(CH3)2
9 salbutamol 3-CH2OH,4-OH H C(CH3)3
It had already been demonstrated that p- and Ac-p-CD were able to chirally resolve 
members of this group of analytes by CE (section 4.2.) and that peracetyl-p-CD could 
separate the enantiomers of three phenethylamines by HPLC (section 3.2.4.). 
Unfortunately an investigation by NMR of the 'host-guest' interactions seen in the HPLC 
experiments was inconclusive. This occurred because it was necessary to use a deuterated
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organic solvent (CDC13) to allow the dissolution of sufficient quantities of peracetyl-p- 
CD for NMR analysis. However this very non-polar environment understandably did not 
favour inclusion complex formation, resulting in the peracetyl-p-CD: analyte signals 
showing little or no chemical shift changes ( 0.002 A6ppm) compared to those in the 
free state (Lehmann et al. 1991 noted a similar problem when studying peraceyl-p-CD 
by NMR). The possibilty that peracetyl-P-CD would be able to interact with the solutes 
via a 'polar-organic' mechanism (section 3.1.3.), may have been precluded by the total 
absence of hydrogen donor groups in the 2, 3 and 6 positions.
5.2.1. Analyte Complexation with p and Ac-P-CD.
The successful CE buffer conditions were replicated for the NMR measurements, using 
the nine phenethylamines as 'guest' molecules, with p and Ac-p-CD as the 'hosts'. For 
the measurement of complex-induced shifts, sufficient quantities of the analytes with and 
without the appropriate CD were dissolved in deuterated 0.1M phosphate buffer 
equivalent to pH 4.5 to give 12 mmol concentrations of each.
The assignments of the free analytes are shown in Table 5.2. while Tables 5.3. and 5.4. 
show the change in chemical shift (A6) observed on complexation with each CD and the 
separation between signals arising from the individual enantiomers (| 6R-6S|).
144
Table 5.2. *H NMR assignments of phenethylamines. For key to 1-9 see Fig. 5.2.
H2' H3' H4' H5' H6' HI H2 r 2 2-CH3
1 7.355 5.060 3.476 CH3 2.699 1.062
2 6.862 7.245 - 7.245 6.862 4.904 3.230, 3.207 CH3 2.693 -
3 6.871 7.217 - 7.217 6.862 4.951 3.416 CH3 2.676 1.078
4 6.861 - 6.826 7.271 6.918 4.885 3.277, 3.085 - -
5 6.847 - 6.812 7.254 6.901 4.906 3.249, 3.197 CH2 3.071 
CH3 1.213
-




7 6.876 - - 6.868 6.789 4.798 3.206, 3.094 - -




9 7.275 c h 2
4.593
“ 6.882 7.205 4.841 3.207, 3.128 Bu‘ 1.310
As representative spectra, Figure 5.3. shows the NMR spectra of uncomplexed etilefrine 
and oxedrine with their corresponding signals in the presence of p-CD and Ac-p-CD. In 
the case of etilefrine (5) the two aromatic doublets (H4' and H6 ') were distinguished with 
the aid of a 2D proton detected !H-13C chemical shift correlation spectrum and substituent 
increment tables.
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Figure 5.3. (a) The NMR signals for etilefrine IIC1. Aromatic protons, III and CH3 
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Figure 5.3b. The NMR signals for oxedrine IIC1. Aromatic protons, HI, H2 and CH3 (R2) in 
(a) the absence of CD, (b) the presence of p-CD and (c) the presence of Ac-P-CD.
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Table 5.3. Chemical shift changes (A6) in ‘H NMR spectra of various phenethylamines induced by P -cyclodextrin. The average change in chemical shift for both enantiomers
is given with |6R- 8,| in parentheses. A dash in parentheses indicates no signal splitting and an asterisk indicates that full analysis was not possible.
»  ■ '  ■ H3' |  H 4’ |  H5' H6' HI H2 r , 2-CH,
i -0.002 (*) 0.072 (-) -0.096(0.018) CH, 0.046 (-) -0.027 (-)
2 0.000 (-) -0.024 (-) - -0.024 (-) O.CXXX-) 0.008 (-) 0.037 (*) CH, 0.010 (-) -
3 -0.010 (0.005) -0.058
(0.005)
- -0.058 (0.005) -0.010 (0.005) 0.086 (-) -0.100(0.017) CH, 0.052 (0.002) -0.015 (0.003)
4 -0.013 (-) - -0.027 (-) -0.040 (0.003) 0.023 (-) 0.000 (-) -0.024 (0.013) 
-0.044 (0.009)
- -

















8 -0.012 (-) - -0.028 (-) 0.019 (-) 0.007 (-) -0.051 (-) 
0.024 (-)
CH 0.007 (-) 
CH, 0.012 (-) 
CH, 0.011 (-)
-
9 0.000 (-) CH, 0.000 (-) - -0.007 (-) 0.001 (-) 0.008 (-) -0.033 (-) 
-0.005 (-)
Bu‘ 0.006 (-) -
Table 5.4. Chemical shift changes (A6) in 'H NMR spectra of various phenethylamines induced by Aeptafcis(2,3-di-0-acetyI)p -cyclodextrin. |6R- 6,| shows the average change
in chemical shift for eachenantiomer given in parentheses. A dash in parentheses indicates no signal splitting and an asterisk indicates that full analysis was not possible.
£  1 « ,  |1 « ,  |1 HS’ | H6' HI H2 R, 2-CH,
1 0.026 (*) 0.063 (0.040) 0.050 (0.036) CH, 0.041 (0.026) 0.016 (-)
2 0.015 (0.006) -0.007 (0.003) - -0.007 (0.003) 0.015 (0.006) 0.030 (0.018) 0.001 (-) 
-0.003 (-)
CH, 0.022 (0.007) -
3 0.039 (0.021) -0.010(0.018) - -0.010(0.018) 0.039 (0.021) 0.062 (0.046) -0.042 (0.037) CH, -0.043 (0.031) 0.019 (-)
4 0.009 (-) - -0.001 (0.006) -0.004 (-) 0.023 (0.016) 0.038 (0.030) 0.043 (0.013) 
-0.008 (0.015)
- -
5 0.011 (0.006) 0.006 (0.006) -0.019 (0.016) 0.029 (0.018) 0.081 (0.067) * C H ,*
CH, 0.034 (0.033)
-
6 -0.005 (-) - •0.011 (0.008) * -0.005 (-) 0.025 (*) 0.010 (0.004) 
0.005 (0.032)
CH 0.039 (0.016) 
CH, 0.029 (-) 
CH, 0.034 (0.005)
-
7 -0.005 (-) - - -0.026 (-) -0.004 (-) 0.022 (*) 0.033 (-) 
-0.018 (-)
- -
8 0.002 (-) - - -0.012 (0.003) 0.006 (0.005) * 0.003 (-) 
0.019 (-)
CH 0.030 (0.016) 
C H ,0.025 (0.008) 
CH, 0.025 (0.008)
-
9 0.011 (-) CH, 0.004 (-) - 0.002 (-) 0.010 (-) 0.014 (*) 0.032 (*) Bu1 0.036 (0.015) -
147
All the compounds show evidence of inclusion by P-CD with substantial changes in chemical 
shift (except salbutamol) caused by the presence of the oligosaccharide. In those compounds 
lacking a methyl group at C2, HI showed very small changes in chemical shift, whereas in 
ephedrine and oxilofrine with the additional side-chain methyl group, HI had a large value 
though not as large as H2. A contrasting pattern of values was observed on the addition of 
Ac-P-CD. In this case, the largest values of A6 were observed for H I, although it could not 
be measured in all cases because the shifted signal was obscured by CD peaks. The other 
signals were shifted to a lesser extent than when p-CD was added and the direction of the shift 
differed in some cases. The aromatic signals showed a different pattern of shifts in most 
compounds e.g. in oxedrine and oxilofrine, with a para-hydroxy group, the ortho-protons had 
a smaller shift with P-CD but a larger one with the acetylated CD.
Chiral discrimination was much higher with Ac-p-CD. All compounds, except noradrenaline, 
had at least one signal that was split when this CD was added. The HI signal had the highest 
|6r-6s| values in the molecule in the instances where it was not obscured by CD signals and 
could be measured.
5.2.2. A5 of p and Ac-p-CD Protons on Complexation with Phenethylamines.
Tables 5.5. and 5.6. show the chemical shifts experienced by the CD protons upon 
complexation with the various analytes. The H3" and H5" .protons had the largest shifts 
(upfield) in both CDs, with the H3" and H5" shifts of P-CD being much larger than those of 
Ac-p-CD. The analyte aromatic rings induced a shielding effect due to their proximity to these 
inner CD protons thus indicating that complexation had occurred. H6" shifts of both CDs were 
also of considerable size suggesting the narrower (primary) end of each CD torus may have 
been involved in the complexation process.
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Table 5.5. A6 of p-CD protons upon complexation with phenethylamines. For key
1-9 see Fig. 5.2.
HI" 112" H3" H4" H5" H6"
1 -0.024 -0.007 -0.091 -0.021 -0.154 -0.058
2 -0.015 -0.003 -0.076 -0.010 -0.101 -0.038
3 -0.013 0.001 -0.063 -0.006 -0.108 -0.029
4 -0.011 -0.003 -0.044 -0.004 -0.055 -0.040
5 -0.027 -0.011 -0.064 -0.016 -0.081 -0.059
6 -0.019 -0.001 -0.068 0.010 -0.078 -0.054
7 -0.012 -0.005 -0.044 -0.006 -0.043 -0.037
8 -0.013 0.000 -0.054 -0.003 -0.076 -0.045
9 -0.006 -0.002 -0.032 -0.005 -0.019 -0.032
Table 5.6. A6 of Ac-6-CD protons upon complexation with phenethylamines. For
key 1-9 see Fig. 5.2.
2,3-di-O-acetyl HI" H2" H3" H4" H5" H6"
1 -0.007, -0.003 -0.012 -0.005 -0.016 -0.008 -0.016 -0.013
2 -0.013, -0.005 -0.014 -0.006 -0.027 -0.013 -0.027 -0.023
3 -0.002, 0.001 -0.006 0.001 -0.009 0.011 -0.006 0.010
4 -0.002, -0.001 -0.007 -0.003 -0.004 -0.002 -0.018 -0.011
5 -0.018, -0.010 -0.027 -0.015 -0.021 -0.012 -0.090 -0.041
6 -0.011, 0.000 -0.021 -0.009 -0.006 0.000 -0.059 -0.018
7 -0.017, -0.015 -0.022 -0.018 -0.016 -0.008 -0.032 -0.036
8 -0.013, -0.004 -0.016 -0.006 -0.010 -0.005 -0.041 -0.026
9 -0.010, -0.003 -0.004 -0.001 -0.004 0.002 -0.005 -0.006
5,2,3, Analyte Complexation with a and y-CD,
Although neither of these CDs had provided any enantio-resolution for the 
phenethylamines when employed in the HPLC experiments, their interaction with 
several of these analytes was examined. The NMR conditions chosen were those 
which had been used for the p-CD and Ac-p-CD work (section 5.2.1.).
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None of the analytes tested with y-CD showed any significant changes in chemical 
shift. The large size of the y-CD cavity would mean that compounds with only one 
planar aromatic ring would be unable to obtain a ‘tight-fit’ inside the y-CD cavity. 
Their motion would be relatively unrestricted within the CD torus and they would be 
unlikely to favour this environment over that of the bulk solvent with the result that 
interaction with the CD would be weak. It was therefore unsurprising that no change 
in chemical shift of either the analyte protons or the inner CD protons was observed. 
Similar results were seen in the presence of a-CD. In this case the rather small nature 
of the CD cavity (4.5 - 6.0 A) may have proved unfavorable for inclusion 
complexation with the substituted phenyl rings of the compounds. However, other 
workers have noted shifts of the inner protons of a-CD upon interaction with e.g. 
benzoic acid (Bergeron et al. 1978) and /7-iodoaniline (Wood et al. 1977). It may be, 
that the more extensive nature of the phenyl substituent in these compounds sterically 
hinders complexation.
5.2.4. Interpretation of Results.
The two CDs (p- and Ac-p-CD) had different overall effects on the NMR spectra of 
the phenethylamines as shown by chemical shift changes and signal splitting arising 
from diastereomeric complexation with the enantiomeric guest molecules. Both CDs 
demonstrated inclusion of phenethylamines but p-CD discriminated poorly between 
enantiomers and Ac-P-CD on the whole resolved the enantiomers extremely well. 
Neither a-CD nor y-CD were found to induce significant chemical shifts, which 
could have been attributed to the dimensions of the cavities in relation to the overall 
size of the analytes.
The larger chemical shifts of H3" and H5" in p-CD (compared to those in Ac-p-CD) 
indicate that this CD forms stronger inclusion complexes via a 'tighter fit', but not 
necessarily of a better enantio-discriminating nature, as seen from the lack of signal 
splitting. Relative to H5'', the H6" signal shifts were higher with Ac-p-CD than p-
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CD. Conformational changes of Ac-p-CD ascertained with molecular modelling, 
show that the secondary CD rim increased in size relative to the parent CD and that 
the primary opening became smaller (Fig. 5.4.). This was probably due to a total 
removal of the CD intramolecular hydrogen bonding between the OH (2) and OH (3) 
groups, which normally helps to stabilise the torous (Onda et al. 1988) and steric 
interaction between the acetyl groups. Such conformational flexibility was generally 
thought to occur only with /?er-derivatised CDs (Harata et al. 1984 and Ventura et 
al. 1994). Other workers have stated that a significant shift of H6" protons (along 
with H5") indicates a deeper analyte penetration of the CD cavity (Rekharsky et al. 
1994), which would explain the larger H6" shifts with Ac-p-CD found in this work. 
The smaller Ac-p-CD H3" shifts arise from a widening of the secondary opening that 
reduces the analyte interaction at that point.
Changes in analyte chemical shift provide evidence of inclusion by both 
oligosaccharides, although the A6 values for salbutamol are small or insignificant on 
complexation with Ac-P-CD. The presence of P-CD tended to cause larger shifts in 
the aromatic region compared to Ac-p-CD and produced little or no splitting of the 
signals. On the other hand, Ac-p-CD split aromatic signals in several compounds, 
most notably in oxilofrine, norfenefrine and etilefrine.
Mainly upfield shifts (negative A6 values) were observed in the aromatic region of 
the phenethylamine spectra on complexation with either CD and are consistent with 
inclusion of this part of the molecule in the hydrophobic cavity of the macromolecule. 
Downfield shifts in the H6' signal of some N-(2' ,4 '-dinitrophenyl)amino acids, 
together with circular dichroism data, have been interpreted as arising from inclusion 
complexes where the guest molecule is tilted in the cyclodextrin cavity (Li and Purdy 
1992) and are consistent with theoretical calculations on the alignment of guest and 
host dipole moments (Kitigawa et al. 1990). Notable downfield shifts occurred for 
individual aromatic resonances of some phenethylamines and may be indicative of 
such tilting, for example, the H6' resonance is shifted downfield on complexation 
with p-CD in norfenefrine while other signals move upfield. Whilst the overall
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Fig. 5.4. Molecular models of (a) Ac-p-CD and (b) P-CD. Calculated using the 
Discovery package (see section 2.5.).
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pattern of aromatic chemical shifts is similar with both CDs, in the presence of Ac-p- 
CD, the H6' signal for norfenefrine, etilefrine and isoprenaline shifted downfield to 
a greater extent than the other aromatic signals (see Fig. 5.5.).
Side-chain interactions with the CD, presumably at its surface, are apparently also 
important for complexation, although dependant on derivatisation, and the alkyl 
values are larger than for the aromatic signals. The signals of H2 and R2 are 
significantly shifted in the presence of either CD, and often have large values of 
|6 r- 6s|. However, the HI resonance is significantly shifted only by Ac-P-CD for 
compounds without a methyl group at C2. Ac-p-CD gives a large splitting of the HI 
resonance in those compounds where the signal is not obscured but in the presence 
of p-CD no doubling is observed. These results could be explained by different 
hydrogen bonding interactions between each CD and the guest side-chain. Both 
hydroxyl and acetyl groups on the CD rim could act as hydrogen bond acceptors for 
the amine NH thus causing chemical shift changes in the guest (although of variable 
direction) with both CDs. The downfield shifts of the HI resonance noted with the 
derivatised CD may be due to hydrogen bonding between the guest hydroxyl group 
at C l and the carbonyl oxygen of the macrocyclic acetyl groups. Presumably the 
structure of the inclusion complex with p-CD does not have the correct geometry for 
a similar interaction with the secondary hydroxyl groups of this CD.
In the presence of p-CD, ephedrine and oxilofrine with the 2-Me group also show a 
large shift of the H I resonance which could be explained by the side-chain methyl 
group forcing a conformational rearrangement such that a hydrogen bond can be 
accommodated. Differences in hydrogen bonding patterns could also explain why Ac- 
p-CD is better than the parent CD at discriminating between phenethylamine 
enantiomers, as shown by the generally larger values of l5R-6s l obtained with the 
former oligosaccharide.
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Fig. 5.5. Effect of P-CD and Ac-p-CD on A6 of norfenefrine, etilefrine and 
isoprenaline. See text for explanation.
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5.2.4. Calculation of Stoichiometry and Association Constant, (KfL
A Job (continuous variation) plot (see section 5.1.5. for a description of the method 
and section 2.4.3. for details of the experimental procedure) was used to determine 
the stoichiometry of each CD complex in the case of etilefrine HC1 (Fig. 5.6.). 
Selected data for guest or host are shown but other signals reflected the same pattern 
with a peak at 0.5 showing that a 1:1 complex was formed with both CDs. It is 
assumed that the other compounds in the series also formed complexes with this 
stoichiometry due to their lack of a second aromatic ring in the molecules.
154
Fig. 5.6. Representative Job plots. Complexation between etilefrine HC1 and (a) p- 
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Four solutions in 0.1M deuterated phosphate buffer, pH 4.5 with molar ratios 
(guest:host) of 1:2.33, 1:3.0, 1:4.0 and 1:5.7 were prepared to determine the Kf 
between etilefrine HC1 and p-CD and Ac-P-CD. The graphical Foster-Fyfe method 
was used to determine Kf (see section 5.1.3. for details). However, plots of l/A 6 obs 
vs 1/[CD] were not linear using CH3  or a-H on the guest or HI" on the host. It was 
not possible therefore to evaluate Kf using NMR in this instance.
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5.3. NMR Investigation of Propranolol Analogues.
HPLC (section 3.2.) and FSCE (section 4.3.) studies had proven that P-CD, HE-p- 
CD, Me-p-CD, Ac-P-CD and peracetyl-P-CD were able to resolve the enantiomers 
of various propranolol analogues, with FSCE providing the greatest enantio- 
separation values. Consequently these CDs were used for the NMR investigations to 
understand more fully those 'host-guest' interactions involved. As stated previously 
(section 5.2.), it was not possible to examine the peracetyl-p-CD:analyte complexes 
due to the high level of deuterated organic solvent required for this CD's dissolution, 
which in turn prevented the observation of any significant 6 values. However those 
FSCE buffer conditions which gave rise to the highest observed chiral separations 
were replicated in the NMR experiments using the appropriate deuterated solvents 
(D20  and CD3OD) with a host:guest molar ratio of approximately 1:1.
5.3.1. Analyte Complexation with p-CD.
Greatbanks and Pickford 1987 examined propranolol's complexation with p-CD and 
found that mostly downfield shifts occurred for the proton signals of guest molecule 
protons. The result for propranolol obtained in the present work (compound 1; Table 
5.7., see p. 158) is in agreement, with H2', H3' and H8' having the largest downfield 
shifts of the aromatic protons while the side chain protons showed generally lower 
shifts (assignments were readily completed upon inspection and via the 
aforementioned reference). Fig. 5.7. (see p. 157) shows the labelling scheme used for 
compounds 1-6. NOE measurements suggested that the guest adopted a tilted 
conformation within the p-CD cavity, with irradiation at the p-CD H5" giving a 
positive NOE for the guest H5' and H8' signals whilst irradiation of the p-CD H3" 
gave an enhancement at only H8' of the guest. Further, Greatbanks and Pickford 
saturated the isopropyl site and found no intensification for any of the CD signals 
suggesting that it does not occupy the CD torous. However, in the work described
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here, the isopropyl group displayed a strong shift upon complexation with the CD, 
indicating some interaction with the oligosaccharide.
Fig. 5.7. NMR labelling scheme for compounds 1-6.
1 2  3
0 — CHo— CH—  CH0 —N il— R,
8 ' T I
4 '
R =  /-propyl (compound 1) R = /-propyl (compound 4)
R =  /-butyl (compound 2) R =  /-butyl (compound 5)
R =  ethyl (compound 3)
R =  CONH-ethyl (compound 6 )
With all the guest R groups demonstrating significant downfield chemical shifts, 
where they could be readily measured, they apparently underwent some 
conformational change upon interaction of their aromatic moiety with p-CD.
Signal splitting for compounds 1-3 i.e. those analytes which possessed a naphthyl 
ring, occurred at the methylene group in position 3 (in compound 6  the signal was 
obscured) and also in position R for compounds 3 and 6 . Such signal splitting is 
indicative of differential interaction between the guest enantiomers with the host 
macrocycle. Compounds 4 and 5, which possessed only a single aromatic ring, 
displayed a different pattern of aromatic shifts to the other analytes. These shifts 
indicated inclusion into the CD cavity but were generally smaller than the A6  values 
observed for those analogues containing a naphthyl ring.
Observation of the p-CD protons (Table 5.8., see p. 158), assigned with the aid of 
literature values e.g. Casy and Mercer 1988), showed that all the analytes caused a 
significant upfield shift of the H3" signal. H5" shifts were weaker, especially with
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compounds 1, 2, 4 and 5, suggesting less shielding of this proton, perhaps from a 
more shallow insertion into the CD cavity. H6 ", positioned at the primary CD end, 
generally had a much smaller A6  than H5". The lower CD A6  seen for compound 6  
indicated a weaker complexing interaction.
Table 5.7. A 6  of compounds 1-6 upon the addition of p-CD. NMR conditions: 
30% CD3 OD - phosphate buffer, 0.05 M, pH 3.0. ______ _______ ________
2' 3' 4', 6 ' 7' S ' 8’ 1 2 3 R R
i 0.095 0.098 0.059 0.059 0.042 0.088 0.080 * 0.047
(0.004)
CH* (CH3)2 0.065











4 0.060 0.061 0.060 - 0.061 - 0.066 0.096 0.056 CH 0.060 (CH3)2 0.071
5 0.054 0.060 0.054 - 0.060 - 0.072 0.112 0.030 (CH3)3
0.068
-





Table 5.8. A6  of p-CD protons upon complexation with compounds (1-6). NMR
conditions as stated in Table 5.7.
Analyte 1" 2" 3" 4" 5" 6"
1 -0.011 -0.006 -0.009 -0.002 -0.002 -0.001
2 0.001 -0.013 -0.021 0.005 0.004 0.000
3 -0.007 -0.013 0.001 -0.007 -0.007 0.001
4 -0.012 -0.007 -0.010 -0.002 -0.002 -0.002
5 -0.043 -0.032 -0.033 -0.025 -0.024 -0.006
6 -0.017 -0.014 -0.012 -0.008 -0.008 -0.004
5.3.2. Analyte complexation with Ac-P-CD.
The analyte chemical shift values induced by Ac-p-CD (Table 5.9., see p. 158) were 
both up and downfield for the aromatic protons of compounds 1-3 and 6  (naphthyl 
R' group), whilst those of compounds 4 and 5 (phenyl R' group) moved only 
downfield, suggesting a difference in their inclusion position. Virtually all the alkyl 
proton resonances for compounds 1 - 6  moved to lower-field with position 2  having the
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Table 5.9. A6 of compounds 1-6 upon the addition of Ac-p-CD.
NMR conditions as stated in Table 5.7.
Analyte 2’ 3' 4’,6' T 5' 8' 1 2 3 R R
1 0.005 0.001 -0.001 -0.001 0.002 0.002 0.004 0.020 * CH 0.009 (CH3)2 0.012
2 -0.004 -0.002 -0.001 -0.001 -0.005 -0.005 -0.009 0.017 0.010 (CH3)3 0.013 -
3 0.002 0.001 -0.014 -0.014 -0.005 -0.003 0.001 0.007 0.003 CH2 0.008 CH3 0.009
4 0.004 0.002 0.004 - 0.002 - 0.008 0.005 0.019 CH 0.006 (CH3)2 0.010
5 0.004 0.002 0.004 - 0.002 - 0.009 0.006 0.025 (CH3)2 0.013 -
6 -0.017 -0.016 -0.020 -0.020 -0.015 -0.024 * * -0.009 CH2 0.008 CH3 0.008
* signal obscured.
Table 5.10. AS of Ac-p-CD protons upon complexation with compounds (1-6).
NMR conditions as stated in Table 5.7.
Analyte 1" 2" 3" 4" 5" 6" Ac Ac
1 -0.021 -0.020 -0.020 -0.013 -0.013 -0.015 -0.012 -0.015
2 -0.023 -0.020 -0.021 -0.014 -0.012 -0.015 -0.012 -0.015
3 0.011 0.004 0.001 0.003 0.004 0.005 -0.010 -0.013
4 -0.032 -0.023 -0.024 -0.014 -0.013 -0.017 -0.008 -0.008
5 -0.028 -0.024 -0.028 -0.015 -0.014 -0.022 -0.008 -0.008
6 -0.026 -0.027 -0.031 -0.012 -0.012 -0.024 -0.006 -0.008
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highest value for compounds 1-3 and position 3 the largest chemical shift for compounds 
4 and 5. No signal splitting was observed for any of the compounds.
The Ac-P-CD protons were assigned by inspection, with the aid of a 2D COSY 
and by comparison with p-CD. On complexation with compounds 1-6 (Table 5.10.) H5" 
and H6 " had weaker shifts than H3" in the presence of compounds 1-3 and 6 . H I", H2" 
and H4", located on the 'outside' of the CD torous displayed stronger upfield shifts than 
the 2, 3-acetyl groups on the secondary rim.
5.3.3. Analyte complexation with HE-P-CD.
The aromatic protons of compounds 1-5 showed strong upfield shifts indicative of 
shielding when complexed with HE-p-CD although the H2', H3' and H 8 ' aromatic 
protons of compounds 1-3 had considerably smaller shifts than the others (Table 5.11., 
see p. 162). The aromatic protons of compounds 4 and 5 showed very similar shifts with 
little variation between the individual values. The methylene group in position 3 had the 
largest upfield shift of the alkyl protons for compounds 1-3 and the chiral proton 
(position 2) had the smallest shifts in all cases (obscured in compound 6 ). Signal splitting 
was apparent in several instances, most notably of R in 3 and 6  (Fig. 5.8., see p .161) 
and of the methylene groups in positions 1 and 3 for compounds 2, 3 and 5.
Interpretation of the HE-p-CD signals was based on observation and on the assignment 
of heptakis{2, 6-di-0-ethyl)p-CD by Hirayama et al. 1993 and of other alkylated p-CDs 
by Meier-Augenstein et al. 1992. All the HE-p-CD protons were shifted upfield (Table 
5.12., see p. 162) in the presence of compounds 1-6, with the H3" and H5" protons 
showing the largest shifts, indicative of analyte inclusion. Unfortunately the latter two 
signals overlapped preventing individual assignment. Compounds 4, 5 and 6  induced
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lower CD shifts than compounds 1-3. The hydroxyethyl signals displayed stronger shifts 
than H6 ", suggesting preferential analyte interaction at the wider secondary rim of the 
CD torous. The hydroxyethyl group signals were broad because of the non-specific 
substitution pattern (MS = 0.6). An average value of their changing chemical shift is 
given in Table 5.12.
Fig. 5.8. Signal splitting of compounds 3 and 6  in presence of HE-p-CD. (a) 6  plus 
HE-p-CD, (b) 6  uncomplexed, (c) 3 plus HE-p-CD and (d) 3 uncomplexed. NMR 
conditions: 30% CD3 OD - phosphate buffer, 0.05 M, pH 3.0.
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Table 5.11. Ad of compounds 1-6 upon the addition of HE-p-CD.
NMR conditions: 30% CD3OD - phosphate buffer, 0.05 M, pH 3.0.
Analyte 2' 3' 4',6' T 5’ 8’ 1 2 3 R R
1 -0.032 -0.041 -0.105 -0.105 -0.151 -0.050 -0.062 -0.031 -0.143 CH -0.075 (CH3)2 -0.097
2 -0.049 -0.065 -0.118 -0.118 -0.161 -0.059 -0.082 -0.032 -0.133
(0.010)
(CH3)3-0.104 -
3 -0.029 -0.047 -0.107 -0.107 -0.149 -0.040 -0.056 -0.021 -0.098
(0.005)
CH2 -0.086 (0.005) CH3 -0.095
4 -0.108 -0.110 -0.108 - -0.110 - -0.104 -0.057 -0.090 CH * (CH3)z -0 .085
5 -0.093 -0.099 -0.093 - -0.099 - -0.083
(0.004)
-0.050 -0.092 (CH3)3 -0.074 -
6 0.029 0.033 -0.028 -0.028 -0.069 0.009 ♦ * * CH2 0.002 (0.002) CH3 -0.006 
(0.005)
* signal obscured.
Table 5.12. A6  of HE-p-CD protons upon complexation with compounds (1-6).
NMR conditions: 30% CD3OD - phosphate buffer, 0.05 M, pH 3.0.
Analyte 1" 2" 3" 4" 5" 6” OH-CH,-CHr
1 -0.067 -0.071 -0.066 -0.055 -0.045 -0.005 -0.097
2 * * * -0.050 -0.037 -0.009 -0.104
3 -0.090 -0.091 -0.088 -0.064 -0.042 -0.064 -0.104
4 -0.077 -0.079 -0.074 -0.055 -0.055 -0.055 -0.093
5 -0.090 -0.091 -0.088 -0.064 -0.042 -0.064 -0.089
6 -0.075 -0.082 -0.072 -0.043 -0.035 -0.053 -0.093
* Signal obscured.
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5,3,4, Analyte Complexation with Me-p-CD.
All changes in chemical shifts were upfield (shielded) for compounds 1-6 when Me- 
p-CD was added (Table 5.13.), with H2', H31 and H8' of compounds 1-3 and 6  
showing noticably smaller shifts than the other aromatics. There was little variation 
in the aromatic shifts of compounds 4 and 5. The alkyl signal at position 2 (chiral 
proton) was more strongly shielded in compounds 4 and 5, which occurred with all 
the CDs (where measurable) except Ac-p-CD. All the R groups were strongly 
shielded but no splitting was observed.
Table 5.14., see p. 164, shows the Me-p-CD proton shifts induced by compounds 1-6, 
all of which were upfield except for HI", which showed clear downfield movement. 
H3" and H5" overlapped but still possessed the largest shifts from analyte inclusion. 
The high degree of substitution (DS = 1.8) allowed a relatively clear assignment of 
the Me-p-CD signals from inspection and via other references (Yamamoto et al. 1987 
and Inoue et a l  1986).
Table 5.13. A6  of compounds 1-6 upon the addition of Me-p-CD.
Analyte T 3' 4',6' 7' 5' 8’ 1 2 3 R, R.
1 -0.067 -0.090 -0.127 -0.127 -0.157 -0.085 * -0.078 * CH * (CH3)2
-0.123
2 -0.075 * -0.163 -0.163 -0.190 -0.083 * -0.076 * (CH,),
-0.127
-
3 -0.073 -0.064 -0.141 -0.141 -0.184 -0.086 * -0.086 * CH2-0.120 CH3 -0.124
4 -0.142 -0.141 -0.142 - -0.141 - * -0.105 * CH * (CH3)2
-0.108
5 -0.129 -0.140 -0.129 - -0.140 - * -0.112 * (CH3)3
-0.110
-
6 -0.091 -0.096 -0.166 -0.166 -0.124 -0.112 * * * CH2 -0.115 CH3 -0.129
* signal obscured.
With compounds 4 and 5 the Me-P-CD H3" was noticably more strongly shielded 
than H5". The H6" protons did not display significantly different chemical shifts to
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those of the external protons. Interaction with the secondary rim seems then to be 
favoured with this CD derivative.
Table 5.14. A6  of Me-p-CD protons upon complexation with propranolol 
analogues (1-6). NMR conditions: 30% CD3 OD - phosphate buffer, 50 mM, pH 3.0.
Analyte i" 2" 3" 4" 5" 6" M e-2 M e-3
1 0.144 0.142 0.140 0.162 0.164 0.146 -0.134 -0.126
2 -0.114 -0.113 -0.136 -0.131 -0.137 -0.113° -0.133 -0.129
3 -0.113 -0.113 -0.130* -0.138 -0.130* -0.110 -0.136 -0.133
4 -0.116 -0.119 -0.133 -0.127* -0.116 -0.118 -0.131 -0.127
5 -0.123 -0.123 -0.145 -0.138 -0.120 -0.120 -0.137 -0.126
6 -0.116 -0.122 -0.120 -0.129 -0.128 -0.113 -0.133 -0.128
* signal overlap with Me-2. * signal overlap between 3" and 5" protons.c signal overlap with Me-3.
5.3.5. Comparison of Results for Propranolol Analogues.
The direction of analyte chemical shifts i.e. whether up or downfield was dependant 
on the CD employed; p-CD caused deshielding of the aromatics for compounds 1-6, 
Me-p-CD caused upfield shifts, HE-p-CD did likewise (except for compound 6 ) and 
Ac-p-CD had a more varied effect. The overall magnitude of the aromatic and alkyl 
chemical shifts for compounds 1-6 was greatest with Me-p-CD and decreased in the 
order HE-p-CD, p-CD and Ac-p-CD, whilst this actual pattern of signal shifts was 
similar for compounds 1-3 and 6  but unlike that of compounds 4 and 5 (Fig. 5.9., see 
p. 166). Analytes bearing a single aromatic ring (compounds 4 and 5) are likely to 
induce smaller CD shifts than analytes with a naphthyl ring, perhaps due to the fact 
that the phenyl ring has a 'looser fit' within the P-CD type cavity (Technicol 1992).
The guest proton alkyl signals in positions 1, 2 and 3 were markedly shifted in every 
case and along with the large Rchemical shifts, point to the influences of hydrogen 
bonding and a likely conformational rearrangement of the guests during the 
complexation mechanism. Inoue et al. 1987 and Uccello-Barretta 1993 have also
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reported structural changes in the guest molecule upon inclusion with CDs. Analyte 
signal splitting ( compounds 1, 2, 3 and 6 ) was only seen with p-CD and HE-p-CD, 
mostly in the 3 and R positions. Interestingly, these were the only CDs used which 
can hydrogen-bond donate from their 2 and 3 positions. Clearly then, the alkyl chains 
and the terminal R groups are experiencing different chemical environments and must 
be important in the complexation process. This is in contrast to the result of 
Greatbanks and Pickford 1987, who found that the /-propyl group of propranolol (1) 
underwent a negligable chemical shift in the presence of p-CD. However their work 
was performed in pure D20  and it is clear that solvent differences can have a 
profound effect upon the geometry and relative stabilities of various conformations 
(Sherrod 1992).
In all the complexes except those with p-CD, H6 " experienced a significant change 
in chemical shift compared to H5". Widening of the secondary rim, as purported in 
section 5.2., would allow a deeper penetration of the guest mlecules and explain the 
relatively higher H6 " signals seen with Ac-P-CD. Me-p-CD and HE-P-CD also 
displayed significant H6 " shifts and therefore it appears that derivatisation has 
allowed a deeper analyte penetration. Yamashoji et al. 1992 attributed the relative 
H5"-H6" shift magnitude to analyte interaction (alanine p-naphthylamine) at the 
narrow rim of Ac-p-CD, where the naphthyl ring approached the H6 " protons. 
However they failed to account for the sizable chemical shifts seen in their analyte's 
alkyl chain, now directed away from the CD, which appears inconsistent with their 
proposed mode of inclusion.
Chemical shift changes were largest with the derivatised groups of Me-p-CD and 
decreased successively for HE-p-CD and Ac-p-CD in the presence of compounds 1- 
6 . When hydrogen bonding occurs, those hydrogens most directly attached to the 
atoms involved are likely to experience the greatest change in electron distribution 
and hence the largest chemical shift. The methyl protons on Me-p-CD are two bonds 
removed from an oxygen atom, those of Ac-p-CD are four bonds removed and the 
protons of HE-p-CD are three bonds distant from a site of possible hydrogen
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bonding, which may explain the relative AS’s, assuming hydrogen bonding at these 
points.
Fig. 5.9. A6  pattern of compounds 1-6 upon complexation with CDs. (a) compound 
1, (b) 2, (c) 3, (d) 4, (e) 5 and (f) compound 6 .
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It seems then that all the analytes approached each CD torus from the wider secondary 
rim and entered the CD cavity, whereupon their alkyl chains interacted with those groups 
on the secondary CD rim, presumably via hydrogen-bonding and steric forces. The three 
modified CDs displayed increased H6 " chemical shifts, which was linked to a 
conformational change of the torus that allowed deeper penetration of the analytes into 
the cavity.
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5.4. NMR Investigation of Mequitamiiim.
Prior to any complexation studies with the various CDs it was necessary to assign 
the NMR spectrum of mequitamium.
5.4.1. Determination of Mequitamium Structure.
The structure of mequitamium was confirmed using the experimental techniques 
described in section 2.4.4. Table 5.15 gives the *H and 13C-NMR signals assigned 
according to the numbering scheme of the compound as depicted in Fig. 5.10.
Table 5.15. *H and 13C-NMR chemical shifts of Mequitamium.
Nuclei Position 
(see Fig. 5.6.)
13C  Chemical Shift (ppm) Chemical Shift (ppm)
1 / 1 0 ° 116.46 7.24 (m)
2/9“ 127.50 7.24 (m)
3/8“ 123.04 7.01 (split t)
4/7“ 127.76 7.24 (m)
5/6“ 124.86 -
1 1 / 1 2 “ 144.93 -
13 d 59.56 13a 3.47 (m), 13b 3.12 (q)
14 31.15 2.59 (quintet)
15c 48.10 4.06 (dd), 4.12 (dd)
16/20* 55.77/55.61 3.35 (m)
17/19“ 19.20 1.82 (m)
18 2 1 . 2 1 2.13 (bd)
19/17“ 24.52 1.93 (m)
2 1 51.24 2.89 (s)
“ Overlapping signal due to molecular symmetry.* Signals not assigned to respec­
tive nuclei.c Calculated according to equation 2.1. d Overlap with 16/20.
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Fig. 5.10. NMR Labelling Scheme Adopted for Mequitamium.
c h 2
CH
Initially, a broad-band decoupled 13C spectrum and two DEPT experiments were 
performed to determine the bonding types of each carbon atom i.e. whether 
quaternary, CH, CH2 or CH3. A normal *H spectrum then enabled the direct iden­
tity of some signals by examination of the peak integral sizes and the expected 
splitting patterns (e.g. CH3 - a sharp singlet with a peak integral proportional to 
that of three protons could only belong to the methyl group on carbon 21). A !H- 
13C COSY (Correlation Spectroscopy) experiment and comparison with literature 
data on similar molecules allowed further signal assignments. *H splitting patterns 
are given in brackets in Table 5.15 e.g. (m) designates a multiplet, (t) is a triplet, 
(s) is a singlet etcetera.
Finally a ^ - ‘H COSY and data from 'Specinfo' (a computerised NMR database 
operated by Daresbury Laboratory) provided unequivocal proof for all the signals 
except as stated in Table 5.15. For example, the ‘H quintet signal seen at 2.6 ppm 
(Fig. 5.11.) was shown to belong to the proton on carbon number 14 (the chiral 
centre) and not carbon number 18 (the only other non-aromatic CH bonded car­
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bon) by virtue of the cross peaks arising between itself and carbon number 15 (it­
self already distinguished from carbon 13 due its further downfield position caused 
by greater electron withdrawal of the attached quaternary nitrogen group). It 
would not be possible to observe such crosspeaks between carbons 15 and 18 due 
to the structure of the molecule. A portion of the mequitamium COSY is 
depicted in Fig. 5.11., showing how coupled resonances produce off diagonal 
cross peaks, the intensity of which relate to the distance between the coupling nu­
clei. Attempts to obtain a ROESY spectra for this compound, which would have 
provided information on its conformation, were unsuccessful.
Fig. 5.11. COSY of Mequitamium depicting the region between 1.7
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5.4.2. Complexation with a-, p- and y-CD.
Table 5.16. gives the changes in mequitamium chemical shift (A6 ) observed upon 
complexation with the three parent CDs when analysed under equivalent condi­
tions to those which produced optimum enantio-resolution using y-CD in CE 
studies ( section 4.4.).
Table 5.16. Chemical shift changes (A6 ) in !H-NMR spectra of mequitamium 
induced by various CDs. A negitive value indicates an upfield shift (shielded) 
whilst a positive one indicates a downfield shift (deshielded). Signal splitting pat­
terns are the same as those given in Table 5.15. An asterisk indicates that the sig­
nal was obscured. NMR conditions: 10 mM CD, 9.5% MeCN-dj-NaH2Citrate (50 
mM, pH 3.5). The analyte was added in an equimolar concentration.
Proton position a-CD p-CD y-CD
1,10/2,9/4,7 -0 . 0 0 2 -0.009 -0.031
3,8 + 0 . 0 0 1 +0.008 -0.041
13a -0.024 -0 . 0 2 0 -0.034
13b * -0.018 +0.039
14 -0.006 -0.007 -0.008
15* -0.017, -0.015 -0.018, -0.014 -0.019, -0.013
16/20 -0.004 -0.018 +0.094
17 -0.009 -0.019 -0.047
18 -0.005 -0.007 -0.014
19 -0.008 -0.013 -0.033
2 1 -0.017 -0.018 -0.024
a These are the shifts observed for the two (AB) protons.
The magnitude of chemical shifts induced by a  and b-CD are generally weaker 
than those observed in the presence of y-CD. The pattern of shifts i.e. whether up
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or downfield is identical for a- and p-CD but different in three instances to those 
induced by y-CD. This difference in both shift patterns and strength may suggest 
that mequitamium binds with y-CD in a dissimilar manner to that of a- and p-CD. 
a-CD produced the weakest shift changes especially in the alkyl proton signals. 
The cavity of a-CD may have been too small to accommodate the analyte’s bulky 
non-aromatic ring, with the protons in positions 14, 18 , 17 and 19 showing little 
or no chemical shifts. Only the methyl group on carbon 21 and the methylene 
protons on carbon 15 showed any significant chemical shift (a shielding effect), 
perhaps from a partial inclusion by a-CD, which may have been sterically 
hindered from deeper inclusion by the nuclei in positions 19 and 20. The aromatic 
protons of mequitamium were not significantly affected in the presence of a-CD, 
suggesting that little or no host-guest interaction occurs in this region of the 
analyte.
p-CD produced slightly stronger chemical shifts than a-CD for the protons on 
16/20, 17 and 19, whilst the shifts of 15 and 21 were very similar in magnitude to 
those caused by a-CD. The larger cavity dimensions of p-CD would allow it to 
envelop a bigger portion of the bridged alkyl ring structure, which could account 
for the observed difference in chemical shifts. Spatially, it would certainly be eas­
ier for p-CD to accommodate part of the tricyclic aromatic moiety into its cavity 
than the smaller a-CD and this seems to be reflected in the larger A6  of all the 
aromatic protons when p-CD was present. Interestingly, the split triplet represent­
ing protons 3/8 was deshielded, whilst the remaining aromatic protons were then 
shifted upfield.
y-CD produced the strongest A6  in mequitamium although those shifts 
experienced by protons 14 and 15 did not significantly differ in the presence of 
any of the three parent CDs. The guest aromatic protons were moved strongly 
upfield, evidence of their inclusion by the macrocycle and subsequent shielding
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from the externally applied magnetic field. Amato et al 1993 employed NMR and 
molecular modelling to study the interaction between certain CDs and suronacrine 
(9-[(phenylmethyl)amino]-l,2,3,4-tetrahydro-9-acridin-l-ol), which is structurally 
similar to mequitamum. They found that its phenyl ring entered the CD cavity 
from the secondary side so that its tricyclic moiety was brought into close contact 
with the opening of the cavity, especially in the case of p-CD. They discounted 
the molecules interaction with y-CD as the analyte chemical shifts ‘were not sig­
nificant*. However, the more hydrophobic tricyclic moiety of mequitamium cou­
pled with its bulkier alkyl substituient (not the planar phenyl ring of suronacrine), 
would seem to have enhanced the host-guest interaction, as supported by the obvi­
ous changes in mequitamium A6  upon interaction with y-CD. Furthermore, the 
increased size of the y-CD cavity, 9.5 A as compared to 7.8 A of p-CD (Smith et 
al 1994), would allow the tricyclic group and hence the entire molecule, easier 
access to the inner CD cavity. y-CD is capable of complexing with large bulky 
analytes such as fullerene-60 (Andersson et al 1994) and macrocyclic lanthanides 
(Sherry et al 1994). Therefore it could readily incorporate mequitamium within 
its cavity, explaining the observed shielding effects in both the tricyclic and alkyl 
moieties of the guest.
The protons on the mequitamium alkyl group experienced upfield A6 ’s except for 
those of the 16/20 multiplet. They were moved very strongly downfield as was 
proton 13b of the inter-connecting methylene group. Guest A6  changes in the 
presence of CDs may be caused by conformational changes induced by binding to 
a CD. The strong deshielding effect experienced by proton 13b when y-CD was 
added could have been brought about by a conformational change in which this 
proton experienced a stronger deshielding effect of the nearby nitrogen nuclei. No 
deshielding was noted for this proton in the presence of any other CD. A similar 
deshielding effect occured for protons 16/20, which may have been caused by the 
connecting quaternary nitrogen nuclei exerting a powerful A6  on these protons as
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their spatial arrangements altered following CD complexation. Yamashoji et al. 
1990 noted just such an effect when examining DL:alanine p-naphthylamide salts 
interacting with various CDs, where conformational changes of the guest molecule 
upon complexation with p-CD caused certain of the guest proton signals to experi­
ence a greater deshielding effect when electronegitive nuclei were nearby.
Perhaps the most notable aspect of the spectra in all three cases is the total lack of 
guest signal splitting, a factor which was expected at least in the presence of y- 
CD, due to its previous ability to chirally resolve mequitamium by HPLC (section 
3.4.) and CE (section 4.4.).
5.4.3. Chemical Shift of a-. p- and y-CD Protons Upon Guest Interaction.
Table 5.17. shows the chemical shift values observed for the host CD protons 
when mequitamum was present (measured under those same conditions as the 
spectra in section 5.4.2.).
Table 5.17. Chemical Shift (A6 ) of a-, p- and y-CD protons. A negative value 
indicates an upfield shift (shielded) whilst a positive one indicates a downfield shift 
(deshielded).
Cyclodextrin H -l H-2 H-3 H-4 H-5 6 -CH2
a-CD -0.003 0 . 0 0 1 -0.004 -0 . 0 0 1 -0.003a -0.003a
P-CD -0.003 -0.004 -0.008 0 . 0 0 1 -0.007 -0.005
y-CD -0.004 -0.004 -0.015 -0 . 0 0 2 -0.013 -0.008
a It was not possible to differentiate between these two sets of signals due to spec­
tral overlap.
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The external protons of y-CD i.e. H I, H2 and H4 were only slightly shifted com­
pared to H3 and H5 when mequitamium was introduced. These latter mentioned 
protons are inside the CD cavity and clearly experienced an upfield shift (negative 
value) consistent with the insertion of an aromatic guest molecule (or an aromatic 
portion of a guest structure). P-CD underwent a similar though weaker affect to y- 
CD while a-CD displayed rather smaller chemical shift changes which were not 
significantly different between the inner and outer CD proton positions.
5.4.4. Complexation with Hvdroxypropyl Derivatized CDs.
The hydroxypropyl derivatives of a-, p- and y-CD were examined to see if they 
would enhance the chiral recognition for mequitamium over that observed with the 
three parent CDs. The induced chemical shift changes of mequitamium (under the 
same conditions as stated for Table 5.16.) are shown in Table 5.18.(see p. 175). 
No analyte signal splitting was observed with any of the CD derivatives.
The weakest analyte shifts were generally associated with the addition of HP-a- 
CD although in two instances, nuclei 15 and 18, HP-y-CD induced no observed 
change in the mequitamium protons. HP-p-CD produced the greatest analyte A6  
overall, most notably in the case of the aromatic protons, 13a and 16/20. These 
suggest a greater interaction between HP-p-CD and mequitamium in these areas. 
The pattern of guest alkyl shifts i.e. up or downfield, was quite different in the 
case of each CD derivative e.g. the methyl group on carbon 21 was deshielded 
(+0.018 ppm) by HP-a-CD but shielded (-0.017 ppm) to an equal extent by HP- 
p-CD and HP-y-CD, whilst proton 18 was deshielded by HP-a-CD, shielded by 
HP-p-CD but apparently not shifted by HP-y-CD.
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The deshielding of the methyl group on carbon 21 by HP-a-CD may, as has previ­
ously been stated, have been caused by a conformational change of the analyte 
induced by binding to the CD, where the methyl protons experience a greater 
deshielding effect from the adjoining quaternary nitrogen nuclei. Ion-dipole inter­
actions could also have affected the 6  of protons near the quaternary nitrogen nu­
clei.
Table 5.18. Mequitamium A6  in the presence of HP-a-CD, HP-p-CD and HP- 
y-CD. NMR conditions as stated in text. * Indicates the signal was obscured.
Proton Position HP-a-CD HP-P-CD HP-y-CD
1,10/2,9/4,7 + 0 . 0 0 1 -0.013 -0.004
3,8 +0.004 +0.015 +0.006
13a -0.007 -0.026 -0.014
13b -0.009 -0.015 + 0 . 0 1 1
14 -0.005 -0.005 +0.003
15 -0.011, -0.009 -0 .0 1 2 , -0 . 0 1 0 0
16/20 * +0.031 +0.009
17 -0.009 -0 . 0 2 2 -0.038
18 +0.007 -0.006 0
19 +0.008 -0.017 -0.029
2 1 +0.018 -0.017 -0.017
Although the extended chains of these three CD derivatives also provide 
hydrogen-bonding sites that could aid chiral resolution, mequitamium itself does 
not possess any hydrogen nuclei which are directly capable of participating in such 
a bonding mechanism. Only the tertiary nitrogen nuclei could possibly act as 
hydrogen-bond acceptors with the HP chains if they were in the correct spatial 
orientation to do so. If however, as has been argued, this portion of mequitamium 
were to enter the CD cavity, it would not then be able to undergo hydrogen-bond 
formation with the external HP chains. Therefore, for this compound, any nega-
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tion or enhancement of chiral resolution found with these derivatives using other 
analytical techniques (i.e. HPLC or FSCE) may not be attributable to their 
extended hydrogen-bonding capability.
Table 5.19. shows the proton shifts of the HP CD derivatives themselves, upon 
their interaction with mequitamium, which produced the largest shielding effect on 
the internal H3" and H5" protons of HP-p-CD, providing further proof of its 
inclusion complexation with this CD derivative. HP-y-CD also displayed signifi­
cant shielding of its internal protons, whilst the chemical shifts of HP-a-CD were 
generally lower and did not differ greatly between the inner and outer protons. 
Overall it would seem that the strength of host-guest interaction, as judged by 
analyte and CD chemical shift differences, is in the order HP-p-CD >  HP-y-CD 
>  HP-a-CD.
Table 5.19. Chemical Shift (A6 ) data for the HP CD protons. NMR conditions 
as stated in Table 5.16.
CD type 1 2 3 4 5 6 HP side 
chains
HP-a-CD + 0 . 0 0 1 -0 . 0 0 2 -0.003 * -0.004 -0.005 -0.007"
HP-P-CD -0.006 -0.005 -0.009 ♦ -0 . 0 1 1 -0.006 -0 .0 1 1 "
HP-y-CD -0 . 0 0 2 -0.007 -0.007 * -0.009 * -0.008"
* Signal was obscured. "Average shift of the HP side chains.
There was not a great difference in the HP side chain chemical shifts observed for 
each CD derivative. This may again reflect the peripheral nature of their influence 
on the chiral resolution of this analyte, as previously remarked.
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5.4.5. Complexation with Me and HE-p-CD.
Table 5.20. gives the chemical shifts for mequitamium in the presence of Me- and 
HE-p-CD under the same conditions as stated for Table 5.16. There is no 
significant difference between the chemical shifts of mequitamium with each CD. 
Also, no analyte signal splitting was observed. In view of these facts, any interac­
tion between the analyte and either of the CDs would appear to have been rather 
weak.
Table 5. 20. Mequitamium AS in the presence of Me- and HE-p-CD. NMR










15 -0 .0 1 1 , -0.008 -0.007, -0.005
16/20 +0.013 + 0 . 0 1 2
17 -0.008 -0.004
18 + 0 . 0 1 0 +0.009
19 +0.005 +0.003
2 1 -0 . 0 1 0 -0 . 0 1 1
Table 5.21. on p .178 shows the measured shifts of Me- and HE-p-CD themselves 
when mequitamium was present. The inner protons, H3" and H5", do not show 
clear evidence of mequitamium inclusion. Their weak chemical shifts do not differ 
greatly from that of the outer CD protons. The Me and HE chain signals are
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shifted more strongly than any of the other protons on their respective CDs. Per­
haps they participated in a more external interaction with mequitamium i.e. one 
that involved the CD cavity less and hence was unable to provide for enantio-dis- 
crimination.
Table 5.21. Chemical Shift (A6) data for Me- and HE-p-CD protons.
NMR conditions as stated for Table 5.16. * Signal obscured.
CD type 1 2 3 4 5 6 Me-2 Me-3 He
Me-p-CD
0.004
+0.002 -0.005 * -0.004 +0.002 -0.010 -0.008 -
HE-P-CD
0.001
-0.006 -0.004 * -0.001 +0.004 - - -0.012
5.4.6 Calculation of Stoichiometerv and Association Constant (Kfl.
Using the procedure outlined in section 5.1.5. a Job (continuous variation) plot 
was used to determine the stoichiometry of each of the complexes formed between 
mequitamium and y-CD and mequitamium and HP-p-CD. y-CD and HP-p-CD 
had produced the greatest overall chemical shift data for mequtiamium when the 
host and guest were present in a 1 : 1  ratio and it was of interest see if the 
host:guest stoichiometry altered in the presence of the two different CDs. In each 
case four solutions of 9.5% acetonitrile-Jj - NaH^Citrate (50 mM, pH 3.5) with 
varying molar ratios (mequitamium:CD) were prepared. The data for 
mequitamium:y-CD and mequitamium:HP-P-CD complexes are presented in Ta­
bles 5.22. and 5.23. respectively (see p. 179) and the actual plots are shown in 
Figure 5.12. (see p. 180).
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Table 5.22. Job Plot Data for 3/8 Protons of Mequitamium (Meq) : y-CD 
(CD) Complex. NMR conditions as in Table 5.16. except for analyte:CD ratio.
[CD] [Meq] A5 ppm 6 Hz x rc p i
[CD] + [Meq]
[Meq] 
[CD] +  [Meq]
3/4 1/4 -0.0135 5.4 4.05 1/4
2/3 1/3 -0.0203 8 . 1 5.35 1/3
1 / 2 1 / 2 -0.0405 16.2 8 . 1 0 1 / 2
1/3 2/3 -0.0540 2 1 . 6 7.13 2/3
1/4 3/4 -0.0608 24.3 6.08 3/4
Table 5.23. Job Plot Data for 3/8 Protons of Mequitamium (Meq):HP-p-CD 
(CD) Complex. NMR conditions as stated in Table 5.22.
[CD] [Meq] A6  ppm 6 Hz S ^ H z  x [Cp ] 
[CD] + [Meq]
[Meq] 
[CD] +  [Meq]
3/4 1/4 +0.006 2.4 1 . 8 1/4
2/3 1/3 + 0 . 0 1 0 4.0 2.64 1/3
1 / 2 1 / 2 +0.015 6 . 0 3.0 1 / 2
1/3 2/3 +0.017 6 . 8 2.24 2/3
1/4 3/4 +0.019 7.6 1.9 3/4
Each of the Job plots with y-CD and HP-p-CD show a clear maximum at a 
[CD]/[CD] +  [A] ratio of 0.5 indicating the formation of a 1:1 host:guest com­
plex. With the complex stoichiometery being equal in the presence of these two 
CDs, there is no reason to suppose that any of the other CDs employed would 
form a mequitamium complex with a different stoichiometry.
179
Figure 5.12. Job Plots of (a) Mequitamiumiy-CD and (b) Mequitamium:HP-p-
CD. Plots completed using chemical shifts of the mequitamium 3/8 protons signal. 
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The complex formation constant, Kf, was also determined for mequitamium with 
y-CD and HP-p-CD under the experimental conditions described in 2.4.3. Using 
the procedure outlined in section 5.1.3., the chemical shift of one species 
(mequitamium) is measured in the excess of another species (a CD) and plotted by
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the Foster-Fyfe method (A6 obs Hz/[CD] versus ASobs). The negitive slope of such 
plots affords the Kf value. Tables 5.24. and 5.25. detail the NMR data obtained 
form the experiments with y-CD and HP-p-CD respectively, whilst Figure 5.13. 
on p. 182 shows the associated Foster-Fyfe plots of each mequitamium:CD com­
plex.
Table 5.24. Association Constant, Kf, for Mequitamium:y-CD complex. NMR
conditions as stated in Table 5.16. except for analyte:CD concentrations. Data 
obtained using measured shifts of mequitamium 18 proton.
[Meq] mM [y-CD] mM A&nhs ^ A5ppm A6 Hz/ [y-CD]
3 5 5.4 -0.0135 1080
3 1 0 6.4 -0.0160 640
3 14 6.9 -0.0173 493
3 25 7.6 -0.0190 304
Table 5.25. Association Constant, Kf, for Mequitamium:HP-P-CD complex. 
NMR conditions as stated in Table 5.16 except for analyte:CD concentrations. 
Data obtained using measured shifts of mequitamium 13a proton.
[Meq] mM [HP-p-CD]
mM
A&obs m A6 ppm A6 0 bsHz/[HP-p-CD]
3 5 1 1 . 2 -0.Q28 2240
3 1 0 16.3 -0.041 1630
3 14 19.1 -0.048 1364
3 25 24.3 -0.061 972
The Kf values calculated were 333 M ' 1 for mequitamium:y-CD and 110 M1 for 
mequitamium:HP-p-CD, indicating that y-CD forms a stronger complex with 
mequitamium.
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Figure 5.13. Foster-Fyfe plots of (a) mequitamium: y-CD and (b) 


















5.5 6  6.5 7 7.5
o b s  Hz
(b) Mequitamium:HP-p-CD.
2200  —  «; 
2000
„ 1 8 0 0
Q
y. 1600
=  1400 












i i......*........ --- 1---
10 12 14 16 18 2 0  
o b s  Hz
22 24 26
182
5.4.7. Comparison of Results.
The greatest mequitamium chemical shift values (1:1 host-guest ratio) were 
recorded in the presence of y-CD. The guest aromatic protons were especially 
strongly shielded indicating that inclusion complexation was significant. P-CD and 
a-CD induced smaller analyte chemical shifts than y-CD and they also 
experienced weaker shielding of their H3H and H5" protons. These facts point to a 
weaker interaction of a-CD and p-CD with mequitamium probably because of the 
decreasing size of their cavities.
It is proposed that mequitamium enters into the cavity of y-CD, accounting for 
both the upfield proton shifts of the guest (via a shielding effect) and certain guest 
downfield chemical shifts (due to conformational changes), which would also ex­
plain the strong shielding effect experienced by the inner protons of y-CD itself. 
Due to the large size of the mequitamium structure, it seems prudent to suggest 
that inclusion interaction initiates at the wider secondary opening of y-CD and not 
at the narrower primary end of the torus where steric constraints would prevent 
the large tricyclic moiety of mequitamium from entering the cavity. The difference 
between the H r7H 2" and 6 -CH2  proton shifts of P- and y-CD (located at opposite 
ends of the CD torus) may have been caused by the bulky alkyl moiety of 
mequitamium protruding from the cavity at the primary end following 
complexation. This could have allowed the quaternary nitrogen of this group to 
influence the chemical environment around the 6 -CH2  protons via electronic inter­
actions and so account for their observed chemical shift. Figure 5.14. on p. 184 
shows a schematic representation of the proposed inclusion complexation structure 
formed between y-CD and mequitamium.
Chemical shifts were much more varied with the derivatised CDs than with the 
parent CDs. HP-y-CD induced smaller analyte chemical shifts than its parent, y-
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CD, and showed less shielding of the inner H3” and H5" protons than y-CD. This 
suggests a weaker association of HP-y-CD with mequitamium, where 
derivatization of the normal CD hydroxy groups to form HP substituents, has 
reduced the ability of the macrocycle to affect enantio-resolution. Similarly, HP-a- 
CD did not increase guest chemical shifts over those observed with the parent a- 
CD. However HP-p-CD did produce larger guest chemical shifts than p-CD (espe­
cially of the aromatic protons). Increasing the number of derivatised groups 
around the rim of a CD can alter the size of the CD cavity due to a reduction of 
intramolecular hydrogen-bonding in the (OH)2 and (OH)3 positions (Ventura et al. 
1994 and Inoue et al. 1987). This may have allowed mequitamium to interact 
more intimately with HP-p-CD than with the other two HP CD derivatives as a 
change in its cavity dimensions could have been more favourable for effective 
complexation with the guest molecule.
Figure 5.14. Schematic of Inclusion Complex formed between y-CD and 
Mequitamium.
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Comparing the host and guest chemical shifts obtained in the presence of the three 
HP CD derivatives with those found using the three parent CDs, an increasing 
interaction in the order y-CD > HP-p-CD > HP-y-CD >  p-CD >  a-CD “  HP- 
a-CD was found.
Me-p-CD and HE-p-CD did not produce any evidence of their having a significant 
interaction with mequitamium. Both the guest and host chemical shifts were 
smaller than those measured in the presence of the other CD types, except a- and 
HP-a-CD, where the chemical shifts covered an equally small range. 
Derivatization of the parent oligomers did not prove beneficial for enantio-resolu- 
tion in these cases. The proposed inability of mequitamium to engage in hydrogen- 
bonding with the external hydroxy groups present on all of the CDs (except to an 
extent Me-p-CD) negates any possible improvement on enantio-resolution which 
these derivatives could incur through a hydrogen-bonding mechanism. Only subtle 
changes in cavity dimensions, as a consequence of certain hydroxy group modifi­
cation, may have enabled HP-p-CD and to a lesser degree HP-y-CD to provide for 
chiral discriminination.
The complex stoichiometery with y-CD and HP-p-CD was demonstrated to have 
been the same i.e. 1:1 host/guest complexation ratio. With a large structure such 
as mequitamium it is unlikely that more than one molecule could enter into the CD 
torous at a time, whilst the large inner CD cavity of e.g. y-CD would be quite 
capable of accommodating the full bulk of mequitamium, removing the chance of 
two CDs complexing the structure at the same time.
The association constant, Kf, of y-CD with mequitamium (333 M 1) was found to 
be greater than that of HP-p-CD (110 M'1). This was reflected in the larger guest 





The initial two sections of chapter six attempt to draw comparisons between firstly, the 
various HPLC methodologies used in this work and secondly the results of the FSCE 
experiments when compared to those of the HPLC techniques. The ability of each 
method to provide chiral resolution for the analytes is discussed along with the 
advantages and disadvantages of each. The final section draws together these findings in 
conjunction with NMR spectroscopy data, in order to consider how the results of each 
technique may be related.
6.1. Overall Comparison of HPLC Methods for Chiral Enantio-Resolution.
All the analytes tested in this work have been examined using the following range of 
HPLC methods: bonded CD columns operated in the reversed phase mode, CDs as 
mobile phase additives in the reversed phase mode, bonded CD columns operated in the 
polar organic mode and CDs as mobile phase additives using porous graphitic carbon as 
a stationary phase. There are no publications which examine a similar range of HPLC 
methods to that employed here in order to draw comparisons between those enantio- 
resolutions obtained with different groups of chiral compounds. The following sections 
discuss the ability of the four stated HPLC methods to effect enantio-resolutions for the 
various analytes when examined in the presence of different CDs. The influence of 
analyte / CD structure on enantio-resolution is discussed, along with the role played by 
the relevant inherent chromatographic mechanisms.
6.1.1. Bonded CD column in Reversed Phase Mode.
All the analytes utilised i.e. the phenethylamines, propranolol analogues and 
mequitamium were examined using a p-CD column (250 x 4.6 mm) under a range of 
different reversed phase conditions (see Table 6.1. on p. 191 for the optimum results).
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The CD molecules are tethered to 5 /xm silica particles via an ether linkage on a carbon 
chain between 2 and 20 atoms in length (Technicol 1992). The point of attachment on 
the CD molecules is the primary hydroxyl groups. In order for enantio-separation to 
occur the analytes must form a stereospecific inclusion complex with the chiral selector, 
where the transient diastereoisomeric complexes have different stability constants such 
that they provide for chromatographic separation of the enantiomers (Pirkle and Welch 
1992).
Only three of the phenethylamines, ephedrine, oxilofrine and orciprenaline and two of 
the propranolol analogues (compounds 2 and 5) showed any signs of chiral resolution 
(previously unreported) using reversed phase methodology with a p-CD column. 
However, upon lowering the temperature to 10°C, compounds 1 and 4 also showed signs 
of chiral discrimination. Lamparczyk et al. 1994 have shown how the presence of 
multiple interaction/retention mechanisms can lead to non-linear van’t Hoff plots, van’t 
Hoff plots of compounds 1-6 suggested that all the analytes, except the unresolved 
compounds 3 and 6 , interacted in a similar fashion with the CD macrocycles, by means 
of more than one mechanism. Mequitamium did not resolve with either a p- or y-CD 
bonded phase and eluted from both columns with k' values <  4 under a range of 
differing mobile phase conditions.
P-CD is known to be able to complex substituted phenyl and naphthyl rings (Abidi and 
Mounts 1994, Rizzi et al. 1994 and Piperaki et al. 1994). The substituents on the 
aromatic moieties of the propranolol analogues were clearly influential in their inclusion 
complexation. A bulky and non-polar f-butyl group on the alkyl chain of compounds 2 
and 5 promoted their chiral resolution over that of their i-propyl counterparts, 
compounds 1 and 4. When examined at the same temperature, the k' values of 
compounds 2 and 5 were also larger than compounds 1 and 4 suggesting a stronger 
interaction with the immobilised p-CD macrocycles on the surface of the column. The
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hydrophilic conditions prevalent in the mobile phase may have encouraged the most non­
polar of the analytes i.e. compounds 2 and 5 to interact more strongly with the apolar 
cavity of the p-CD molecules, which in turn would help to explain their increased chiral 
resolution by promoting other analyte-CD interactions e.g. hydrogen-bonding, dipole- 
dipole interactions. It is the presence of a number of such differing forces which is 
known to lead to chromatographic chiral resolution based on the three-point interaction 
model proposed by Dagleish 1952 and advanced by others e.g. Gaskell and Crooks 1991.
Compound 2 displayed higher chiral resolution than compound 5 (R' = phenyl) and 
possessed a physically larger aromatic group (compound 2 R' =  naphthyl) which 
supports the idea that analyte steric bulk can influence resolution by causing a ‘tighter 
fit’ between the CD cavity and the analyte. The more tightly retained the analyte the 
greater influence its stereochemical structure would have on its interaction within the 
chiral environment of the CD molecule.
With the phenethylamines the position of the hydroxyl substituents on the phenyl ring 
was found to greatly alter the observed chiral resolutions. The structures of ephedrine 
and oxilofrine differ only in that oxilofrine possesses a hydroxyl group in the 4' position, 
yet its enantio-resolution was nearly twice that of ephedrine (67% CRF compared to 36% 
CRF). Sherrod 1992 has stated that CDs possess large dipole moments which may play 
an important role in analyte complexation depending on the strength and direction of the 
dipole moment in the guest molecule. The position of the hydroxyl group on oxilofrine 
will alter its dipole moment compared to that of ephedrine. It is this difference in the two 
molecules electrostatic nature which appears responsible for enhancing the chiral 
resolution of oxilofrine over that of ephedrine. The position of the hydroxyl groups on 
the phenyl ring was also found to be important. The enantiomers of orciprenaline were 
separated (39% CRF) while those of isoprenaline were not. The two compounds differ 
only in the position of their aromatic substituents i.e. orciprenaline has a 3,5-diOH 
substitution pattern and isoprenaline has a 3,4-diOH pattern. The plane of analyte
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inclusion can be influenced by the positioning of polar groups on the guest structure 
(Technicol 1992), which would likely account for the results obtained here. If the 
molecules entered the CD cavity at different angles their alkyl chains (containing 
hydroxyl and secondary amine functions) would also be positioned differently so that the 
potential for dipolar and hydrogen-bonding interactions will vary, accounting for the 
observed changes in their enantio-resolutions.
The absence of chiral resolution and low k' values obtained with mequitamium when 
employing either a p- or y-CD bonded column in the reversed phase mode would suggest 
that this analyte interacts weakly with these two macrocycles. However, subsequent 
experiments have shown that mequitamium does complex significantly with y-CD in the 
free state (see sections 3.4.3., 4.4.3. and 5.4.2.) i.e. when it is not bound to a silica 
surface. Tethering the y-CD molecules has clearly resulted in a reduction of their ability 
to stereo-specifically interact with the enantiomers of mequitamium, possibly through 
constraints on the CD orientation or guest interaction with the linking spacer arm 
between the CD and stationary phase surface. The possibility of these effects occurring 
has been proposed before (Stalcup et al. 1990). Furthermore, section 3.4.5. states that 
the difference in Kf values for the R and S enantiomers may not be high enough to permit 
their resolution and that the observed chiral separation in section 3.4.3. was strongly 
influenced by the high retention of the guest-host complexes (k'a cd) on an achiral 
stationary phase. In view of these facts it may not be unexpected that enantio-resolution 
was not found for mequitamium using a CD bonded stationary phase.
Overall 7 analytes out of a total of 16 were chirally resolved to some extent using a 
bonded CD column in the reversed phase mode. Inclusion was favoured by the more 
hydrophobic of the analytes in the case of the propranolol analogues while the 
electrostatic nature and substitution pattern of the included aromatic ring of the 
phenethylamines was seen to be alter their chiral separation.
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Table 6.1. Summary of optimum enantio-resolution factors measured using HPLC methodologies. See Chapter three for details.
Analyte
CD Bonded Column - Reversed 
Phase
CD Bonded Column - 
Polar Organic
CDs as Mobile Phase Additive - Reversed 
Phase (phenethylamine values are with P-CD)
CDs as Mobile Phase Additive - PGC 
Column
Resolution %CRF k7 Resolution %CRF k' Resolution K Resolution %CRF k'
Ephedrine 36 4.3,4.4 0 43 0 4.2 < 5' / 45^ 3.8, 4.0* / 4.0, 4.5/'
Oxedrine 0 2.8 - 46 0 3.4 0 2.3
Oxilofrine 67 3.5,3.8 0 >100 0 3.3 35'/ 82^ 2.8, 3 .3 * /3 .3 , 3.8^
Norfenefrine 0 2.1 - >100 0 2.4 0 2.1
Etilefrine 0 2.9 0 52 0 2.6 0 2.7
Orciprenaline 39 3.2,3.4 0 80 0 3.0 20 / 78^ 1.8, 2 .3 * / 1.3, 2 . ^
Noradrenaline 0 2.3 - >100 0 2.1 0 2.2
Isoprenaline 0 2.9 0 90 0 2.2 0 3.1
Salbutamol 0 2.2 32 59,62 0 1.9 0 3.0
Propranolol (1) 9* 13.3, 13.4 62 16.8, 17.2 0 13.5° 0 6.6
Compound 2 43 12.5,13.0 89 12.5, 12.8 30 %CRF* 24.1, 24.3° 0 7.2
Compound 3 0 11.1 17 20.0, 20.3 0 11.4° 0 5.4
Compound 4 l d 6.4, 6.5 78 17.9, 18.3 0 3.2* 42* 0.8, 0.9
Compound 5 32 7.1, 7.6 93 13.3, 13.6 0 4 .1 ° 47* 0.9, 1.0
Compound 6 0 20.2 0 < 3 0 52 0 0 11.8
Mequitamium 0 < 4 0 <2 1.06 R /  /  0.3 Rj* 18.7, 20.7 c /  6.75, 7.74* 0 >100
a Obtained with 12 mM HE-P-CD. * Obtained with 2.5 mM Peracetyl-P-CD. c Obtained with 12 mM y-CD. d Measured at 10°C. * Obtained with 2.5 mM P-CD. f  Obtained with 2.5 mM peracetyl-p-CD. 
g Obtained with 12 mM HP-P-CD. -  Not measured due to long analyte retention on column.
191
6.1.2. Bonded CD Column in Polar Organic Mode.
The use of polar organic mobile phases is a relatively recent approach for chiral 
separations in HPLC. Armstrong et al. 1992 and Zukowski et al. 1992 were amongst 
the first to publish work which tentatively dealt with the subject. Since then there has 
been much debate on the exact nature of the operating mechanism which is 
responsible for the observed chiral resolutions (see section 3.1.3. for a more details). 
Although all the phenethylamines possess more than one hydrogen-bond 
donor/acceptor group, which is believed to be a necessary prerequisite for chiral 
separation in the polar organic mode (Technicol 1992, Chang et al. 1993), only one 
phenethylamine, salbutamol, was chirally resolved (32% CRF, k' = 59, 62) 
compared to three other phenethylamines in the CD bonded reversed phase mode. 
Sterically, salbutamol is the most bulky of the phenethylamines and it is more non­
polar than the others, containing a f-butyl group on its alkyl chain. All the 
phenethylamines had much larger k7 values on the p-CD bonded column in the polar 
organic mode (all k' values >40, see section 3.2.2.) than when using the same 
column under reversed phase conditions (all k' values < 5 , see section 3.2.1.). The 
solubility of the analytes in the high organic content mobile phase may have been 
reduced, which would have contributed to these long k7 values. The selectivity of the 
P-CD molecules and therefore their interaction with the guest analytes was clearly 
different in the two HPLC modes.
This view is supported by an examination of the results obtained with the propranolol 
analogues. As explained in section 3.3.5. the order of analyte retention was unique 
in the polar organic mode (compound 3 > 4 > 1 > 5 > 2 > 6 )  and the relative strength 
of analyte chiral resolutions (compound 2 > 5, 1 >  4 and 3 = 6 ) was also different 
in every case to those obtained in the reversed phase CD bonded mode, with 
compound 5 >  2, 4 > 1  and 3 > 6 . Increasing the hydrophobicity of the propranolol 
analytes caused a decrease in k' values but an increase in chiral separations. It is 
proposed here that a size dependant repulsive steric effect was responsible for this 
observed trend in chiral resolutions (Matchett et al. 1996).The effects of structural
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alterations in the non-polar regions of the analytes were found to exert profound 
changes upon chiral resolution and capacity values, indicating that features which 
cannot hydrogen-bond with the CD molecule can still play an important role in this 
chiral recognition process. This mechanism agrees with the proposal that analytes do 
not enter the CD cavity in the polar organic mode due to the high percentage of 
organic modifier (Armstrong et a l  1992 and Chang et al. 1992) but rather come into 
closer contact with the external structure of the macrocycle e.g. positioning 
themselves as a ‘lid’ over the CD cavity. The inability of compound 6  to display 
chiral resolution and its rapid elution from the column was linked to the urea linkage 
in its alkyl chain, which reduced or negated the ability of the molecule to engage in 
hydrogen-bonding with the external CD hydroxyl groups.
Those three compounds which showed the largest enantio-resolutions from their 
respective analyte groups i.e. the phenethylamine salbutamol and the propranolol 
analogues, compounds 2 and 5, all possessed a J-butyl group on their alkyl chains. 
These alkyl chains were identical except that compounds 2 and 5 possessed an extra 
-0-CH2- link at the beginning. The f-butyl group would seem then to have been 
important in the successful chiral resolutions of both classes of compounds, which 
means that the alkyl chains of the analytes must be in relatively close contact with the 
CD molecules. The greatest structural difference in the three analytes lay in their 
aromatic moieties. The phenyl and naphthyl rings of compounds 5 and 2 respectively 
allowed for greater chiral separation than the 3,4-substituted ring of salbutamol, 
which appears to have reduced the ability of salbutamol to stereospecifically interact 
with the p-CD molecules.
6.1.3. CDs as Mobile Phase Additives - Reversed Phase Mode.
It has previously been established that chiral resolution in this mode may occur as a 
result of the differences in the adsorption of analyte-CD complexes on the stationary 
phase and /or differences in the Kf values of the complexes themselves (Sybilska et
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al. 1986 and Zukowski et al. 1988). Section 3.1.5. details the equilibria involved in 
CD modified HPLC systems. This approach is more flexible than the two previously 
mentioned HPLC methods in that different mobile phases containing various CDs can 
be quickly prepared and equilibrated on different achiral stationary phases. One 
additional factor which may be varied here is the actual concentration of the CD 
additive although this is clearly limited by its solubility in the mobile phase. Also the 
achiral stationary phase itself can readily be changed.
Despite the potential to alter more variables in the chromatographic process this was 
the least successful of the HPLC methods to be tested. None of the phenethylamines 
could be chirally separated despite being examined in the presence of over seven 
different CD types dissolved in the mobile phase (see section 3.2.3.). There are no 
reports in the literature concerning the successful chiral resolution of any of the 
phenethylamines examined in this work when using CDs as mobile phase additives 
without prior derivatisation of the analytes. Mularz et al. 1988 were however able to 
resolve the enantiomers of pseudoephedrine, which is the diastereoisomer of 
ephedrine. They proposed, via chromatographic and NMR analysis, that the inability 
of p-CD as an additive to resolve the enantiomers of ephedrine was caused by the 
arrangement of the analytes amine and hydroxyl functions in relation to the hydroxyl 
groups of the CD.
Many of the phenethylamines examined here showed changes in their k' values in the 
presence of the different CDs, indicating that they may have formed inclusion 
complexes. The absence of any observed enantio-specific resolution in these HPLC 
experiments would suggest that none of the phenethylamines formed stereospecific 
inclusion complexes with any of the tested CDs. However further analysis using 
FSCE and NMR (see sections 4.2.1. and 5.2.2. respectively) has shown that many 
of these analytes may be chirally resolved with several of those CDs unsuccessfully 
employed as mobile phase additives. One possible reason for the absence of 
observable enantio-resolution when using this form of HPLC is the generally low 
chromatographic efficiency of the system. Resolution is strongly influenced by the
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number of theoretical plates and the addition of CDs to a mobile phase has been 
shown to lower column efficiency by as much as 30% (Sybilska et al. 1992). The 
measured efficiencies in these experiments were between 8 , 0 0 0  and 1 2 , 0 0 0  theoretical 
plates, which is not very high for a reversed phase column. If the CDs were 
responsible for lowering the column efficiency this would also reduce the potential 
to observe chiral resolution and may explain the absence of such a phenomenon in 
these experiments. FSCE showed that chiral resolution could be obtained with p-CD, 
one of those CDs tested as a mobile phase additive in the HPLC experiments, which 
then provided no resolution. The very high column efficiencies present in FSCE, 
averaging >  2 0 0 , 0 0 0  plates in this work, may have been the key element in 
determining that enantio-resolution was actually occurring.
The only analyte from amongst the six propranolol analogues to be chirally resolved 
was compound 2 (R' =  naphthyl, R = r-butyl) using HE-p-CD as the chiral additive 
to give a CRF value of 30%. Despite changes to the chromatographic conditions e.g. 
pH, organic modifier, CD concentration, no other instances of chiral resolution were 
recorded. All of the CDs tested in section 3.2.3. reduced the k' values of the 
propranolol analogues when compared to the k' values of the uncomplexed analytes, 
except for a-CD which produced little change. As in the case of the phenethylamines, 
this suggests that the propranolol analogues were complexing with the CDs, though 
not stereo-specifically. However, enantio-resolution in FSCE (sections 4.3.1. to
4.3.4.) and signal splitting in NMR studies (sections 5.3.1. and 5.3.3.) have 
established that chiral complexation can occur with several of the CDs unsuccessfully 
tested in this HPLC mode.
Mularz 1988 has reported the separation of the enantiomers of propranolol (a = 
1.04) using p-CD as a mobile phase additive in conjunction with a reversed phase 
column. However no separation of propranolol could be achieved here under similar 
chromatographic conditions. Besides the obvious importance of the CD type, the 
nature of the stationary phase can also be influential for chiral resolution. Takeuchi 
and Nagae 1992, employing y-CD as a mobile phase additive, have shown that the
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nature of the stationary phase may affect the ability of the system to provide chiral 
separation. Walhagen and Edholm 1991 have also demonstrated how different 
commercially available stationary phases with ostensibly equivalent packings i.e. 
C18, could dramatically effect the chiral resolution of terbutaline enantiomers using 
p-CD as a mobile phase additive. These findings may help to account for the inability 
to achieve analyte chiral resolution using P-CD in this work, where a C8  Inertsil 
column was employed in comparison to a C l 8  column used by Mularz 1988. Guest 
enantiomers may interact with the chiral selector via a two point interaction and then 
contact simultaneously a solid surface, the stationary phase, so that the transient 
diastereomeric complexes are retained to different extents, which will then lead to 
their chiral resolution (Davankov and Kurganov 1983). Stationary phases with 
different extents of surface coverage and / or different carbon chain lengths are likely 
to show different selectivities which would help account here for the observed lack 
of chiral resolution of propranolol. The reduction in column efficiency noted when 
using CDs as mobile phase additives may also have been a contributing factor 
(Sybilska et al. 1992).
Mequitamium was the only analyte examined which was well resolved using this 
HPLC method. y-CD and HP-p-CD were able to resolve the enantiomers of 
mequitamium, giving Rs values of 1.06 and 0.3 respectively (section 3.4.3.). Because 
of the high retention of mequitamium on a conventional 250 x 4.6 mm reversed 
phase column, two pKb pre-columns (20 x 4.6 mm) were used as the stationary phase 
in order to lower k' values within practical limits. However, this system had a very 
low chromatographic efficiency, 2500 - 4500 plates, which reduced the Rs of the 
enantiomers despite their measured selectivity (a) value of 1.11. Higher resolution 
values were obtained in FSCE (section 4.4.1.) using y-CD (Rs =  1.82), HP-p-CD 
(Rs =  1.22) and also HP-y-CD (JR. = 0.86). The latter mentioned CD did not 
display any resolution of mequitamium’s enantiomers in this HPLC mode. The high 
efficiency of the FSCE systems with >  200,000 plates would clearly have helped in 
the achievement of these greater Rs values.
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One interesting feature of the changes in the k' values of mequitamium was that p-CD 
and HP-y-CD reduced them to a level below that caused by y-CD and HP-p-CD, 
perhaps indicating stronger inclusion complexation, but they did not produce enantio- 
resolution. As stated above however, HP-y-CD did then demonstrate chiral resolution 
of mequitamium in FSCE (section 4.4.1.) although p-CD still did not. Also, NMR 
studies (section 5.4.2. and 5.4.4.) showed that HP-y-CD induced stronger chemical 
shifts of mequitamium than p-CD, though neither CD caused signal splitting. 
Therefore although p-CD can form inclusion complexes with mequitamium there is 
no evidence for such complexes being stereo-specific unlike those formed with HP-y- 
CD.
It was also found that the nature of the organic modifier affected the resolution of 
mequitamium. MeOH removed observable chiral separation when used in place of 
MeCN at the same concentration. Li and Purdy 1992 found that different organic 
modifiers could generate different selectivities when using a bonded CD column. It 
is not unexpected then that a similar effect could occur when using CDs as mobile 
phase additives. According to Sherrod 1992, solvation can radically alter both the 
geometry and the relative stabilities of various conformations, which would help to 
explain the differences found in the abilites of the two organic modifiers to induce 
chiral resolution.
When the Kf values for each enantiomer were calculated in the presence of varying 
amounts of y-CD (see section 3.4.3.) there was little difference between the values 
(R Kf= 396 M '1, S Kf = 427 M*1). Therefore the calculated cd values of each 
enantiomer-CD complex (R k'a cd = 8.5, S k'a cd =  6 .8 ) seem to have had a stronger 
influence on their measured chiral resolution. Sybilska et al. 1986 have also shown 
how chiral resolution may arise solely as a result of differential adsorption of the 
diastereomeric complexes of mephenytoin on a C 18 column. The separation of the 
enantiomers of mequitamium appears to be another example of chiral resolution 
occurring by the same mechanism proposed by Sybilska et al. 1986.
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6.1.4. CDs as Mobile Phase Additives - PGC Column.
The unique surface of porous graphitic carbon (PGC) may be expected to provide 
different selectivities to that of standard reversed phase columns such as C18 and C8 . 
The 2 dimensional surface with no functional groups, provides an extremely uniform 
phase where analyte retention is strongly influenced by electronic donor-acceptor 
interactions with the delocalised electron conduction bands of the PGC. Planar 
molecules have been shown to be preferentially retained by virtue of the flat surface 
of the column and high levels of organic modifiers are often required to elute analytes 
(Tanaka et al. 1993).
Three phenethylamines, ephedrine, oxilofrine and orciprenaline were chirally 
resolved using 2.5 mM P-CD as a mobile phase additive on the PGC column, where 
the organic modifier was 30% v/v. Chiral resolutions were lower than those achieved 
using a p-CD bonded column (section 3.2.1.) but higher than those observed using 
p-CD as a mobile phase additive with a C8  column (section 3.2.3.). The chiral 
separation of these three analytes was greatly improved when peracetyl-p-CD was 
used in place of p-CD (see Table 6.1. on p. 190). Peracetyl-p-CD is insoluble in 
water and is also unable to hydrogen-bond donate from the 2, 3 or 6  positions, unlike 
any of the other CDs examined. Of the six propranolol analogues, compounds 4 and 
5 (R' =  phenyl) were uniquely resolved in under two minutes using peracetyl-p-CD. 
None of the other analogues, which all have R' =  naphthyl, were separated. This 
may indicate that these larger analytes were hindered from interacting with the CD, 
perhaps by steric crowding as a result of the acetyl chains on the rim of peracetyl-p- 
CD preventing close interaction between the bulky analytes and the CD interior. Or, 
as postulated below, electron rich groups on the analytes e.g. naphthyl rings, may be 
preferentially interacting with the PGC surface. These previously unreported results 
demonstrate that correct selection of the stationary phase can be advantageous in 
chiral separations with CDs.
Mequitamium did not resolve in the presence of any of the CDs examined (section
198
3.4.4.). It displayed very high k' values probably as a result of its electron rich 
tricyclic system interacting with the delocalised electron conduction bands of PGC 
(Bell et al. 1994). The high levels of organic modifier required (<  60%) to give 
practical elution times are likely to have reduced the ability of the analyte to interact 
with any of the CDs, which would help to account for the absence of chiral 
resolution.
Of all the HPLC methods examined, chiral resolution was greatest in the polar 
organic mode (6.1.2.), especially with the propranolol analogues. A unique size 
dependent, steric repulsive effect was proposed to explain the observed %CRF and 
k7 values. Resolution was generally very poor using CDs as mobile phase additives, 
either with standard reversed phase columns (section 6.1.1.) or a PGC column 
(6.1.4.). The low chromatographic efficiency of these methods was suggested as a 
major factor in their inability to show significant chiral resolution. A bonded CD 
column operated in the reversed phase mode (6 .1 .1 .) proved able to resolve over half 
the analytes examined. However, immobilisation of P- and y-CD onto a solid 
chromatographic support was found to engender different selectivities of the CDs 
towards the analytes when compared to the CDs as mobile phase additives.
6.2. Comparison of FSCE and HPLC Results.
One of the first comparative reports of HPLC and FSCE for chiral resolution was by 
Gassman et al. 1985 although they did not employ CDs as the chiral selector. They 
attempted to resolve the enantiomers of a number of dansyl amino acids using a FSCE 
buffer containing Cu (II) ions and L-histidine i.e. via a chiral ligand exchange 
mechanism. However the separation values obtained were not as good as those found 
using HPLC. In a non-chiral application, Terabe et al. 1988 observed that FSCE 
provided better separation of oxygen isotopic benzoic acids than HPLC, even though 
the number of theoretical plates was approximately 30,000 which is low for FSCE. 
There are few reports comparing the abilities of HPLC and FSCE to provide chiral
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separations using CDs. Szeman and Ganzler 1994 used coated p- and y-CD columns 
in FSCE for the separation of several compounds including hexobarbital and 
ephedrine. In the same work they used carboxymethyl- and carboxyethyl-P-CD as 
mobile phase additives in HPLC to again study the same compounds. However, 
because they did not employ the same chiral selectors in each analytical method a 
direct comparison of their results is impossible. In a comprehensive review of 
capillary electrophoresis, HPLC and GC, Issaq 1994 concluded that capillary 
electrophoresis provided higher efficiencies and better chiral separations for a large 
selection of chiral analytes than either of the other two methods.
Sections 3.1.1. - 3.1.6., 4.1.1. and 4.1.7. give details of the under-lying theories 
involved in the analysis of chiral analytes when CDs are utilised in various HPLC and 
FSCE methodologies. The following sections compare and contrast the chiral 
separations obtained with the analytes employed in this work when they were 
examined in the presence of different CDs using FSCE and HPLC.
6.2.1. Phenethvlamine Analogues - Comparison of HPLC and FSCE Results.
Chiral resolution values were measured using %CRF (see equation 2.05) in the 
HPLC studies as enantiomer separations were generally not very high. In FSCE the 
parameter for measuring chiral separation was Rg (see equation 2.04), which is more 
usefully employed when peak separations are relatively large. A %CRF of 100% 
equals a Rg value of 1.5. Rg values higher than 1.5 cannot be measured using %CRF 
and consequently such peak separations are reported using the Rs function.
The highest chiral separations recorded for all of the phenethylamines were achieved 
using FSCE with Ac-p-CD as the chiral selector dissolved in the running buffer (see 
Table 6.2., p.200). Unfortunately it was not possible to use Ac-p-CD in HPLC as 
this CD derivative was especially prepared in the Pharmazeutisches Institut, Bonn and 
there was insufficient CD to prepared a mobile phase for HPLC work. Typically
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around 500 ml of mobile phase was required to flush the HPLC system and to 
equilibrate the column. In the FSCE studies only 1 - 5 ml of CD containing buffer 
was required. This in itself is a major advantage of FSCE over HPLC: the ability to 
employ small amounts of chiral selectors which may be in short supply and yet still 
achieve chiral resolution.
p-CD was variously employed in HPLC and FSCE (see Table 6.2.). This CD 
resolved the enantiomers of oxilofrine and orciprenaline in both techniques, separated 
ephedrine and salbutamol enantiomers in HPLC only and resolved etileffine by FSCE 
only. Only noradrenaline and isoprenaline were not separated by either FSCE or 
HPLC methods. The highest chiral resolution values of oxilofrine and orciprenaline 
were found using FSCE rather than HPLC (FSCE Rs of 1.16 compared to HPLC
67%CRF “  1.01 Rg for oxilofrine and FSCE R s of 0.89 compared to HPLC
39%CRF “ 0.59 Rg). Both these HPLC separations occurred using a bonded p-CD
column. When p-CD was dissolved in an HPLC mobile phase in a similar approach 
to FSCE, chiral resolution was either non-existant or very low (Table 6.2.). If chiral 
resolution could be achieved using p-CD as a buffer additive in FSCE but not in 
HPLC, either the much lower efficiency of the HPLC column was responsible viz. 
chiral interaction was occurring but the efficiency of the system was too low to 
observe optical resolution, or stereo-specific interaction between the analytes and the 
p-CD molecules was in some way adversely affected by the stationary phase of the 
HPLC column. However, as the interaction of the phenethylamines on a C8  column 
in the absence of any CD was low (k7 values were <  6 ) and the adsorption of p-CD 
onto reversed phase columns is also believed to be low (Zukowski et al. 1988), the 
influence of the stationary phase in this case may not have been strong. A more 
plausible reason then for the lack of chiral resolution is the low efficiency of the 
HPLC system (8000 -12000 theoretical plates), which is exacerbated in the presence 
of CDs as stated in section 6.1.3.
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Table 6.2. Comparison of phenethylamine resolution in HPLC and FSCE.
Analyte
%CRF bv HPLC® 
RP-Bonded PGC PGC 
p-CD P-CD PerAc-P-CD
Rg in FSCE 
with P-CD
Rs in FSCE 
with Ac-P-CD
ephedrine 36 <5 45 0 1.25
oxedrine 0 0 0 0 1.62
oxilofrine 67 35 35 1.16 1.74
norfenefrine 0 0 0 0 1.31
etilefrine 0 0 0 0.47 4.28
orciprenaline 39 20 78 0.89 1.32
noradrenaline 0 0 0 0 0
isoprenaline 0 0 0 0 0
salbutamol 32b 0 0 0 0.85
100% CRF equals Rs value of 1.5. a No chiral resolution was obtained using CDs as mobile phase 
additives in the reversed phase HPLC mode. b %CRF obtained in polar organic mode.
The unique separation of salbutamol enantiomers in the polar organic mode shows 
that the flexibilty of HPLC methodology can still provide an advantage over FSCE, 
where there are currently few reports of CDs bound to a column. Mayer and Schurig 
1992, Armstrong et al. 1993 and Cruzado and Vigh 1992 have all used derivatised 
CDs bound to fused silica capillaries for separations in capillary electrophoresis but 
these phases are not readily available and several of them suffer from low stabilities 
and efficiencies.
Peracetyl-p-CD provided better chiral separation for ephedrine and orciprenaline 
enantiomers, in conjunction with a PGC column, than did any other method except 
FSCE with Ac-p-CD. Furthermore, it also resolved the enantiomers of oxilofrine 
(%CRF = 35%). It was not possible to employ this water insoluble CD derivative 
in FSCE buffers because the high levels of organic modifier necessary for its 
dissolution (>  35%) prevented the generation of a stable current. Again, this 
demonstrates some of the limiting factors in FSCE which do not apply in HPLC.
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6.2,2. Propranolol Analogues - Comparison of HPLC and FSCE Results.
In HPLC experiments the propranolol analogues were best separated using a bonded 
p-CD column operated in the polar organic mode while in FSCE experiments HE-p- 
CD provided the highest Rg. Table 6.3. on page 204 shows the chiral resolution 
values obtained for the propranolol analogues using both analytical techniques.
Overall chiral resolution values for compounds 1-3 and compound 5 were highest 
when using FSCE, whilst the polar organic mode of HPLC provided the largest chiral 
separation for compound 4 (see Table 6.3.). Compound 6  was not resolved in HPLC 
and the weakly basic nature of its urea linkage prevented its examination by FSCE 
as the analyte could not be readily protonated, which resulted in impractical migration 
times, usually greater than one and a half hours.
It is of interest to note that HE-p-CD provided the highest enantio-resolution values 
for all the propranolol analogues in FSCE and that it was also the only CD to display 
any chiral separation, for compound 2 , when used as a mobile phase additive in 
HPLC. Furthermore, compound 2 had the largest Rg value of all the propranolol 
analogues in FSCE. There were also very strong reductions for all the analyte’s k' 
values upon the addition of HE-p-CD to the mobile phase in HPLC (see Fig. 3.16. 
in section 3.3.3.), indicating that analyte-CD complexation, whether stereospecific 
or not, was certainly occurring. Therefore it may have been possible that chiral 
interaction between HE-p-CD and the other analogues did happen in HPLC. 
However, the efficiency of the HPLC system (10,000 -12,000 theoretical plates) may 
have permitted only the strongest analyte:HE-p-CD interaction, that involving 
compound 2, to become apparent as a chromatographic chiral resolution. P-CD and 
Me-p-CD were also more successfully employed as additives in FSCE than HPLC. 
This may again reflect on the low efficiency of the HPLC set-up as both CDs were 
also found to lower the k' value of compounds 1-5 upon their addition to the mobile 
phase indicating that complexation occurred.
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Table 6.3. Comparison of enantio-resolution values for propranolol analogues in 
HPLC and FSCE.
% CRF bv HPLC8 TL in FSCE










Propranolol (1) 9 0 62 (0.83) 1.05 0.26 0.83 0.54
Compound 2 43 0 89(1.34) 1.31 0.81 1.67 0.73
Compound 3 0 0 17 (0.26) 0.28 0 0.77 0.32
Compound 4 7 42 78(1.17) <0.1 0 1.03 0.68
Compound 5 32 47 93 (1.40) 0.63 0 1.54 1.54
Compound 6 0 0 0 - - - -
a Only compound 2 was resolved (30% CRF) with HE-p-CD as mobile phase additive in reversed phase 
HPLC. b Comparative Rs values are given in parenthesis.
The ability of P-CD when employed in the polar organic mode to enable greatly 
improve analyte enantio-resolution values compared to those of the other HPLC 
techniques (see Table 6.3.) supports other evidence (section 6.1.2.) that this analyte- 
CD interaction mechanism is somewhat different to that present in the other HPLC 
and FSCE conditions.
Analyte migration times in FSCE were similar in length to chromatographic retention 
times except in the case of compounds 4 and 5. When these two analytes, with R' = 
phenyl, were examined with peracetyl-p-CD on a PGC column, k' values were < 1 .1  
corresponding to analysis times of under one minute. As explained in section 6.1.4. 
the steric bulk and electronic nature of the analytes seems important in interactions 
with this CD on the PGC stationary phase. It is also possible that adsorption of the 
hydrophobic peracetyl-p-CD onto the PGC surface may have generated a ‘dynamic 
chiral stationary phase’ as postulated in section 3.4.4. Zukowski and Nowakowski 
1989 and Zukowski et al. 1988 have reported the generation of such phases although 




of compounds 4 and 5, coupled with their chiral resolution, would be readily 
explained by the adsorption of peracetyl-p-CD onto the PGC surface allowing chiral 
interaction with the analytes while hastening their elution from the column by 
reducing their direct interaction with the PGC column.
6.2.3. Mequitamium - Comparison of HPLC and FSCE Results.
Table 6.4. on page 205 shows the enantio-resolution values achieved for 
mequitamium in HPLC and FSCE. Of the ten different CDs variously examined (see 
sections 3.4. and 4.4.) only three provided chiral resolution and one of those, HP-y- 
CD was effective only as a mobile phase additive in FSCE and not in HPLC.
Both the HPLC mobile phase and the FSCE running buffer were similar in make-up 
(aqueous solutions containing CDs and approximately 9 - 10 % MeCN) so they would 
not have been expected to play a major role in the chiral resolution differences 
observed with each technique and recorded in Table 6.4.
Table 6.4. Summary of maximum enantio-resolution values of mequitamium in
HPLC and FSCE.
Analyte
R„ bv HPLC 
mobile phase additive 
Y-CD HP-y-CD HP-p-CD y-CD
Rs in FSCE 
HP-y-CD HP-p-CD
Mequitamium 1.06 0 0.3 1.82 0.86 1.22
a No chiral resolution was obtained using any of the other HPLC methodologies.
It was noted in HPLC and FSCE that the nature of the buffer was crucial for chiral 
resolution of the mequitamium enantiomers. A KH2 PO4  buffer prevented chiral 
recognition when used in place of N a^citrate, ceteris paribus. Increasing the buffer 
concentration from 50 to 75 or 100 mM lowered resolution of the mequitamium 
enantiomers while increasing migration times. Increased buffer levels reduce EOF
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(Weinberger 1991) and are known to compete with analytes for the CD cavity 
(Technicol 1992).
Furthermore, when MeOH was substituted for MeCN, HPLC analysis times more 
than doubled and enantio-resolution was removed. As the percentage of MeCN was 
varied in FSCE the separation of the mequitamium enantiomers reached a maximum 
at 9.5 % MeCN. Migration times also increased with rising MeCN concentration, up 
to a maximum of over 16 minutes, also at 9.5% MeCN (see Table 4.9., p. 127). Such 
enantio-selectivity differences in the presence of various buffer additives have been 
noted previously in HPLC. They are believed to occur as a result of competitive 
interaction between the analyte and the additive for the CD cavity (Technicol 1992) 
and/or the ability of organic modifiers to alter the geometry and relative stabilities of 
complexing species in solution (Sherrod 1992). Wren and Rowe 1992 have suggested 
that this effect may also occur in FSCE, with induced changes in chiral resolution of 
the analyte also being dependent upon the CD concentration. Resolution values will 
approach a maximum as the CD concentration is raised and then begin to fall above 
this optimum level. The results found in section 4.4. agree with these proposals and 
demonstrate that it is necessary to adjust a large number of analytical variables before 
definitive conclusions concerning the presence or absence of chiral resolution can be 
made.
Chiral resolution values of mequitamium were significantly higher in FSCE than in 
HPLC. As stated in section 6.1.3. this discrepancy between HPLC and FSCE analyte 
separation ability may be related to the HPLC system having only 2500 - 4500 
theoretical plates, whilst the FSCE column routinely produced values >  200,000.
The Kf values for the enantiomers of mequitamium were measured in HPLC and 
FSCE by varying the concentration of y-CD in solution. HPLC experiments gave Kf 
R =  396, Kf S =  427 M ' 1 and FSCE experiments gave Kf R = 316 and Kf S =  355 
M" 1 (see sections 3.4.3. and 4.4.4. respectively for further details). The results from 
the two different analytical methods are in close agreement and show that the S
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enantiomer forms a stronger complex with y-CD than does its R antipode. Separate 
injections of the enantiomers in FSCE (section 4.4.1.) showed that the R enantiomer 
had a faster migration time than the S isomer i.e. its interaction with y-CD was lower 
and consequently it migrated fastest. Injections of the enantiomers in HPLC showed 
that the R enantiomer had a larger k' value than the S isomer, which indicates that the 
R enantiomer was more strongly retained by the chromatographic system and so 
formed a weaker complex with y-CD. These results are in accordance with the 
relative strength of Kf values calculated above. The optimum concentration of y-CD 
for chiral resolution of mequitamium in FSCE was determined to be 5.0 mM (section
4.4.3.) while in HPLC (section 3.4.3.) 12 mM was found to be optimal.
Plots of k ^  versus (k'g - k'obs)/(CD) in section 3.4.3. showed a linear relationship, 
which according to Allenmark 1991, is indicative of 1:1 host-guest complex 
stoichiometry. Subsequent NMR Job experiments and Foster-Fyfe plots (see section 
5.4.6.) also showed that a 1:1 complex was formed with a racemic Kf of 333 M '1. 
^s.cd- values of the R and S enantiomers in section 3.4.3. suggested that resolution 
of the antipodes in HPLC was influenced by significant retention of analyte:y-CD 
complexes on the stationary phase surface. FSCE experiments did not involve such 
interaction with a stationary phase. Therefore the higher enantio-resolution values 
generated with FSCE seem to arise as a consequence of the very high efficiency of 
the system allowing separation based solely on relatively small differences in the 
enantiomeric Kf values which produce differences in migration times of the resulting 
diastereoisomeric complexes. Chiral resolution values of mequitamium were 
significantly higher with all three CD types in FSCE than in HPLC and only 5.0 mM 
of y-CD was required to produce the highest chiral resolution value in FSCE whereas 
HPLC required a y-CD concentration of 12 mM. As stated in section 6.1.3. the 
discrepancy between HPLC and FSCE analyte separation abilities and the need for 
lower concentrations of y-CD in FSCE may be related to the HPLC system having 
only 2500 - 4500 theoretical plates, whilst the FSCE column routinely produced 
values >  200,000. All these results concerning the interaction between y-CD and 
mequitamium are in good agreement with one another and provide a strong insight
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into the strength and nature of the inclusion complex formed by the two interacting 
species.
In summary, FSCE generally proved to be a better analytical technique for generating 
enantio-resolution values for the various analytes than did HPLC. All of the 
phenethylamines, four of the five examined propranolol analogues and the 
enantiomers of mequitamium were best separated using FSCE. This was linked to the 
much higher number of theoretical plates in FSCE enabling higher enantio-resolution 
values. The CDs responsible for the maximum observed chiral resolution values in 
each analytical technique were seen to vary for the phenethylamines and the 
propranolol analogues. For mequitamium, y-CD provided the highest chiral 
resolution in both HPLC and FSCE. However, the four different modes of HPLC 
examined in this work allowed a more flexible approach to the problem of chiral 
separations e.g. peracetyl-p-CD proved impractical to utilise in FSCE but in HPLC 
experiments with a PGC surface, novel chiral resolutions for two propranolol 
analogues were achieved within very short analysis times. In practical terms, CDs in 
short supply can be more efficiently employed in FSCE which requires much small 
amounts of buffer and hence buffer additives than HPLC.
The influence of CD concentration, pH, buffer and solvent additives in HPLC and 
FSCE was also examined. Small changes in these parameters were shown to be 
capable of strongly influencing the measured enantio-resolution values.
6.3. Comparison of NMR. FSCE and HPLC.
Analyte-CD interactions in FSCE experimental conditions may be more comparable 
with NMR experimental data than HPLC, as the host and guest molecules in both 
FSCE and NMR interact with each other purely in solution without the involvement 
of a solid surface, as in HPLC. The nature of the HPLC stationary phase, whether 
chiral or even achiral (Walhagen and Edholm 1991), can play an important role in
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chiral separations. Therefore to investigate analyte-CD interactions it could be more 
prudent to compare FSCE and NMR results.
Sections 5.1.2. - 5.1.6. include many references of how NMR chemical shifts of host 
and guest molecules, often related to other analytical data e.g. HPLC, GC and FSCE, 
may be employed to more fully understand the complexation process involving CDs 
in aqueous media. In the following sections Kf values of the analytes, determined by 
NMR, HPLC or FSCE, are used to estimate the relative strengths of complexation 
between the analytes and various CDs. Along with NMR measured chemical shifts 
and stoichiometry ratios, HPLC k' values and FSCE migration times, it is hoped to 
show whether meaningfull comparisons can be drawn between the analytical data 
generated in each technique. Molecular modelling results of p- and Ac-p-CD, given 
in section 5.2.4., are also alluded to with the purpose of providing further insights 
into the CD inclusion complexation process.
6.3.1. Phenethylamines - a Comparison of FSCE. HPLC and NMR.
p- and Ac-p-CD were shown to cause enantio-resolution of all phenethylamines, 
except noradrenaline and isoprenaline, when using FSCE and/or HPLC (see sections
4.2. and 3.2 respectively). Peracetyl-p-CD also resolved the enantiomers of 
ephedrine, oxilofrine and orciprenaline in conjunction with a PGC column. However, 
complementry NMR experiments using peracetyl-p-CD were not successful. CDCI3  
was required for the dissolution of this hydrophobic CD derivative and the resulting 
chemical shifts of the analytes were all very low, £ 0 . 0 0 2  ppm, probably due to the 
highly non-polar environment preventing significant analyte-CD interaction. It was 
not possible then to use NMR to probe the analyte-CD interaction in this instance.
Other CDs examined e.g. a- and y-CD, did not induce significant chemical shift 
changes of the analytes nor did they show evidence of analyte inclusion themselves 
by virtue of insignificant chemical shifts of their inner H3" and H5" protons. Neither
209
a-, HP-a- nor y-CD markedly altered the migration times of the analytes in FSCE 
or HPLC experiments. In conjunction with the NMR data this indicates that these 
CDs interact weakly, if at all, with the phenethylamine analogues. The small size of 
the a-CD cavity, 5.7 A and the much larger size of the y-CD cavity, 9.5 A (see Table 
1.2 ., p. 1 0 ), would not be sterically favourable for a ‘tight-fit* of the analytes, 
precluding their ability to elicit a stereo-specific inclusion interaction.
Only p- and Ac-p-CD, which had provided analyte chiral resolution in FSCE, were 
found to show significant analyte chemical shifts in the NMR experiments. p-CD 
caused a larger shift in the aromatic region of the analytes than Ac-P-CD, but Ac-P- 
CD was the only CD to produce analyte signal splitting for all the phenethylamines, 
except noradrenaline and salbutamol. The inner H3" and H5" protons of p-CD 
experienced strong upfield shifts (shielded) from all the phenethylamines, while the 
equivalent protons in Ac-p-CD showed weaker shielding. These results suggest that 
the strength of analyte inclusion is greatest in the presence of P-CD but that Ac-p-CD 
was the better chiral discriminating agent of the two CDs. In FSCE the highest Rs 
were obtained with Ac-p-CD but the migration times of the analytes were always 
faster than with p-CD i.e. analyte complexation was weaker with Ac-p-CD than p- 
CD (by virtue of the faster migration times with Ac-p-CD) but the chiral resolution 
values were greater. Therefore, the strength of binding and chiral discrimination of 
each CD towards the phenethylamines, based on relative CD chemical shift strengths 
and analyte signal splittings in NMR, may be related to the chiral resolution values 
and relative migration time results of the FSCE experiments.
Resolution in FSCE depends on the free analyte having a different apparent 
electrophoretic mobility than its complexed form and on the formation constants, Kf, 
for each enantiomer-CD complex being different (Wren and Rowe 1992). In NMR 
signal splitting may arise as a result of differences in Kf values and / or intrinsic 
chemical shift differences of the complexes (Uekama et al. 1985 and Cooper et al. 
1991). If, as above, certain analytes such as ephedrine are chirally resolved in FSCE 
(indicating differences in Kf values), but no signal splitting is observed in NMR
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under the same conditions, it appears that the absence of enantiomeric separation in 
NMR is due mainly to the lack of intrinsic magnetic inequivalence differences in each 
enantiomer-CD complex.
Attempts were made to measure the Kf values of etilefrine with P- and Ac-P-CD 
(section 4.2.4., p. 104) by FSCE. Although the actual Kf values could not be 
measured with Ac-p-CD due to its low solubility, it was found that etilefrine formed 
a weaker complex with Ac-P-CD than P-CD. This result also agrees that the NMR 
evidence that the proposed strength of analyte interaction is greatest with p-CD. 
NMR data for the measurement of Kf values proved inconclusive. Foster-Fyfe plots 
of etilefrine with p- and Ac-P-CD were not linear, (section 5.2.4.) so it proved 
impossible to obtain a Kf value. The reason for this is unclear. However it has been 
shown here that stronger analyte binding to a given CD does not guarantee greater 
chiral discrimination. The stoichiometry of the etilefrine:p- and Ac-p-CD complexes 
was measured and both were found to be 1:1 (see Fig. 5.6., p. 155). It is presumed 
that the other phenethylamines form complexes of the same stoichiometry as they all 
possess only one aromatic ring, the main site of inclusion.
Compounds with R2  =  methyl i.e. ephedrine and oxilofrine, showed a large shift of 
their HI resonances with p- and Ac-P-CD, but the chiral centre of each analyte, the 
HI proton signal, was split only by Ac-p-CD. Differences in hydrogen bonding 
interactions between each CD and the guest side chains or conformational 
rearrangement of the guest side-chains were thought likely to have been influential 
in the observed differences in analyte side-chain signal splitting and chemical shifts. 
The positioning of the 2 and 3 acetyl groups of Ac-p-CD would allow them to act as 
hydrogen bond acceptors with analyte NH or OH groups in a manner which would 
not be possible for the underivatised hydroxyl groups of p-CD.
However relative to H3" / H5", the CD H6 " signals were more strongly shifted in 
AC-p-CD than p-CD indicating that the CH2  protons at the primary end of the Ac-p- 
CD torus were significantly involved in the analyte-CD interaction mechanism.
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Molecular modelling (section 5.2.4.) showed that the secondary end of Ac-p-CD had 
an increased width compared to that of P-CD. Such conformational changes were 
thought to occur only with per-derivatised CDs (Harata et al. 1984 and Ventura et al. 
1994). The increased width of the Ac-p-CD cavity could have allowed the analytes 
a deeper insertion, which in turn may have altered the chemical shift of the H6 " 
protons located towards the primary end of the CD. Rekharsky et al. 1994 stated that 
deeper penetration of guest molecules may account for observed changes in CD H6 " 
signals. Furthermore, Dodziuk et al. 1994 found that high Kf values of 1,2,3 tri-t- 
butylnaphthalene with y-CD were accompanied by a shallow insertion of the guest 
into the CD cavity. In this case, it appears that lower Kf values of the 
phenethylamines with Ac-p-CD occur with a deeper insertion into the CD cavity. The 
strength of analyte-CD binding cannot then be solely linked to the depth of analyte 
insertion within the CD cavity.
HPLC studies showed that only three of the phenethylamines could be chirally 
resolved using either a p-CD containing mobile phase with a PGC column or a 
bonded p-CD column (see Table 6.1). In NMR, all the analytes showed chemical 
shift changes of their aromatic and side-chain protons in the presence of p-CD and 
five of them gave signal splitting. Brown et al. 1993 noted that thermodynamic 
differences that may allow chiral detection were not always large enough to produce 
enantiomeric resolution in NMR. Cooper 1991 found no clear correlation in chiral 
resolution between NMR and HPLC (which relies on thermodynamic differences for 
separation) with a series of pharmaceutical compounds when examined with p-CD. 
Therefore sufficient thermodynamic differences that may allow detection of chiral 
complexation by NMR spectroscopy, where the energy differences involved in 
distinction are small, may not necessarily be sufficient to induce chromatographic 
separation of the complexes. This would help explain the poor NMR/HPLC 
correlation found here with p-CD and the phenethylamines. Isoprenaline was the only 
phenethylamine to show NMR signal splitting in the presence of Ac-p-CD which was 
not subsequently resolved by FSCE experiments with Ac-p-CD. There was clearly 
a closer correlation between NMR signal splitting and chiral resolution ability in
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FSCE than with HPLC. FSCE appears to have been better suited than HPLC to 
enable small thermodynamic differences in analyte-CD interactions to be translated 
into observable chiral resolutions, probably due in part to the much greater separation 
efficiencies of FSCE noted throughout this work.
6.3.2. Propranolol Analogues - Comparison of FSCE. HPLC and NMR.
These compounds were generally well resolved by HPLC and FSCE (sections 3.3. 
and 4.3. respectively) using p-CD, He-p-CD, Me-p-CD and to a lesser extent Ac-p- 
CD and peracetyl-p-CD. Under similar conditions to those present in the FSCE 
studies, NMR experiments utilised these CDs which had proven capable of resolving 
the propranolol analogues. Although compound 6  was not resolved by HPLC and 
proved impractical to examine by FSCE, it was still studied in the presence of the 
various CDs using NMR spectroscopy.
Peracetyl-p-CD did not show any marked analyte chemical shifts in the NMR 
experiments even though it had resolved the enantiomers of compounds 4 and 5 by 
HPLC. Once again however, it was necessary to use the highly non-polar solvent 
CDCI3  to allow dissolution of a sufficient amount of peracetyl-P-CD to examine by 
NMR. As stated before, the resulting non-polar environment was likely to have been 
the cause of the very small chemical shifts then observed.
In the presence of P-CD all the propranolol analogues showed downfield shifts of 
their aromatic protons indicative of inclusion with the CD, which agrees in part with 
the findings of Greatbanks and Pickford 1987 who examined propranolol with p-CD. 
The alkyl side-chains of the analytes were strongly deshielded and signal splitting was 
observed at the methylene group in the 3 position for compounds 1-3 and at the 
terminal R group for compounds 3 and 6  (see Table 5.7. on p. 158). In FSCE 
experiments, upon which the NMR solvent conditions were based, enantio-resolution 
values were in the order compound 2 >  1, 5 >  4 and 1 >  4, 2 >  5 i.e. a r-butyl group
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in the R position promoted chiral resolution as did the presence of a naphthyl ring. 
It was also noted that on average the NMR chemical shifts of the naphthyl protons of 
compounds 1-3 were generally greater than those of the phenyl protons of compounds 
4 and 5, suggesting a stronger complexation. Related to this was the FSCE migration 
times of those compounds with a naphthyl group i.e. compounds 1-3, which were 
longer than those of compounds 4 and 5, with R' = phenyl. This again indicates that 
these analytes were interacting more strongly with P-CD. There is thus concurrancy 
between the size of analyte aromatic chemical shifts, the migration times of the 
analytes in FSCE and their resulting enantio-discrimination.
The H3" protons of p-CD were more strongly shielded than the H5” protons 
suggesting a more shallow insertion of all the analytes into the P-CD cavity. H I", 
H2" and H4" protons located outside the CD cavity were more strongly shifted than 
the H 6 " protons, indicating that analyte interaction is not significant at the narrow 
primary end of the torus.
A f-butyl R group promoted chiral resolution in both FSCE and HPLC (using a 
bonded p-CD column) with the resolution of compound 2 >  1 and 5 >  4. The presence 
of a naphthyl group on the analytes did likewise i.e. resolution of compound 1 >  4 and 
2 > 5 . Analyte migration times and HPLC k' values followed the same pattern in the 
presence of p-CD, whereby longer analysis times were directly related to the analytes 
having either a naphthyl ring or a f-butyl group i.e. compound 1 > 2 , 5 > 4  and 1 > 4 , 
2 > 5 . Therefore increases to the size and hydrophobicity of the analytes caused 
increased complexation with p-CD, directed towards the wider secondary end of p- 
CD, which in turn promoted chiral recognition.
Ac-P-CD produced some of the lowest analyte NMR chemical shifts of all the CDs 
examined. There was little difference between the chemical shift values obtained with 
each analyte and no signal splitting was recorded. The H5" protons of Ac-P-CD were 
less strongly shielded than the H3" protons with all the analytes, which suggests a 





nuclei, HI",  H2" and H4", generally displayed stronger shielding effects than the 
acetyl groups on the secondary rim of the CD. Low FSCE chiral resolution values 
of the propranolol analogues were also found with this CD. These analytes appear to 
be interacting with the periphery of Ac-p-CD in a poorly stereogenic manner, hence 
their related pattern of weak chemical shifts, absence of signal splitting and low 
FSCE chiral resolution.
The overall magnitude of the aromatic and alkyl chemical shifts of compounds 1-6 
were greatest in the presence of Me-p-CD. The chiral proton in position 2 on the 
alkyl side-chain was more strongly shifted for compounds 4 and 5 (R' = phenyl) than 
with the other analytes (R' =  naphthyl). Furthermore, it was found in FSCE 
experiments with Me-p-CD that compounds 4 and 5 tended to be chirally resolved to 
a greater extent than the other analogues. All the analyte signals in NMR were shifted 
upfield by Me-p-CD but no signal splitting was observed for any of the compounds.
The resolution in FSCE was adversely affected by the presence of a naphthyl group, 
with the enantiomeric separation of compound 4 > 1  and 5 > 2 .  These results are 
exactly opposite in trend to those observed with p-CD (see Table 4.6.), where a 
naphthyl group increased analyte resolution i.e. compound 1 > 4  and 2 > 5 .  A /-butyl 
R group was seen to enhance chiral resolution in the order compound 2 >  1 and 5 >  4, 
which is in agreement with the trend observed using p-CD. These results demonstrate 
clearly how derivatisation of the CD rim can lead to differences in chiral selectivity. 
The large and bulky naphthyl group of compounds 1, 2 and 3 seems to have been 
sterically less favourable for chiral discrimination with the derivatised Me-P-CD 
macrocycle, whereas a /-butyl R group was beneficial for separation. Strong chemical 
shifts of the R groups in NMR support the FSCE observation that these groups were 
influential in the chiral recognition process.
The Me-p-CD H3" signal was more strongly shifted than the H5" signal only by 
compounds 4 and 5 (see Table 5.14.), which suggests these compounds had a 
shallower insertion into the CD cavity than the other analogues. FSCE experiments
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had shown these two analogues to be well resolved by Me-p-CD within relatively 
quick analysis times when compared to the other analytes. A subsequent measurement 
of each analyte’s Kf value with Me-p-CD in FSCE (section 4.3.6.) showed they 
complexed in the order - compound 2 > 1 > 3 > 5 > 4 .  Weaker binding to the CD of 
compounds 4 and 5, coupled with their relatively more shallow inclusion into the CD, 
did not cause lower chiral resolution values in FSCE but infact produced an increase 
in enantio-resolution. The order of Kf values exactly matches the order of analyte 
hydrophobicity indicating that hydrophobicity is a major factor in complex formation 
but not necessarily of chiral resolution. As pointed out with the phenethylamines and 
Ac-p-CD in section 6.3.1., the strength of analyte-CD binding cannot be solely linked 
to the depth of analyte insertion within the CD cavity. Changes to the CD rim or 
cavity dimensions as a result of derivatisation of the hydroxyl groups, may also be 
important as demonstrated e.g. see section 5.2.4., where the width of the CD cavity 
was seen to vary from p- to Ac-p-CD.
No chiral resolution was found for any of the propranolol analogues in HPLC when 
using Me-p-CD as a mobile phase additive with either a C8  or PGC column. Strong 
decreases in k' value of all the analytes, except compound 6 , were noted in the 
presence of the CD. Analyte-CD complexation may have been occurring in solution 
or the formation of a ‘dynamic stationary phase’ on the column surface may have 
been responsible for the observed changes. Any comparison with the results of FSCE 
and NMR was therefore not meaningful.
All the analytes showed chemical shifts of their aromatic and alkyl protons in the 
presence of HE-p-CD. Compounds 2, 3, 5 and 6  showed clear signal splitting in 
either their side-chains positions 1, 3 or their R groups, which shows that this portion 
of each analyte was in close proximity to the CD chiral environment. The H3" and 
H5" protons of HE-p-CD were strongly shielded in the presence of compounds 1-6 
and the hydroxyethyl signals were more strongly shifted than the H6 ” protons at the 
primary end of the torus, indicating that analyte interaction was occurring at the 
wider secondary opening of the CD. The FSCE resolution values of the analytes were
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higher with this CD derivative than with any of the other examined CDs. The chiral 
separations were in the order - compound 4 >  1 (the trend same as with Me-P-CD but 
opposite to P-CD) and compound 2 >  5 (the opposite result to Me-p-CD but similar 
to p-CD). Kf values were higher with HE-p-CD than Me-P-CD indicating stronger 
complexation. The relative Kf values of the propranolol analogues in FSCE were 
found to be in the order - 2 > 1 > 3 > 5 > 4 ,  which is identical to that found with Me- 
P-CD. The migration times of compounds 1-5 were also longer upon the addition of 
HE-P-CD than any of the other CDs, which itself may suggest greater complexation 
between the analogues and this CD. As stated before however, changes in the nature 
of the groups on the CD cavity can result in selectivity differences between the CDs 
and the strength of analyte-CD complexation does not necessarily equate to greater 
chiral resolution.
HE-P-CD was the only CD derivative to resolve the enantiomers of one of the 
propranolol analogues by HPLC, namely compound 2, which also had the largest Kf 
value in the presence of HE-p-CD and the greatest chiral resolution value (Rs = 
1.67) in FSCE experiments. The low effeciency of the chromatographic system was 
probably the reason why this technique only provided chiral resolution for that 
analyte which had been proven to undergo the greatest chiral discriminating action 
with HE-P-CD.
6.3.3. Mequitamium - a Comparison of FSCE. HPLC and NMR.
From amongst the ten different CDs examined with mequitamium in NMR, the 
magnitude of analyte chemical shifts were noted to be in the order y-CD > HP-p- 
CD > HP-y-CD > p-CD > a-CD -  HP-a-CD. This was especially true in the case 
of the aromatic protons of the tricyclic group. These protons were most strongly 
shielded by y-CD indicating significant inclusion complexation. Three CDs were able 
to produce enantio-resolution of mequitamium in FSCE in the following order, y ->  
HP-p- >  HP-y-CD. Analyte migration times in FSCE with these three CDs were
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found to increase as follows y-CD < HP-y-CD < HP-p-CD. Therefore high 
enantio-discrimination in FSCE was not always accompanied by longer analyte 
migration times (suggesting greater analyte-CD interaction), although they did 
correlate better with chemical shift strengths in NMR, where the order was found to 
be y-CD >  HP-p-CD >  HP-y-CD.
The stoichiometry of the complexes formed by mequitamium with both y-CD and 
HP-P-CD (section 5.4.6.) were found to be 1:1 via NMR generated Foster-Fyfe plots 
and HPLC plots (section 3.4.3.) of k' 0^s vs (k^ - k7 obs)/(CD), measured in the case 
of y-CD only. Of the two mequitamium enantiomers, the R antipode was seen to have 
the fastest migration times in FSCE and the longest k' value in reversed phase HPLC, 
when examined in the presence of y-CD. Both results show that this enantiomer 
formed a weaker complex with the CD than did the S isomer. The magnitude of Kf 
values obtained with y-CD for each enantiomer in both FSCE and HPLC (see section
6.2.3.) were found to be in close agreement and proved that the R isomer was 
interacting more weakly with y-CD in each technique, accounting for the value of its 
migration times and k' values relative to those of the S enantiomer. The NMR 
measured Kf value of mequitamium with HP-p-CD was found to be much lower than 
that found with y-CD, although its FSCE migration time in the presence of HP-p-CD 
was longer. Similarly the HPLC k7 value of mequitamium with HP-p-CD (6.75, 7.44) 
was lower than that of y-CD (18.7, 20.7) but chiral resolution was lower (Rs = 0.3 
compared to Rg = 1.06 with y-CD). Therefore an inverse relationship between NMR 
measured Kf values and both FSCE and HPLC analysis times of mequitamium in the 
presence of HP-P-CD was observed. This is in direct contrast to the aforementioned 
relationship found with these techniques using y-CD.
If the enantiomers possessed sufficiently different Kf values to allow their resolution 
in FSCE and HPLC, it follows that the absence of enantiomeric signal splitting in 
NMR was probably caused by the absence of intrinsic differences in the magnetic 
environments of the enantiomer-CD complexes. This phenomenon was also observed 




In summary, certain trends were noted between the analytical techniques when 
examining the same chiral analytes. There was no continuous direct relationship 
between Kf values, FSCE migration times / chiral resolution values and NMR 
generated chemical shifts / signal splitting of the analytes.
With the phenethylamines, lower Kf values were associated with higher FSCE 
resolution, weaker analyte chemical shifts, and the absence of NMR signal splitting 
when comparing the results obtained with p- and Ac-p-CD. With the propranolol 
analogues no consistant pattern could be established between these parameters when 
examining a range of CDs. Increased FSCE chiral resolution and analyte migration 
times were not always complemented by greater NMR chemical shift strengths or 
signal splitting e.g. Me-p-CD produced lower FSCE resolutions than HE-P-CD but 
overall analyte chemical shift values were greater, Kf values were lower and 
migration times were faster. The results with HE-P-CD did show a good comparison, 
with increased chemical shifts and signal splitting accompanied by greater FSCE 
resolution and longer migration times. With Ac-p-CD chemical shifts were low, there 
was no signal splitting and chiral resolution was poor. When using p-CD increased 
analyte aromatic shifts were matched with longer migration times and higher enantio- 
resolutions in FSCE. The trend in results with mequitamium, like those of the other 
analytes, was found to depend on the CD in use. y-CD and HP-p-CD produced 
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